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Summary 
Leishmania parasites are the causative agent of the neglected tropical disease 
leishmaniasis. The sand fly vector-borne, disease-initiating Leishmania promastigote life 
stage (Lm) is comprised of viable and apoptotic parasites. Targeting of the latter by LC3-
associated phagocytosis (LAP) leads to a decreased activation of the adaptive immune 
system. Based on these findings, this study focuses on (1) the internalization of apoptotic 
Lm by human monocyte-derived pro- (hMDM1) and anti-inflammatory (hMDM2) 
macrophages, (2) evasion of viable Lm from degradation as well as (3) identification and (4) 
functional characterization of factors that lead to uptake of apoptotic Lm and LAP 
induction. For detailed analysis of the apoptotic Lm population we separated viable from 
apoptotic Lm. Phagocytosis assays by flow cytometry in which hMDMs were differentially 
infected with viable or apoptotic Lm showed that hMDMs ingested apoptotic Lm more 
rapidly than viable parasites. Investigations of supernatants from differentially infected 
hMDMs and hMDDCs by ELISA revealed not only a higher release of the anti-inflammatory 
cytokine IL-10 but also an increase in secretion of the pro-inflammatory cytokines IL-1β, 
IL-6 and IL-8 in presence of apoptotic Lm. Live cell microscopy showed that LAP can be 
triggered by viable and apoptotic Lm. Phagosomes harboring apoptotic parasites were 
targeted more frequently and more rapidly by eGFP-LC3 in hMDM2 as compared to 
phagosomes containing viable parasites. To identify factors that initiate apoptotic parasite 
internalization and LC3 recruitment, magnetic isolation of apoptotic Lm-containing 
phagosomes was performed. Subsequent mass spectrometry and data analysis revealed 
the phagocytic receptors low-density lipoprotein receptor-related protein 1 (CD91) and 
Complement Receptor 3 (CR3) to be highly abundant in phagosomes harboring apoptotic 
Lm. Blocking of CD91 with a monoclonal antibody was not efficient and knockdown of CD91 
with siRNA did not affect uptake of Lm, but the interaction still might be relevant and 
should be investigated in more detail. Inhibition of CR3 with a functional antibody 
significantly reduced uptake of apoptotic Lm by hMDMs. This receptor blocking in turn 
resulted in a decreased production of pro-inflammatory TNF-α by hMDM1 and a 
significantly diminished IL-10 secretion by hMDM2. Inhibition of CR3 strikingly reduced LC3 
lipidation as a measure for LAP induction in hMDM2 challenged with apoptotic or 
stationary phase Lm. Intriguingly, decreased internalization of apoptotic Lm neither 
resulted in a higher T cell proliferation nor in an increased survival of viable Lm within 
  
 
 
hMDMs. In conclusion, the data for the first time describe CR3 to play a significant role in 
the interaction of hMDM2 with especially apoptotic Lm and indicate a role of the receptor 
in LAP. Control of receptor-mediated internalization and LAP of apoptotic Lm could serve 
as a novel therapeutic approach to combat the neglected tropical disease leishmaniasis. 
  
  
 
 
Zusammenfassung 
Parasiten der Gattung Leishmania sind die Erreger der vernachlässigten Tropenkrankheit 
Leishmaniose. Das durch einen Sandfliegenvektor übertragene promastigote 
Lebensstadium der Leishmanien (Lm) umfasst lebendige als auch apoptotische Parasiten. 
Aufnahme der Letzteren durch LC3-assoziierte Phagozytose (LAP) führt zu einer 
verminderten Aktivierung des adaptiven Immunsystems. Basierend auf diesen 
Erkenntnissen konzentriert sich die vorliegende Studie auf (1) die Internalisierung von 
apoptotischen Lm durch primäre, humane pro- (hMDM1) und anti-inflammatorische 
(hMDM2) Makrophagen, (2) das Entkommen der lebendigen Parasiten vor der Degradation 
in der Zelle sowie (3) die Identifizierung und (4) funktionelle Charakterisierung von 
Faktoren, die zur Aufnahme der apoptotischen Lm und einer Induktion von LAP führen. Für 
eine detaillierte Analyse der apoptotischen Parasiten wurden diese von lebendigen Lm 
getrennt. Phagozytose-Assays mittels Durchflusszytometrie zeigten, dass nach 
differenzieller Infektion von hMDMs mit apoptotischen und lebendigen Lm die Aufnahme 
apoptotischer Lm schneller erfolgte als die Aufnahme lebendiger Parasiten. 
Untersuchungen von Zellüberständen differentiell infizierter hMDMs und hMDDCs mittels 
ELISA zeigten nicht nur eine erhöhte Freisetzung des anti-inflammatorischen Zytokins IL-10, 
sondern auch eine Erhöhung der Sekretion der pro-inflammatorischen Zytokine IL-1β, IL-6 
und IL-8 durch hMDMs in Gegenwart von apoptotischen Lm. Die Analyse der LAP von Lm 
mittels Lebendzell-Mikroskopie ergab, dass eGFP-LC3 in hMDM2 in größerem Maße und 
schneller zu Phagosomen rekrutiert wurde, die apoptotische Parasiten beinhalteten, als zu 
Phagosomen, die lebendige Parasiten enthielten. Um Faktoren zu identifizieren, die die 
Internalisierung der apoptotischen Parasiten und die Rekrutierung von LC3 auslösen, 
wurde eine magnetische Isolierung von apoptotischen Lm-enthaltenden Phagosomen 
durchgeführt. Markierungsfreie Massenspektrometrie und eine anschließende 
Datenanalyse zeigten, dass die Phagozytoserezeptoren Lipoprotein receptor-related 
protein 1 (CD91) und Complement Receptor 3 (CR3), in Phagosomen mit apoptotischem Lm 
in großer Zahl vorhanden waren. Die Blockierung von CD91 mit einem monoklonalen 
Antikörper war nicht effizient und auch der Knockdown des Rezeptors hatte keinen Einfluss 
auf die Wechselwirkung mit Lm. Die Inhibierung von CR3 mit einem funktionellen 
Antikörper hingegen reduzierte signifikant die Wechselwirkung von hMDMs mit 
apoptotischem Lm. Diese Blockierung des Rezeptors führte wiederum zu einer 
  
 
 
verminderten Produktion von pro-inflammatorischem TNF-α durch hMDM1 und einer 
signifikant verminderten anti-inflammatorischen IL-10-Sekretion durch hMDM2. Zusätzlich 
verringerte die Inhibierung von CR3 die LC3-Konversion in hMDM2, welche mit 
apoptotischen oder stationäre Phase-Lm inkubiert wurden. Interessanterweise führte eine 
verringerte Internalisierung von apoptotischen Lm weder zu einer höheren T-Zell-
Proliferation noch zu einem erhöhten Überleben lebendiger Lm in infizierten hMDMs. 
Zusammenfassend zeigen diese Daten zum ersten Mal, dass Complement Receptor 3 eine 
signifikante Rolle in der Wechselwirkung von hMDM2 mit apoptotischen Lm spielt und 
lassen zudem auf eine Rolle des Rezeptors in LAP schließen. Rezeptor-vermittelte 
Internalisierung und LAP von apoptotischen Lm könnte als neuer therapeutischer Ansatz 
zur Bekämpfung der vernachlässigten Tropenkrankheit Leishmaniose dienen.
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1. Introduction 
1.1 The neglected tropical disease leishmaniasis 
Neglected tropical diseases (NTDs) are a group of infectious diseases of humans mainly 
occurring in poor populations in tropical and subtropical regions throughout the world. The 
World Health Organization (WHO) estimates that about 1 billion people in 149 countries 
are affected, leaving their economies with annually costs of billions of dollars which 
represents a major global public health problem (WHO, 2019a). NTDs are mainly connected 
to poor hygiene and a lack of proper sanitation in rural areas as well as the close vicinity to 
livestock leading to increased risks of zoonotic NTDs. In addition, malnutrition and hence, 
a weakened immune system, contributes to infections (WHO, 2017a).  The major NTDs, as 
classified by the WHO, are listed below (Table 1). 
Table 1: List of the 20 neglected tropical diseases as classified by the World Health Organization (WHO, 
2019a). 
Buruli ulcer    Lymphatic filariasis 
Chagas disease Onchocerciasis (river blindness) 
Dengue and Chikungunya Rabies 
Dracunculiasis (guinea-worm disease) Scabies and other ectoparasites 
Echinococcosis Schistosomiasis 
Foodborne trematodiases Soil-transmitted helminthiases 
Human African trypanosomiasis (sleeping sickness)  Snakebite envenoming 
Mycetoma, chromoblastomycosis and  
other deep mycoses 
Taeniasis/Cysticercosis 
Leishmaniasis Trachoma 
Leprosy (Hansen's disease) Yaws (Endemic treponematoses) 
 
Human leishmaniasis is one of the major NTDs and endemic in 97 countries, mainly in 
Africa, Asia and Latin America. In addition to humans, leishmaniasis can also occur in other 
mammals including dogs and rodents (WHO, 2019b). It is estimated that 0.7 - 1 million new 
cases of the human disease occur annually resulting in 20000 - 30000 deaths per 
year (WHO, 2019b). Three clinical manifestations of leishmaniasis can be distinguished: the 
  Introduction 
2 
 
most severe form of the disease, visceral leishmaniasis (VL, also known as Kala-Azar), the 
most frequent form, cutaneous leishmaniasis, (CL) and mucocutaneous leishmaniasis 
(MCL) (WHO, 2019a). VL results from infection of phagocytic cells of the reticuloendothelial 
system. It is marked by strong fever, weight loss and splenohepatomegaly and is lethal if 
left untreated (Figure 1A). A sequela of VL is termed post-Kala-Azar dermal leishmaniasis 
(PKDL) which appears as skin-rashes in 5 - 10 % of patients that overcame VL. The majority 
of new cases of VL (94 %) in 2017 were reported from Brazil, Ethiopia, Kenya, Somalia, 
South-Sudan and Sudan (Figure 1D, VL). The most recent epidemic, caused by famine and 
mass movement as results of civil war in South-Sudan led to approximately 30000 new 
cases of VL in the years 2009 - 2012 of which 900 were lethal (WHO, 2019c). CL is the most 
prevalent form of leishmaniasis and occurs mainly in the middle-east, Afghanistan, Algeria 
but also in Brazil and Columbia (Figure 1D, CL). It causes self-healing skin lesions and ulcers 
on limbs, leaving lifelong scars (Figure 1B). This renders the disease as a high psychological 
burden for the affected patient. MCL affects the mucosal tissues of nose, mouth and throat 
which possibly results in erosion of the tissue (Figure 1C). It is mainly prevalent in southern 
America, where, in addition to Ethiopia, the highest numbers of new cases were reported 
in 2015 (Figure 1D, MCL) (WHO, 2019a). Therapy of leishmaniases is mainly based on 
administration of pentavalent antimony, amphotericin B, miltefosine or paromomycin 
(DNDi, 2019; WHO, 2010). Chemotherapy is the most effective way to battle all three 
clinical manifestations. However, the risk of drug toxicity, adverse effects and hence a low 
therapy compliance weaken the success of anti-leishmanial therapy (Ghorbani and 
Farhoudi, 2018; López et al., 2018). In addition, deficient healthcare systems in most 
countries that are endemic for leishmaniases account for the restriction of access to the 
expensive and often unaffordable medicines (WHO, 2019d). To date, no human vaccine has 
been approved for clinical use (Duthie et al., 2016). 
Leishmaniasis is caused by protozoan parasites of the genus Leishmania from the order of 
Trypanosomatida (Cavalier-Smith, 2016; Ross, 1903). The different clinical outcomes 
described above are linked to the respective parasite species infecting the host. VL is 
caused by Leishmania donovani, L. infantum or L. tropica (McGwire and Satoskar, 2014; 
Ready, 2014). CL is caused by infection with L. major, L. mexicana, L. aethiopica, 
L. amazonensis, L. panamensis or L. braziliensis (Goto and Lauletta Lindoso, 2012). 
Parasites of the species L. braziliensis are also the causative agent for MCL (De Oliveira and 
Brodskyn, 2012).  
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Figure 1: Exemplary images of the three clinical manifestations of leishmaniases and new occurrences of 
leishmaniases in 2017. Exemplary images of patients suffering from (A) visceral leishmaniasis, (B) cutaneous 
leishmaniasis and (C) mucocutaneous leishmaniasis (images: WHO). D Brazil was amongst the countries that 
reported most cases of VL, CL and MCL. Ethiopia was amongst the countries that reported most cases of VL 
and MCL (VL: Visceral leishmaniasis, CL: Cutaneous leishmaniasis, MCL: Mucocutaneous leishmaniasis, graph 
was generated according to data of the WHO, 2017b). 
 
1.2 The life cycle of Leishmania parasites 
Leishmania parasites are transmitted by sand flies during a blood meal. These sand flies of 
the genus Phlebotomus and Lutzomyia are 2 - 3 mm long (Maroli, 2013). They are mainly 
distributed in Asia, Africa, Australia, southern Europe and America whilst they are absent 
from New Zealand and the Pacific Ocean (Lane, 1993; Maroli, 2013). Recent research on 
the geographical distribution of phlebotomine sand flies revealed their presence in the 
Black Forest and near the city of Gießen in Germany (Melaun, 2014). Within the lumen of 
the sand fly’s mid-gut, Leishmania promastigotes are initially non-infective with a long body 
and a short flagellum (pro-cyclic) but develop into an infective, metacyclic form during their 
growth in the vector. During this so-called process of metacyclogenesis, expression 
patterns of genes are altered. Abundance of the major surface component 
lipophosphoglycan (LPG) and the glycophosphatidylinositol-anchored zinc-dependent 
metalloprotease GP63 is increased. Changes in morphology include a decrease in body 
VL
CL
MCL
VL + MCL
VL + CL + MCL
D
A B C
Cutaneous 
leishmaniasis
Mucocutaneous 
leishmaniasis
Visceral leishmaniasis
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length while the flagellum growths (McConville, 1992; Sacks, 1989). When the sand fly 
takes a blood meal, the infectious inoculum, containing the metacyclic promastigotes and 
the fly’s saliva, is injected into the host’s body (Teixeira et al., 2005). 
 
 
Figure 2: Life stages of Leishmania sp. Left Metacyclic Leishmania promastigote characterized by its long 
body morphology and the flagellum. Right Leishmania amastigote marked by its lentil-like shape and the lack 
of a flagellum (modified according to Besteiro, 2007). 
 
After a given time, the parasites at the infection site are internalized by macrophages, their 
final host cells. Inside this antigen-presenting cell, the promastigotes transform into the 
aflagellated, non-motile amastigote stage (Figure 2, right drawing) and start to multiply 
within a compartment termed the parasitophorous vacuole (PV). Multiplication is induced 
by the increase of temperature and fusion of the PV with lysosomes resulting in their 
acidification (Alcolea et al., 2010; Moradin and Descoteaux, 2012). Infected macrophages 
possibly burst, releasing amastigotes that can re-infect other cells. During another sand 
fly’s blood meal, this aflagellated, non-motile amastigote stage of the parasite is 
internalized by the vector through ingestion of infected host cells or free amastigotes. 
Within the insect they relocate to the mid-gut where they attach to the epithelium. The 
alkaline milieu within the digestive tract induces the re-transformation of amastigotes into 
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the flagellated, motile promastigote stage (Figure 2, left drawing) closing the life cycle 
(Dostálová and Volf, 2012). The schematic life cycle is depicted in Figure 3.  
 
 
Figure 3: Life cycle of Leishmania parasites. (1) Injection of Leishmania promastigotes into the host by the 
sand fly vector of the genus Phlebotomus and Lutzomyia. (2) Phagocytosis of parasites by phagocytic cells 
such as macrophages. (3) Transformation into the amastigote stage. (4) Multiplication of amastigotes, burst 
of infected macrophages and re-infection of other cells. (5 and 6) Uptake of infected macrophages or free 
amastigotes by sand flies. (7 and 8) Re-transformation into the promastigote stage and multiplication in the 
fly’s midgut (Burza et al., 2018). 
 
In addition to direct phagocytosis of promastigotes by macrophages, parasites can also be 
internalized by polymorphonuclear neutrophils (PMNs) (Peters et al., 2008; van 
Zandbergen et al., 2004). Promastigotes do not multiply within this cell type but use PMNs 
as a “trojan horse” (van Zandbergen et al., 2004). Infected PMNs eventually go into 
apoptosis which leads to their uptake by macrophages. Subsequently, when apoptotic 
PMNs are degraded, Leishmania promastigotes are set free into the macrophage, 
transform into amastigotes and start to multiply (van Zandbergen et al., 2004). 
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1.3 Myeloid cells 
Myeloid cells are a group of cells originating from hematopoietic stem cells in the bone 
marrow (Kawamoto and Minato, 2004). They are comprised of granulocytes, monocytes, 
the progenitor of macrophages, and myeloid dendritic cells (herein: dendritic cells). 
Monocytes, macrophages and dendritic cells are professional antigen-presenting cells 
(APCs) as they are specialized in antigen processing and presentation to T lymphocytes 
(Mann, 2014).  Macrophages and dendritic cells belong to the innate immune system and 
serve as a first barrier against invading pathogens. In steady-state, monocytes, 
characterized by their major surface marker CD14, circulate in the blood stream. Upon 
pathogen invasion, they are attracted by chemokines prompting them to infiltrate the 
affected tissue where they differentiate into pro- or anti-inflammatory monocyte-derived 
macrophages (MDMs) or monocyte-derived dendritic cells (MDDCs). Differentiation into 
the respective cell type depends on the inflammatory microenvironment (Ginhoux and 
Jung, 2014; Lee et al., 2015). 
Monocytes differentiate to MDDCs in presence of TNF-α and prostaglandin E2 (Soruri et al., 
2003). Dendritic cells are the major APCs, constantly sensing e.g. bacterial and viral 
antigens. Contact with self or foreign antigens leads to their activation that results in 
maturation and migration to the lymph node where they initialize the adaptive immune 
response. MDDCs in particular are characterized by high expression of CD1a and secretion 
of IL-12 (Tamoutounour et al., 2013). Stimulation of monocytes with T helper cell 1 (TH1)-
derived interferon (IFN)-γ or lipophosphosaccharides from bacteria yields classically 
activated type 1 macrophages (M1) with a round-shaped morphology (Biswas et al., 2012). 
M1 macrophages display a high level of phagocytic activity, production of reactive oxygen 
species (ROS) and hence efficient pathogen killing. Moreover, they have a high antigen 
presentation capacity by major histocompatibility complex (MHC) II (reviewed in Atri et al., 
2018; Tomiotto-Pellissier et al., 2018). Establishment of a pro-inflammatory environment 
elicits the adaptive immune response and leads to tissue injury. M1 macrophages produce 
high amounts of pro-inflammatory cytokines (TNF-α, Interleukin (IL)-1, IL-6, IL-12, IL-23 and 
type I IFNs). When infiltrating monocytes are stimulated with TH2-derived IL-4 and IL-13, 
IL-10 or macrophage-colony stimulating factor (M-CSF), they differentiate into the ant-
inflammatory type 2 macrophage subset (M2), also termed alternatively activated 
macrophage. These M2 macrophages have a long-shaped morphology and an important 
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role in clearance of apoptotic cells, resolution of inflammation and tissue healing (Anderson 
and Mosser, 2002; Atri et al., 2018). They are characterized by surface expression of 
scavenger receptor CD163 and a high production of anti-inflammatory mediators such as 
IL-10 and TGF-β (Jaguin et al., 2013). 
Due to the restricted number of primary, fully differentiated macrophages and dendritic 
cells in the blood, in vitro studies mainly employ MDMs and MDDCs (Haniffa et al., 2015). 
Thus, in the laboratory, initial differentiation from monocytes into pro-inflammatory type 1 
macrophages is achieved by stimulation with granulocyte-macrophage colony stimulating 
factor (GM-CSF). M2 macrophages are yielded by monocyte stimulation with M-CSF 
whereas hMDDCs can be generated by cultivation in presence of IL-4 and GM-CSF 
(Ohradanova-Repic et al., 2016).  
 
1.4 Phagocytosis 
Phagocytosis, first described by Metchnikoff in 1884, is defined as the internalization of 
particles bigger than 0.5 μm in size (Metchnikoff, 1884; Richards and Endres, 2014). It is an 
important mechanism in development and cell homeostasis. The uptake of apoptotic cells 
(termed efferocytosis) but also foreign, pathogenic particles such as bacteria, fungi or 
parasites, is mainly facilitated by professional antigen presenting cells such as dendritic 
cells and macrophages.  
In a first step that precedes phagocytosis, chemoattractants, so-called ‘find-me’ signals, are 
released by dying cells or pathogens and lead to the recruitment of phagocytes. 
Phosphatidylserine (PS) and calreticulin (eat-me signals) mark apoptotic cells as cargo and 
are recognized by specific surface receptors on phagocytic cells. Subsequent uptake of 
these dying cells stimulates production and secretion of anti-inflammatory mediators 
(reviewed in Arandjelovic and Ravichandran, 2015; Elliott et al., 2018). Phagocytosis of 
foreign particles or pathogens serves the inflammatory resolution of infection by 
destruction of the invading microbe. Here, phagocytosis is mainly initiated by binding of 
antibody- or complement-opsonized particles to specific receptors on the surface of 
phagocytic cells (Rosales and Uribe-Querol, 2017).  
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Figure 4: Major steps in phagocytosis. Cargo is 
internalized upon binding to a specific 
receptor. It comes to fusion and fission events 
with vesicles of the endosomal system which 
results in the acquisition of the ROS-generating 
NADPH oxidase which is the first step in cargo 
processing. The phagosome fuses with 
lysosomes that harbor proton-pumping 
ATPases. This lowers pH and activates 
hydrolytic enzymes, nucleases, lipases and 
glycosidases. Finally, processed antigens are 
presented on the surface of the phagocyte via 
MHCII molecules to activate the adaptive 
immune system. 
In addition, antigens on the pathogen’s 
surface can be recognized directly by 
receptors which prime the phagocyte 
and activate phagocytosis through 
different receptors (Pauwels et al., 
2017; Rosales and Uribe-Querol, 
2017). Receptor signaling leads to actin 
rearrangement and formation of a 
phagocytic cup around the yet to be 
internalized cargo. Upon closure of the 
phagocyte’s membrane around the 
cargo, a single-membrane 
compartment, the phagosome, is 
formed (Swanson, 2008; Yeo et al., 
2016). The maturation of this 
phagosome is characterized by fusion 
and fission with components of the 
endosomal system as well as by 
acquisition of proteins that support 
degradation of the cargo. One important player for phagosome maturation is the NADPH 
oxidase which is recruited to the phagosomal membrane and generates reactive oxygen 
  Introduction 
9 
 
species (ROS) within the compartment lumen. Subsequent fusion of the phagosome with 
lysosomes to a phagolysosome is characterized by acquisition of the marker proteins 
lysosome-associated membrane protein 1 and 2 (LAMP1/2). Consequently, ATPases are 
introduced to the compartment membrane that pump protons into the lumen, resulting in 
a decrease in pH. This serves the establishment of an optimal milieu for lysosomal 
proteases (cathepsins), nucleases, glycosidases, lipases and disulphide reductases that 
process antigens for presentation and hence activation of the adaptive immune system 
(Nunes et al., 2013; Pauwels et al., 2017; Yates et al., 2005). 
 
1.5 LC3-associated phagocytosis 
A decade ago, a novel discovered mechanism for pathogen elimination and apoptotic cell 
clearance termed LC3-associated phagocytosis has been described (Sanjuan et al., 2009, 
2007). LC3-associated phagocytosis (LAP) is a process of particle internalization that links 
several members of the autophagy-machinery - but not all - to the process of conventional 
phagocytosis (Sanjuan et al., 2009, 2007). Many pathogenic microbes have been found to 
be, at least partially, processed by LAP (reviewed in Schille et al., 2017). Upon recognition 
of apoptotic cells or microbes by cell surface receptors, LAP is initiated. Binding to the 
receptor is followed by phagocytosis of the cargo which is sequestered within a unilamellar 
phagosome. Recruitment of the class III phosphatidylinositol-3-phosphate kinase (PI3K)-
complex that consists of VPS15, VPS34, Beclin-1, UVRAG and Rubicon leads to introduction 
of phosphatidylinsolitol-3-phosphate into the phagosomal membrane (Figure 5). 
Of note, Ulk1 a crucial protein of the autophagic pre-initiation complex, is dispensable for 
LAP induction (Martinez et al., 2011). As in conventional phagocytosis, the NADPH oxidase 
complex is recruited and generates ROS in the phagosomal lumen (Huang and Brumell, 
2009; Lam et al., 2010; Martinez et al., 2015). The NADPH oxidase complex is stabilized by 
Rubicon (Martinez et al., 2015). Rubicon, known to be a negative regulator of canonical 
autophagy, activates the function of the PI3K-complex resulting in PI3P generation on the 
phagosome. This leads to recruitment of the NADPH oxidase subunit p40phox and hence, 
formation of the NADPH oxidase complex by further recruitment of the subunits gp91phox 
and p22phox of which the latter is directly bound by Rubicon (Boyle and Randow, 2015; 
Martinez et al., 2015; Matsunaga et al., 2009; Sanjuan et al., 2007).  
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Figure 5: LC3-associated phagocytosis. LAP is initiated by engagement of specific receptors such as toll-like 
receptor (TLR) 2 and 4, FcγRs (upon antibody opsonization), TIM-4, Dectin-1 or CR3 on the phagocyte. The 
cargo is internalized receptor-dependent and engulfed within a single-membrane phagosome. Recruitment 
of the NADPH oxidase initiates production of reactive oxygen species (ROS). ROS generation leads to rapid 
lipidation of cytosolic LC3-I on the phagosomal membrane (LC3-II) by the autophagy protein complexes Atg3-
Atg7 and Atg12-Atg-5-Atg16. The emerging LC3-positive phagosome matures by fusion with lysosomes and 
the cargo is degraded (modified according to Schille et al., 2017).  
ROS production is essential for recruitment of the autophagic protein microtubule-
associated protein 1A/1B light chain 3B (MAP1LC3B, hereafter: LC3). The soluble form of 
LC3 (LC3-I) is processed and conjugated to phosphatidylethanolamine (PE) on the cytosolic 
phagosomal surface (now termed LC3-II) by two autophagy protein complexes Atg7-Atg3 
and Atg12-Atg5-Atg16 (Henault et al., 2013; Martinez et al., 2011; Sanjuan et al., 2007; 
Tanida et al., 2004). However, a study by Cemma et al. showed that autophagy proteins 
Atg5 and Atg7 are expendable at least in Fcy receptor-mediated LAP (Cemma et al., 2016). 
LAP has been proposed to serve three functions: (1) Rapid phagosomal maturation by 
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promoting fusion of phagosomes with lysosomes, (2) cargo delivery to intravesicular 
pattern recognition receptors (PRRs) and (3) enhancement of antigen presentation via 
MHCII (Romao and Münz, 2014). Phagocytosis as well as LAP relies on the induction by 
receptor signaling upon antigen recognition. This is mediated by specific receptors on the 
surface of APCs. 
 
1.6 Receptors in conventional phagocytosis and LC3-associated phagocytosis 
The initiation of phagocytosis as well as LAP relies on the recognition of microbial structures 
or apoptotic cell-associated ligands by specific receptors. Phagocytosis or LAP of apoptotic 
cells is facilitated by receptors that bind ‘eat-me signals’ on the surface of dying cells. The 
best studied ‘eat-me’ signals are phosphatidyl-serine (PS) and calreticulin. During 
apoptosis, the phospholipid PS is flipped from the inner leaflet of the plasma membrane to 
the outer leaflet (Mariño and Kroemer, 2013). The brain-specific angiogenesis inhibitor 1 
(BAI1) and T cell immunoglobulin- and mucin-domain-containing molecule (TIM4) are well 
studied representatives for PS receptors (Miyanishi et al., 2007; Park et al., 2007). The latter 
is involved in LAP induction upon engagement of apoptotic lymphocytes (Martinez et al., 
2011). In addition to PS, other 'eat-me’ signals, e.g. calreticulin (in a PS-bound form) or 
complement C1q, can serve as a recognition signal for phagocytes. The receptor for both 
'eat-me’ signals is the low density lipoprotein receptor-related protein 1 (LRP1/CD91) 
(Gardai et al., 2005; Ogden et al., 2001). In addition to calreticulin and C1q, CD91 recognizes 
at least 30 ligands from several protein families including complement component C3 
which indicates a possible role in phagocytosis of pathogenic microbes (Herz and Strickland, 
2001). 
Phagocytic receptors that recognize specific microbial antigens, so-called pathogen-
associated molecular patterns (PAMPs), are termed pattern-recognition receptors (PRRs). 
A well described PRR is the mannose receptor (CD206) which is known to specifically bind 
carbohydrates such as mannose, N-acetylglucosamine and fucose (Rajaram et al., 2017). 
Other important PRRs are represented by the family of toll-like receptors (TLRs). They sense 
microbial lipoproteins (TLR1, TLR2, TLR6), double stranded RNA (TLR3), lipopolysaccharide 
(TLR4), flagellin (TLR5), single-stranded RNA (TLR7, TLR8) and DNA (TLR9). TLRs can be 
exposed on the surface of phagocytic cells or associated with compartments of the 
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endosomal system (reviewed in Kawai and Akira 2011). TLR signaling results in the 
induction of inflammatory signaling by activation of nuclear factor NF-κB (Medzhitov, 
2007). TLR2 was amongst the first PRRs described to induce LAP in response to zymosan, a 
yeast cell wall extract, or to the TLR ligand PAM3CSK4 (Sanjuan et al., 2007). Another well 
investigated PRR, Dectin-1 that recognizes polysaccharides such as β-glucan, initiates 
phagocytosis upon stimulation with fungal pathogens and was also found to trigger LAP 
(Akoumianaki et al., 2016; Martinez et al., 2015). 
Opsonic receptors comprise the family of Fc (fragment crystallizable) receptors and 
complement receptors. Immunoglobulin G (IgG) is an important opsonin that induces 
efficient phagocytosis by Fcγ receptors upon decoration of pathogens (Nimmerjahn and 
Ravetch, 2010). Complement receptors (CRs) facilitate uptake of complement-opsonized 
pathogens and apoptotic cells by phagocytes. Analogous to antibody opsonization, 
complement deposition on the surface prepares the microbe for effective phagocytosis. 
The complement system can be activated by three different pathways: The classical 
pathway, the lectin pathway and the alternative pathway (reviewed in Merle et al., 2015a, 
2015b). Each pathway results in the deposition of C3b on the pathogens surface. Moreover, 
C3b can be further cleaved to an inactive form (iC3b) which also attaches to the surface of 
microbes (Amin Arnaout, 1990). Complement receptor 1 (CR1, CD35) plays an important 
role in clearance of immune complexes bound by C1q but also directly binds C3b (Klickstein 
et al., 1997; Taylor et al., 1997). Complement receptor 2 (CR2) is mainly involved in B cell 
immunity and not present on macrophages and dendritic cells (Weis et al., 1984). 
Complement receptors 3 and 4 (CR3 and CR4) both are highly expressed by macrophages. 
They consist of heterodimers comprising a common β2 (CD18) integrin subunit and a 
distinct α-chain (αM/CD11b or αX/CD11c) (Vorup-Jensen and Jensen, 2018). The CD11b 
subunit of CR3 binds inactive C3b (iC3b) with high affinity leading to a silent, anti-
inflammatory internalization of iC3b opsonized particles (Nakamura et al., 2017). This is 
also of relevance in clearance of apoptotic cells which can be decorated by iC3b and hence, 
phagocytosed after binding to CR3 (Hashimoto et al., 2007; Mevorach et al., 1998). 
Recently, Gluschko and colleagues found CR3 to induce LAP of Listeria monocytogenes. 
Interestingly, this was linked to a reduced ROS generation in cells lacking CR3 
(Gluschko et al., 2018). 
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1.7 Cytokine secretion of myeloid cells and activation of the adaptive immune 
system 
When myeloid cells are challenged with pathogen-derived stimuli or apoptotic cells, a 
broad repertoire of pro- or anti-inflammatory cytokines is secreted mainly by macrophages. 
Upon binding of an antigen to its specific receptor e.g. a surface TLR, intracellular signaling 
leads to activation of the transcription factor NF-κB. This mediates the induction of pro-
inflammatory genes such as IL-1, IL-6, IL-8 or TNF (reviewed in Liu et al., 2017). An interplay 
between these mediators in connection with chemokines results in establishment of an 
inflammatory milieu, an increase in vascular permeability and recruitment and activation 
of other cells of the adaptive or innate immune system (Arango Duque and Descoteaux, 
2014). When an apoptotic cell-associated antigen binds its cognate receptor, anti-
inflammatory cytokines are secreted of which the most important are IL-10 and TGF-β. 
They mainly serve the suppression of pro-inflammatory cytokine production and 
macrophage activation. IL-10 e.g. effects other macrophages to lower their microbicidal 
activity (Oswald et al., 1992). TGF-β also suppresses pro-inflammatory cytokine effects but 
is also a potent down-regulator of T helper cell (TH) 1 and TH2 responses (Arango Duque 
and Descoteaux, 2014). 
Upon internalization and degradation of foreign material by the phagocyte, dendritic cells 
and macrophages activate the adaptive immune system by major histocompatibility 
complex II (MHCII)-dependent antigen presentation to antigen-specific CD4+ T cells. This 
mechanism is restricted to APCs whereas MHCI-dependent antigen presentation is 
executed by all cell types. Thus, MHCI presentation allows for constitutive presentation of 
proteasomal degraded self-peptides presented to antigen-specific cytotoxic CD8+ T cells 
(Roche and Furuta, 2015; Rossjohn et al., 2015). A characteristic feature of dendritic cells 
is the ability to present also internalized foreign antigens via its MHCI complex in a 
mechanism termed cross-presentation (reviewed in Embgenbroich and Burgdorf, 2018). 
Antigen presentation to CD4+ lymphocytes is a crucial step in combatting pathogenic 
invaders. In phagocytosis and LAP, MHCII molecules must be located to the phagolysosome 
where the processed antigens can be loaded onto the complex. The MHCII-antigen complex 
is translocated to the plasma membrane of the APC where a CD4+ T lymphocyte can bind 
with its specific T cell receptor (TCR) (Neefjes et al., 2011). TCR engagement results in T cell 
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activation which requires an additional co-activation signal (Pagan et al., 2012). If no co-
stimulatory signal is provided by the APC, T cells will go into apoptosis or become 
inactivated. The cytokine environment at the time of activation of CD4+ T cells is directing 
the differentiation into TH1 or TH2 cells. In presence of IL-12 or IFN-γ, mainly secreted by 
pro-inflammatory M1 macrophages, CD4+ cells differentiate in TH1 cells (Hsieh et al., 1993; 
Lighvani et al., 2001). Presence of IL-4 during TCR-dependent antigen presentation results 
in differentiation into TH2 lymphocytes. 
  
1.8 Uptake of Leishmania promastigotes by myeloid cells 
Several receptors have been described to be involved in phagocytosis of Leishmania 
parasites whereas to date, no receptor has been found to specifically induce LAP of 
Leishmania. TLRs, although not directly linked to phagocytosis of Leishmania 
promastigotes, serve their uptake in a regulatory manner (reviewed in Chauhan et al., 
2017). TLR2, TLR4 and TLR9 have been suggested to be involved in Leishmania major 
recognition (Abou Fakher et al., 2009; de Veer et al., 2003; Kropf et al., 2004; Liese et al., 
2008). Fcγ receptors are of particular interest in secondary infections by amastigotes, since 
the host already has specific IgGs that readily bind to the parasites surface. Nonetheless, in 
an initial infection by the promastigote stage, naturally occurring antibodies decorate the 
parasites which are in turn engaged by dendritic cell and macrophage Fcγ receptors 
(Polando et al., 2013; Woelbing et al., 2006). It is long known that the mannose receptor 
CD206 is involved in phagocytosis of Leishmania promastigotes (Wilson and Pearson, 
1988). A recent report showed that anti-inflammatory macrophages that express high 
levels of CD206 are permissive for parasite growth, even in pro-inflammatory environments 
(Lee et al., 2018). The macrophage fibronectin receptor (FnR) was suggested to be involved 
in parasite uptake in cooperation with complement receptors (Kane and Mosser, 2000). 
Intensive studies of CRs revealed major roles for CR1 and CR3 in the infection of 
macrophages with Leishmania promastigotes. CR1, the receptor for complement C3b, is 
involved in the internalization of viable Leishmania major promastigotes (Da Silva et al., 
1989; Wenzel et al., 2012). In addition to C3b, CR1 directly binds Leishmania surface LPG 
(Rosenthal et al., 1996). Modulation of this receptor resulted in a decreased infection of 
primary human M1 macrophages but an increase of survival of promastigotes within the 
infected cell (Da Silva et al., 1989). CR3 is the best investigated receptor implicated in 
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Leishmania promastigote infection (Mosser and Edelson, 1985; Rosenthal et al., 1996; 
Schönlau et al., 2000; Wilson and Pearson, 1988). It is employed by Leishmania 
promastigotes for entry of host macrophages by three different mechanisms: (1) Binding 
of iC3b that is generated by cleavage  of membrane-bound C3b by the Leishmania surface 
protease GP63, (2) direct binding of GP63 on the parasite surface or (3) similar to CR1, 
binding of Leishmania surface-LPG (Brittingham et al., 1995; Mosser and Edelson, 1985).  
 
1.9 The importance of apoptotic promastigotes in Leishmania major infection 
Most studies on Leishmania promastigote infection concentrate on viable parasites since a 
liquid parasite cultivation system is used which mainly restrains the apoptosis of 
Leishmania promastigotes (Grekov et al., 2011). One study showed that these viable 
L. major promastigotes are partially internalized by LAP in murine macrophages. 
Interestingly, targeting by LC3 could be evaded by action of the surface protease GP63 
(Matte et al., 2016). Moreover, our group detected a viable promastigote to reside within 
a phagosome that had an opening to the extracellular space by electron microscopy 
possibly serving for evasion of degradation (PhD thesis M. Thomas, 2015). Of note, the 
infectious inoculum that is injected into the host by the sand fly is comprised of an almost 
equal mixture of viable and apoptotic parasites (van Zandbergen et al., 2006; Wanderley et 
al., 2013, 2009). This mixture is also found in a stationary growth phase (stat. ph.) of in vitro 
cultured L. major promastigotes (van Zandbergen et al., 2006). 
Apoptosis is a fundamental mechanism in development and tissue homeostasis. In 
unicellular parasitic organisms it was described as altruistic process regulating parasite 
density within the vector and the host cell (Lüder et al., 2010). To date, the intracellular 
pathways that lead to apoptosis in Leishmania promastigotes are not known. Interestingly, 
the molecular factors described for classic mammalian apoptosis are not found within the 
parasite (Basmaciyan et al., 2018). Nonetheless, apoptotic Leishmania promastigotes show 
the same characteristics as apoptotic mammalian cells. They have a round morphology and 
as general characteristics of apoptotic cells, PS is exposed on their surface, they show 
nuclear condensation, DNA fragmentation and they are TUNEL-positive. In addition, 
apoptotic promastigotes have a short flagellum or lack the flagellum (Crauwels et al., 2015; 
van Zandbergen et al., 2006; Wanderley et al., 2009; Zangger et al., 2002). In vivo studies 
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in susceptible BALB/c mice showed a dependence of disease initiation on the apoptotic 
parasite population within the infectious inoculum (van Zandbergen et al., 2006). When 
apoptotic Leishmania were depleted from a stat. ph., rates of PMNs and macrophages 
infected with viable promastigotes were significantly reduced as compared to cells infected 
with a stat. ph. containing viable and apoptotic parasites. Presence of apoptotic Leishmania 
led to an increase in anti-inflammatory cytokine production in PMNs (van Zandbergen et 
al., 2006). The importance of the uptake of apoptotic cells was underscored by studies that 
found uptake of apoptotic PMNs to silence neutrophils and macrophages during 
Leishmania infection (Afonso et al., 2008; Salei et al., 2017). Our group demonstrated that 
anti-inflammatory macrophage infection in presence of apoptotic L. major promastigotes 
resulted in enhanced survival of the viable parasite population as compared to infection 
with log. ph. promastigotes that are comprised almost exclusively of viable parasites. 
Further, in an in vitro T cell assay, the co-internalization of apoptotic with viable 
promastigotes by anti-inflammatory macrophages led to a significant reduction of a 
Leishmania-specific T cell proliferation. Presence of apoptotic promastigotes decreased 
production of pro-inflammatory TNF-α, IL-6 and IL-1β by macrophages, and IFN-γ secretion 
by T cells, indicating a crucial role for apoptotic parasites in host cell infection by L. major 
(Crauwels et al., 2015). The reduction in the adaptive immune response towards L. major 
was found to be dependent on LAP of these apoptotic promastigotes in the infection 
process. The number of dying promastigotes in the infectious mixture during infection 
correlated with occurrence of LC3+ compartments (Crauwels et al., 2015). This study 
highlighted the importance of apoptotic promastigotes in Leishmania major infection and 
revealed LC3-associated phagocytosis to be of importance for initiation of leishmaniasis. 
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2. Hypothesis and Aims 
Leishmania parasite infection causes the neglected tropical disease leishmaniasis. 
Accession of affected populations to cheap medicines often is challenging and to date, no 
vaccine is available. Therefore, understanding the molecular details of initial Leishmania 
infection is of high importance to find ways for effective treatment of leishmaniasis. 
Viable L. major parasites were found to escape degradation by macrophages, possibly by 
formation of tunnel-like structures from the phagosome to the extracellular space. 
Apoptotic Leishmania major promastigotes were found to be crucial for disease 
development in a susceptible mouse model (van Zandbergen et al., 2006). In previous in 
vitro studies with primary human type 2 macrophages, the presence of apoptotic L. major 
promastigotes resulted in a decrease of pro-inflammatory cytokine production as well as a 
diminished Leishmania-specific T cell response (Crauwels et al., 2015). This could be linked 
to the internalization of apoptotic parasites into a LC3-decorated single membrane 
compartment by LC3-associated phagocytosis. To date, it remains elusive which factors 
contribute to initiation of LAP and maturation of the LC3 positive phagosome that 
surrounds apoptotic L. major promastigotes. Based on the findings of van Zandbergen and 
Crauwels we hypothesize: 
Viable and apoptotic Leishmania major promastigotes are internalized by primary 
human macrophages in a process termed LC3-associated phagocytosis. Viable parasites 
escape degradation and multiply within the phagosomal compartment whereas 
processing of apoptotic parasites results in an anti-inflammatory host cell response that 
supports survival of the viable Leishmania population. 
 
To investigate this hypothesis, we formulated the following aims: 
1) Evaluation of differences in induction of LC3-associated phagocytosis and 
processing of internalized parasites by live cell imaging of eGFP-LC3 expressing pro- 
and anti-inflammatory primary human macrophages upon uptake of viable or 
apoptotic Leishmania major promastigotes. 
2) Investigation of a possible evasion strategy, based on the formation of tunnel-like 
structures by viable promastigotes, using immunofluorescence microscopy. 
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3) Identification of host cell factors that initiate LC3-associated phagocytosis and 
contribute to phagosome maturation by mass spectrometric analysis of 
magnetically isolated phagosomes that contain apoptotic Leishmania major 
promastigotes. 
4) Functional characterization of identified targets regarding their role in uptake of 
apoptotic Leishmania major promastigotes and their effect on the macrophage 
cytokine response and intracellular survival of viable parasites. 
 
 
 
Figure 6: Hypothesis and aims of the study. Viable Leishmania major promastigotes are internalized upon 
recognition by several receptors. Portions of the internalized parasites are sequestered in LC3 positive 
phagosomes by a mechanism termed LC3-associated phagocytosis, escape degradation and transform into 
amastigotes and multiply. Infection with viable promastigotes induces pro-inflammatory cytokine secretion. 
Processing of apoptotic parasites results in an anti-inflammatory host cell response that supports survival of 
the viable Leishmania population. We aimed on (1) assessment of differences in uptake of viable and 
apoptotic L. major promastigotes, (2) investigation of an evasion strategy of viable promastigotes by 
formation of tunnel-like structures, (3) identification and (4) functional characterization of factors regarding 
LAP of apoptotic promastigotes as well as their effect on macrophage cytokine production and intracellular 
parasite survival. 
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3. Material and Methods 
3.1 Material 
3.1.1 Consumables 
Consumable Manufacturer 
CASY cups OLS OMNI Life Science, Bremen, GER 
Cell culture flasks (25 cm2, 75 cm2, 175 cm2) Greiner, Frickenhausen, GER 
Cell culture petri dish (10 cm diameter) Sarstedt, Nürnbrecht, GER 
Cell culture plates (6-well, 24-well) Greiner, Frickenhausen, GER 
Cell funnel for cytospins Tharmac, Waldsolms, GER 
Cell lifter (16 cm, 25 cm) Sarstedt, Nürnbrecht, GER 
Centrifuge tubes polyallomer Beckman Coulter, Krefeld, GER 
Chamber slide (8-well, 12-well), ibidi-treat Ibidi, Planegg-Martinsried, GER 
Cover slip (#1.5) Thermo Scientific, Dreieich, GER 
Cryotube (2 mL) Thermo Scientific, Dreieich, GER 
ECL X-ray film GE Healthcare, Buckinghamshire, UK 
FACS microtube (2 mL) Micronic, Lelystad, NL 
FACS tube (5 mL) BD labware, Le Pont de Claix, FRA 
Filter card for cytospins Tharmac, Waldsolms, GER 
Filter paper (Whatman) VWR, Darmstadt, GER 
Free-flow column for HOKImag HOOCK, Kiel, GER 
Hemocytometer Neubauer improved  
(depth 0.1 mm, 0.02 mm) 
VWR, Darmstadt, GER 
LightCycler plate (96-well) with foil Roche Applied Science, Darmstadt, 
GER 
MACS column (LS/LD) Miltenyi, Bergisch Gladbach, GER 
Microscope slide for cytospins, uncoated Tharmac, Waldsolms, GER 
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Consumable Manufacturer 
Microtiter plate (96-well, V-bottom/flat bottom) Sarstedt, Nürnbrecht, GER 
Microtiter plate (96-well, flat bottom, medium-
binding) 
Sarstedt, Nürnbrecht, GER 
PCR tube (0.2 mL) Sarstedt, Nürnbrecht, GER 
Pipette filter tips 
(0.5-10 µL, 10-200 µL, 100-1000 µL) 
Nerbe plus, Winsen/Luhe, GER 
Pipette tips 
(0.5-10 µL, 10-200 µL, 100-1000 µL) 
Biozym, Hessisch Oldendorf, GER 
Pipette (Pasteur) Sarstedt, Nürnbrecht, GER 
Pipettes (Research Plus) 
(0.5-10 µL, 10-100 µL, 20-200 µL, 
100-1000 µL) 
Eppendorf, Hamburg, GER 
Pipette Multichannel (Research Plus) 
(10-100 µL, 20-200 µL) 
Eppendorf, Hamburg, GER 
Polystyrene lids, PS, high profile Greiner, Frickenhausen, GER 
Polyvinylidene difluoride (PVDF) membrane  GE Healthcare, Buckinghamshire, UK 
Reaction tube (1.5 mL) Eppendorf, Hamburg, GER 
Reaction tube (15 mL, 50 mL) Greiner, Frickenhausen, GER 
Serological pipettes (2 mL, 5 mL, 10 mL, 
25 mL) 
Greiner, Frickenhausen, GER 
Sterile vacuum filter (0.45 µm, 0.22 µm) Merck Millipore, Billerica, USA 
Syringe (1 mL) Beckton Dickinson, Franklin Lakes, USA  
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3.1.2 Devices 
Device Manufacturer/equipment 
Centrifuges 
Cellspin II Universal 320R Cytocentrifuge Tharmac, Waldsolms, GER 
Centrifuge 5430/5430R Eppendorf, Hamburg, GER 
Labofuge 200 Thermo Scientific, Dreieich, GER 
Multifuge 16R with swinging bucket rotor 
BIOliner 
Thermo Scientific, Dreieich, GER 
Optima L-70k Ultracentrifuge with rotor SW28 Beckman Coulter, Krefeld, GER 
Electrophoresis and western blot 
ECL & Fluorescence Imager Chemostar Intas, Göttingen, GER 
Electrophoresis chamber for agarose gels Biotec-Fischer, Reiskirchen, GER 
Electrophoresis chamber for SDS-PAGE 
Mini-Protean Tetra cell 
Bio-Rad, München, GER 
Power Supply “PowerPac™ 200/2.0” Bio-Rad, München, GER 
Semi-dry transfer unit TE 77 PWR GE Healthcare, Buckinghamshire, UK 
UV-transilluminator Genoview VWR International, Darmstadt, GER 
X-ray processor Curix 60 AGFA, Mortsel, BE 
Flow cytometry 
LSR II BD Biosciences, Heidelberg, GER 
LSR II SORP (special order research product) BD Biosciences, Heidelberg, GER 
CytoFLEX Beckman Coulter, Krefeld, GER 
Magnets 
HOKImag free-flow magnetic chamber HOOCK, Kiel, GER 
MACS Separator (Midi) Miltenyi, Bergisch Gladbach, GER 
MACS magnet (Midi) Miltenyi, Bergisch Gladbach, GER 
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Device Manufacturer/equipment 
Microscopy (all microscopes were from Carl Zeiss Microscopy, Oberkochen, GER) 
Primo Star  cell culture 
AxioVert A1 cell culture 
AxioPhot 
 
equipped with a color camera AxioCam 
IC and mercury vapor lamp HBO50 
Observer Z.1 Fluorescence Microscope 
 
equipped with: ApoTome, AxioCam 
MRm, light source HXP120C, reflectors 
DIC TL, 38 HE GFP, 43 HE DsRed, 49 
DAPI, 50 Cy5, 64 HE mPlum, objectives 
LD Achro Plan 20x/0.4 Ph2 DICIII, LD 
Achro Plan 40x/0.6 Ph2, Pln Apo 20x/0.8 
DICII, PlnN 10x/0.3 Ph1 DICI, EC PlnN 
40x/1.3 Oil DICIII, Pln Apo 63x/1.4 Oil 
DICIII 
Confocal Laser Scanning Microscope (LSM) 7 
Live 
Observer Z.1 equipped with: line 
scanner, four laser lines (405 nm, 
488 nm, 561 nm and 635 nm), AxioCam 
MRm, light source HXP120C, piezo z-
controller 24V80CAP, incubation 
chamber, reflectors Pol TL, 26 AF660, 
38 HE GFP, 43 DsRed, 49 DAPI, 
objectives Pln Apo 63x/1.4 Oil DICIII, Pln 
Apo 40x/0.95 DICIII 
Incubators  
Forma Series II Water Jacket Thermo Scientific, Dreieich, GER 
Heraeus Auto Zero Thermo Scientific, Dreieich, GER 
Recirculating cooler Julabo, Seebach, GER 
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Device Manufacturer/equipment 
PCR Thermo cycler 
LightCycler 480 Roche Applied Science, Mannheim, 
GER 
S1000 Thermal Cycler Bio-Rad, München, GER 
Sterile cabinets 
Workbench MSC-Advantage Thermo Scientific, Dreieich, GER 
Steril Gard III Advance The Baker Company, Sanford, USA 
Steril Gard Hood The Baker Company, Sanford, USA 
Miscellaneous 
Analytical balance KB BA 100 Sartorius, Göttingen, GER 
CASY Modell TT Roche Innovatis, Reutlingen, GER 
Freezer (-20°C) Liebherr, Biberach a. d. R., GER, 
Freezer U725-G (-80°C) Eppendorf, Hamburg, GER 
Magnetic stirrer C-MaG HS7 IKA, Staufen, GER 
Microplate reader Infinite F50 Tecan, Männedorf, CH 
Microwave Bosch, Gerlingen, GER 
Minipulse 3 peristaltic pump  Gilson, Middleton, USA 
Nitrogen container Chronos Messer, Bad Soden, GER 
pH-meter PB-11 Sartorius, Göttingen, GER 
Spectrophotometer NanoDrop 2000c Thermo Scientific, Dreieich, GER 
Sonifier Branson 450 II Classic Branson Ultrasonics, Danbury, USA 
Speed control module R2 Gilson, Middleton, USA 
Thermomixer 5437 Eppendorf, Hamburg, GER 
Vortex mixer VV3 VWR, Darmstadt, GER 
Waterbath Köttermann, Darmstadt, GER 
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3.1.3 Software 
Software Manufacturer 
AxioVision (Version 4.8) Carl Zeiss Microscopy, Oberkochen, GER 
FACSDiva (Version 7.0.1) BD Biosciences, Heidelberg, GER 
FlowJo (Version 10) BD Biosciences, Heidelberg, GER 
Prism (Version 7/8) Graphpad Software, La Jolla, USA 
ImageJ/FIJI National Institutes of Health, Bethesda, 
USA 
LEGENDplex Data Analysis Software  
(Version 8) 
Biolegend, San Diego, USA 
LightCycler LC480 Software (Version 1.5.0) Roche Applied Science, Mannheim, GER 
Microsoft Office 2013/2019 Microsoft, Redmont, USA 
NCBI Nucleotide Blast (blastn) database National Library of Medicine, Bethesda, 
USA 
Protein Data Bank The Protein Data Bank 
(www.rcsb.org/pdb/; Berman et al., 2000) 
String database (Version 11) STRING Consortium, ELIXIR, Hinxton, UK 
(www.string-db.org; Szklarczyk et al., 2019) 
Zeiss Efficient Navigation (ZEN) 2012 
(black edition/blue edition) 
Carl Zeiss Microscopy, Oberkochen, GER 
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3.1.4 Chemicals 
Reagents that were obtained from the in-house facilities are marked with ‘Paul-Ehrlich-
Institut’. 
Chemical Manufacturer 
β-Mercaptoethanol Sigma-Aldrich, Steinheim, GER 
Acetic acid (CH3COOH) Roth, Karlsruhe, GER 
Acrylamide/Bisacrylamide solution 30% SERVA Electrophoresis, Heidelberg, GER 
Agarose LE Biozym Scientific, Hessisch Oldendorf, GER 
Ammonium persulfate (APS) SERVA Electrophoresis, Heidelberg, GER 
Aqua bidest. (ddH2O) Paul-Ehrlich-Institut 
Benzonase Merck, Darmstadt, GER 
Bovine Serum Albumin (BSA) Applichem, Darmstadt, GER 
Brain-heart infusion agar BD Biosciences, Sparks, USA 
Bromophenol blue Merck, Darmstadt, GER 
Calcium chloride (CaCl2) Sigma-Aldrich, Steinheim, GER 
CASYton OLS OMNI Life Science, Bremen, GER 
Chloroquine Sigma-Aldrich, Steinheim, GER 
Cytochalasin D Merck, Darmstadt, GER 
DABCO (1,4-Diazabicyclo (2.2.2)-octan) Roth, Karlsruhe, GER 
Developer for X-Ray film G153 A+B AGFA, Mortsel, BE 
Disodium phosphate (Na2HPO4) Merck, Darmstadt, GER 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, Steinheim, GER 
Dithiothreitol (DTT) Sigma-Aldrich, Steinheim, GER 
DNA loading buffer (10x) New England Biolabs, Ipswich, USA 
dNTPs: dATP, dCTP, dGTP, dTTP 
(100 mM) 
PeqLab, Erlangen, GER  
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Chemical Manufacturer 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
Sigma-Aldrich, Steinheim, GER 
ECL Western Blotting Detection Reagents GE Healthcare, Buckinghamshire, UK 
Ethylenediaminetetraacetic acid (EDTA) Paul-Ehrlich-Institut 
Ethanol (EtOH, 96 %) Paul-Ehrlich-Institut 
Fetal Calf Serum (FCS) Sigma-Aldrich, Steinheim, GER 
(L)-glutamine Biochrom, Berlin, GER 
Glycerol (99 %)  Citifluor, London, UK 
Glycine Sigma-Aldrich, Steinheim, GER 
HEPES (4-(2-hydroxyethyl) -1-
piperazineethanesulfonic acid) 
Merck, Darmstadt, GER 
High-purity water Sigma-Aldrich, Steinheim, GER 
Histopaque 1.077 g/mL Sigma-Aldrich, Steinheim, GER 
Human AB serum Sigma-Aldrich, Steinheim, GER 
DRK Blutspendedienst, Frankfurt a. M., GER 
Hydrochloric acid 37 % (HCl) Roth, Karlsruhe, GER 
Hygromycin B solution Invitrogen, San Diego, USA 
Immersion oil (Immersol 518F) Zeiss Microscopy, Oberkochen, GER 
Luminata Forte Western HRP-Substrate Merck, Darmstadt, GER 
Methanol (MeOH) Paul-Ehrlich-Institut 
Magnesium chloride (MgCl2) Merck, Darmstadt, GER 
Mowiol 4-88 Roth, Karlsruhe, GER 
Nuclease-free water Qiagen, Hilden, GER 
Pancoll 1.077 g/mL PAN Biotech, Aidenbach, GER 
Paraformaldehyde (PFA) 4 % Sigma-Aldrich, Steinheim, GER 
Penicillin/Streptomycin solution Biochrom, Berlin, GER 
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Chemical Manufacturer 
PI-103 Sellekchem, Houston, USA 
Potassium chloride (KCl) Sigma-Aldrich, Steinheim, GER 
Protease Inhibitor Cocktail Roche, Mannheim, GER 
Rabbit blood, defibrinated Elocin-Lab, Oberhausen, GER 
Ringer’s solution B. Braun, Melsungen, GER 
Roswell Park Memorial Institute (RPMI) 
1640 
Biowest, Nuaillé, FR 
Sigma-Aldrich, Steinheim, GER 
Saponin (from Quillaja bark) Sigma-Aldrich, Steinheim, GER 
Skim-milk powder EDEKA, Hamburg, GER 
Sodium azide (NaN3) Sigma-Aldrich, Steinheim, GER 
Sodium chloride (NaCl) Sigma-Aldrich, Steinheim, GER 
Sodium dodecyl sulfate (SDS)  Paul-Ehrlich-Institut 
Sodium hydroxide (NaOH) Merck, Darmstadt, GER 
Stemfect RNA Transfection Reagent Stemgent, San Diego, USA  
Sucrose Sigma Aldrich, Steinheim, GER 
Sulfuric acid (H2SO4) Roth, Karlsruhe, GER 
TEMED (Tetramethylethylendiamine) Roth, Karlsruhe, GER 
TMB High Sensitivity Substrate Solution Biolegend, San Diego, USA 
Tris (Tris(hydroxymethyl)-aminomethan) -
solutions 
Paul-Ehrlich-Institut 
Triton X-100 Sigma-Aldrich, Steinheim, GER 
Tween-20 Sigma-Aldrich, Steinheim, GER 
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3.1.5 Media 
Medium Components 
Cryo medium CM 
 40 % FCS (v/v) 
HEK293T/17/HT1080 medium (DMEM) DMEM 
 10 % FCS (v/v) 
 4 mM L-glutamine 
 1 U/mL Penicillin 
 1 µg/mL Streptomycin 
Leishmania liquid medium (Lm medium) RPMI 1640 
 5 % FCS (v/v) 
 2 mM L-glutamine 
 1 U/mL Penicillin 
 1 µg/mL Streptomycin 
 10 mM HEPES buffer 
 50 µM β-Mercaptoethanol 
(for DsRed expressing L. major, Lm 
medium was supplemented with 20 ng/mL 
Hygromycin B) 
Macrophage complete medium (CM) RPMI 1640 
 10 % FCS (v/v) 
 2 mM L-glutamine 
 1 U/mL Penicillin 
 1 µg/mL Streptomycin 
 10 mM HEPES buffer 
 50 µM β-Mercaptoethanol 
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Medium Components 
Medium for cultivation in Teflon bags RPMI 1640 
 2 % FCS (v/v) 
 2 mM L-glutamine 
 1 U/mL Penicillin 
 1 µg/mL Streptomycin 
Novy-MacNeal-Nicolle- (NNN-) blood-agar 400 mL ddH2O 
100 mL PBS pH 7.1 
20.8 g Brain heart infusion agar 
66.2 U/mL 
66.2 µg/mL Streptomycin 
100 mL defibrinated rabbit blood 
 
3.1.6 Buffers and solutions 
Phosphate-buffered saline without Ca2+ and Mg2+ (PBS) pH 7.1 and pH 7.4, ddH2O and Tris-
solutions were obtained from the in-house facility of the Paul-Ehrlich-Institut. All solutions 
used in cell culture were sterile filtered (0.45 µm or 0.22 µm sterile filter) prior to use. 
Buffer/solution Components 
Ammonium chloride solution ddH2O 
 150 mM Ammonium chloride  
Blotting buffer (western blot) ddH2O 
 50 mM Tris 
 40 mM Glycine  
 0.0375 % SDS (w/v) 
 2.5 % MeOH (v/v) 
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Buffer/solution Components 
Calcium chloride solution ddH2O 
 2.5 M CaCl2  
ELISA blocking buffer PBS pH 7.4 
 1 % BSA (w/v) 
ELISA wash buffer PBS pH 7.4 
 0.05 % Tween-20 (v/v) 
ELISA reagent diluent (TNF-α, IL-10, IL-6, IL-1β) PBS pH 7.4 
 1 % BSA (w/v) 
ELISA reagent diluent (IL-8) 20 mM Tris-HCl pH 7.4 
 150 mM NaCl 
 0.1 % BSA (w/v) 
 0.05 % Tween-20 
FACS blocking buffer PBS pH 7.1 
 10 % FCS (v/v) 
 10 % human AB serum (v/v) 
FACS washing/staining buffer PBS pH 7.1 
 1 % FCS (v/v) 
 1 % human AB serum (v/v) 
Hank’s balanced salt solution (HBSS) ddH2O 
w/o Mg2+ and Ca2+ 140 mM NaCl 
 5 mM KCl 
 300 µM Na2HPO4 x 2 H2O 
 400 µM KH2PO4 
 6 mM Glucose 
 4 mM NaHCO3 
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Buffer/solution Components 
HEPES-buffered saline (HBS) 2x ddH2O 
 281 mM NaCl  
 100 mM HEPES  
 1.5 mM Na2HPO4  
Homogenization buffer ddH2O 
 15 mM HEPES  
 0.5 mM MgCl2  
 25 mM Sucrose  
 pH 7.2 - 7.4, sterile filtered 0.22 µm 
IF blocking buffer  PBS pH 7.1 
 10 % FCS (v/v) 
 10 % human AB serum (v/v) 
IF permeabilization buffer  PBS pH 7.1 
 1 % FCS (v/v) 
 1 % human AB serum (v/v) 
 
0.5 % Saponin (w/v) 
or 
 0.5 % Triton X-100 (v/v) 
IF washing/staining buffer PBS pH 7.1 
 1 % FCS (v/v) 
 1 % human AB serum (v/v) 
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Buffer/solution Components 
Laemmli buffer (6x) ddH2O 
 500 mM Tris-HCl pH 6.8 
 38 % Glycerol (v/v) 
 10 % SDS (w/v) 
 600 mM DTT  
 0.01 % Bromophenol blue 
MACS-buffer (CD14-MACS) PBS pH 7.2 
 0.5 % BSA (w/v) 
 0.5 mM EDTA  
MACS-buffer 1 (AnnexinA5-MACS) Ringer’s solution 
 0.5 % BSA (w/v) 
MACS-buffer 2 (AnnexinA5-MACS) PBS pH 7.1 
 0.5 % BSA (w/v) 
Paraformaldehyde solution (4 %) PBS pH 7.1 
 4 % Formaldehyde (w/v) 
Phosphate-buffered saline (PBS) w/o Ca2+/Mg2+ ddH2O 
 140 mM NaCl (w/v) 
 10 mM Na2HPO4 x 2 H2O  
 2.7 mM KCl (w/v) 
 1.8 mM KH2PO4  
 pH 7.1 / pH 7.4 
Ringer’s solution ddH2O 
 147 mM NaCl  
 4 mM KCl  
 2.2 mM CaCl2  
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Buffer/solution Components 
SDS-PAGE Running buffer (5x) ddH2O 
 125 mM Tris  
 1.25 M Glycine  
 0.5 % SDS (w/v) 
Stacking gel buffer ddH2O 
 1.5 M Tris-HCl pH 8.8 
 0.4 % SDS (w/v) 
Separating gel buffer ddH2O 
 0.5 M Tris-HCl pH 6.8 
 0.4 % SDS (w/v) 
TAE buffer (TAE, 20x) ddH2O 
 0.8 M Tris (w/v) 
 2..25 % acetic acid (v/v) 
 20 mM EDTA  
Tris-buffered saline + Tween-20 (TBST) ddH2O 
 50 mM Tris-HCl pH 7.4 
 150 mM NaCl 
Wash buffer (PBMC isolation) PBS pH 7.1 
 5 % CM (v/v) 
Western blot blocking solution 5 % BSA (w/v) + 0.01 % NaN3 (v/v) 
 or 
 5 % skim-milk powder (w/v) 
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3.1.7 Leishmania strains 
Leishmania major wild type (WT): Isolate MHOM/IL/81/FEBNI, isolated from a skin biopsy 
of an Israeli patient. Kindly provided by Dr. Frank Ebert, Bernhard-Nocht-Institut, Hamburg, 
Germany. 
Leishmania major DsRed: Isolate MHOM/IL/81/FEBNI transfected with DsRed (Red 
Fluorescent Protein from Discosoma sp.). A hygromycin phosphotransferase serves as 
selection marker (Campbell et al., 2002; Misslitz et al., 2000). 
 
3.1.8 Human cells 
3.1.8.1 Primary cells 
Human peripheral-blood mononuclear cells were isolated from buffy coats that were 
acquired from healthy anonymous volunteers from the blood bank of Frankfurt (DRK-
Blutspendedienst Frankfurt am Main) with ethical approval #329/10. Written informed 
consent was obtained from the participants of these studies and the ethics committee 
approved the protocol, accordingly. Donations were obtained  
 
3.1.8.2 Cell lines 
Cell line Description Source 
HEK 293T/17 Human embryonic kidney cells (HEK) 293T. Highly 
transfectable derivative of the HEK 293 cell line 
with SV40 T-antigen insertion. 
ATCC CRL-11268 
HT1080 Human fibrosarcoma cell line, epithelial-like cells. 
Highly susceptible to Vesicular stomatitis-virus 
(VSV) infection. 
ATCC CCL-121 
 
 
 
 
  Material and Methods 
35 
 
3.1.9 Antibodies and antisera 
Primary antibodies for western blot (WB) analysis were diluted in TBST + 5 % BSA, 
secondary, HRP-conjugated antibodies were diluted in TBST + 5 % skim-milk powder. 
Primary fluorophore-conjugated antibodies for flow cytometry (FACS) were diluted in FACS 
staining buffer. Primary and secondary antibodies for immunofluorescence (IF) were 
diluted in IF staining buffer. 
Antibody/antiserum Species Manufacturer Use 
Unconjugated primary antibodies 
α-LC3B (polyclonal) rabbit Cell Signaling WB 1:1000  
α-β-actin (clone 8H10D10) mouse, 
IgG2b 
Cell Signaling WB 1:2000  
α-CD11b (clone ICRF44) non-
azide/low-endotoxin 
mouse, 
IgG1 κ 
BD Pharmingen Functional assay  
1 µg/1x 105 cells 
α-CD91 (clone 8G1) mouse, 
IgG1 
Thermo 
Scientific 
Functional assay 
0.53 µg/1x 105 cells 
α-Cox4 (polyclonal) rabbit Cell Signaling WB 1:1000  
α-LAMP1 mouse, 
IgG1 κ 
BD Pharmingen IF 1:100 
α-Nucleoporin p62 (clone 53) mouse, 
IgG2b 
Abcam WB 1:500 
α-Leishmania major 
promastigote  
rabbit, 
polyclonal 
Uwe Ritter, 
Regensburg 
WB 1:500/IF 1:200 
Unconjugated isotype controls 
IgG1 κ non-azide/low-
endotoxin 
mouse Biolegend Functional assay 
1 µg/1x 105 cells 
IgG1 (clone 679.1Mc7) 
purified 
mouse Immunotech Functional assay 
 0.53 µg/1x 105 cells 
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Antibody/antiserum Species Manufacturer Use 
Conjugated primary antibodies 
FITC α-CD1a (clone HI149) mouse, 
IgG1 κ 
BD Pharmingen FACS 0.1 µg/1x 105 cells 
PB α-CD3 (clone UCHT1) mouse, 
IgG1 κ 
Biolegend FACS 0.1 µg/1x 105 cells 
PE α-CD11b (clone ICRF44) mouse, 
IgG1 κ 
BD Pharmingen FACS 16 ng/1x 105 cells 
PE α-CD14 (clone M5E2) mouse, 
IgG2a κ 
Biolegend FACS 0.01 µg/1x 105 
cells 
BV421 α-CD163 
(clone GHI/61) 
mouse, 
IgG1 κ 
BD Pharmingen FACS 0.05 µg/1x 105 
cells 
PE α-CD206 (clone 19.2) mouse, 
IgG1 κ 
BD Pharmingen FACS 0.2 µL/1x 105 cells 
APC α-CD209 (clone DCN46) mouse 
IgG2b κ 
BD Pharmingen FACS 2.5 µL/1x 105 cells 
Conjugated isotype controls 
FITC IgG1 κ (clone MOPC-21) mouse BD Pharmingen FACS 0.1 µg/1x 105 cells 
PB IgG1 κ (clone MOPC-21) mouse Biolegend FACS 0.1 µg/1x 105 cells 
PE IgG1 κ (clone MOPC-21) mouse BD Pharmingen FACS 16 ng/1x 105 cells 
PE IgG2a κ (clone MOPC-
173) 
mouse Biolegend FACS 0.1 µg/1x 105 cells 
BV421 IgG1 κ (clone X40) mouse BD Pharmingen FACS 0.05 µg/1 x105 
cells 
APC IgG2b κ (clone 27-35) mouse BD Pharmingen FACS 2.5 µL/1x 105 cells 
Secondary antibodies 
α-mouse IgG 
AF488 conjugated 
chicken Thermo 
Scientific 
IF 1:100 
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Antibody/antiserum Species Manufacturer Use 
α-mouse IgG 
HRP-conjugated 
goat Santa Cruz 
Biotechnology 
WB 1:2000 
α-rabbit IgG 
AF568 conjugated 
goat Thermo 
Scientific 
IF 1:100 
α-rabbit IgG 
AF647 conjugated 
chicken Thermo 
Scientific 
IF 1:100 
α-rabbit IgG 
HRP-conjugated 
goat Santa Cruz 
Biotechnology 
WB 1:2000 
 
3.1.10 Dyes and magnetic particles 
Dye Manufacturer 
Alexa Fluor 647 succinimidyl ester (AF647-SE) Thermo Scientific, Dreieich, GER  
Bromophenol blue Serva, Heidelberg, GER 
Carboxyfluorescein succinimidyl ester (CFSE) Sigma-Aldrich, Steinheim, GER 
DAPI (4′,6-Diamidin-2-phenylindole) Sigma-Aldrich, Steinheim,GER 
Diff-Quick staining solution 1 (Eosin) and 
2 (Thiazine) 
Medion Diagnostics, Düdingen, CH 
FITC AnnexinA5 Miltenyi, Bergisch Gladbach,GER 
GelRed Biotium, Fremont, USA 
Hoechst 33342 (Bis-benzimide) Sigma-Aldrich, Steinheim,GER 
PKH26 + Diluent C Sigma-Aldrich, Steinheim, GER 
Phalloidin-AF488 Thermo Scientific, Dreieich, GER 
Streptavidin-Cy5 Thermo Scientific, Dreieich, GER 
Trypan Blue Lonza, Basel, CH 
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Magnetic particle Manufacturer 
Microbeads, AnnexinA5-conjugated Miltenyi, Bergisch Gladbach, GER 
Microbeads, α-CD14-conjugated Miltenyi, Bergisch Gladbach, GER 
Bionized nanoferrite (BNF)-dextran beads  
 
(80 nm), Lipobiotin-conjugated 
Micromod, Rostock, GER  
 
 
3.1.11 Enzymes 
Enzyme Manufacturer 
Benzonase Merck, Darmstadt, GER 
Human recombinant granulocyte macrophage 
colony-stimulating factor (GM-CSF) 
Bayer Healthcare, Leverkusen, GER 
Human recombinant macrophage colony-
stimulating factor (M-CSF) 
R&D Systems, Minneapolis, USA 
Human recombinant Interleukin-4 (IL-4) R&D Systems, Minneapolis, USA 
Recombinant RNasin Ribonuclease Inhibitor Promega, Mannheim, GER 
Trypsin (in PBS, supplemented with EDTA) Paul-Ehrlich-Institut 
 
3.1.12 Ready-to-use kits 
Kit Manufacturer 
AnnexinA5 Microbead Kit Miltenyi, Bergisch Gladbach, GER 
CD14 Microbead Kit Miltenyi, Bergisch Gladbach, GER 
Human IL-1β DuoSet ELISA R&D Systems, Minneapolis, USA 
Human IL-6 DuoSet ELISA R&D Systems, Minneapolis, USA 
Human IL-8 DuoSet ELISA R&D Systems, Minneapolis, USA 
Human IL-10 DuoSet ELISA R&D Systems, Minneapolis, USA 
Human IL-TNF-α DuoSet ELISA R&D Systems, Minneapolis, USA 
ImProm II Reverse Transciption Kit Promega, Mannheim, GER 
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Kit Manufacturer 
LEGENDplex Human Inflammation Panel Biolegend, San Diego, USA 
MESA Blue qPCR MasterMix Plus for 
SYBR Assay No Rox 
Eurogentec, Cologne, GER 
Pierce BCA Protein Assay Kit Thermo Fisher, Dreieich, GER 
RNeasy Plus Mini Kit Qiagen, Hilden, GER 
Stemfect RNA Transfection Kit Stemgent, San Diego, USA 
 
3.1.13 Size markers 
Marker Manufacturer Use 
PageRuler Prestained 
(Plus) protein marker 
Thermo Scientific, St. Leon-Rot, 
GER 
5 µL 
SDS-PAGE 
 
3.1.14 Plasmids 
Plasmid name Resistance Source 
pPBj-SW-eGFP-LC3B Ampicillin (PhD thesis M. Thomas, 2015) 
pPBj-pack Ampicillin Plasmid Factory, Bielefeld, GER 
(Wolfrum et al., 2007) 
pVpxPBjsyn Ampicillin Plasmid Factory, Bielefeld, GER 
(Kloke et al., 2010) 
pMD.G2 (VSV-G) Ampicillin Plasmid Factory, Bielefeld, GER 
(Kind gift of D. Trono; Naldini et al., 
1996) 
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3.1.15 Oligonucleotides 
Primers 5‘ - 3‘ sequence Manufacturer 
CD91 forward AAC GAG CAT AACT GCC TGG G Eurofins, Ebersberg, 
GER 
CD91 reverse CGT ACA CTG AGC ACT CAT CAA A 
CD11b forward CGG CAA TAC AAG GAC ATG 
CD11b reverse CAC TTG CAC ACA GAC ACT TG 
GAPDH forward GAG TCA ACG GAT TTG GTC GT 
GAPDH reverse TTG ATT TTG GAG GGA TCT CG 
Small interfering RNA 5‘ - 3‘ sequence  
siCD91 not available Qiagen, Hilden, GER 
siCD11b not available 
Allstar control RNA not available 
 
3.2 Methods 
3.2.1 Cell biological methods 
3.2.1.1 Cell culture of primary human cells 
All cell culture work was performed under sterile conditions in a laminar flow workbench. 
If not stated differently, human cells were incubated at 37°C, 5 % CO2 and centrifuged at 
143x g for 8 min at 20°C. 
 
3.2.1.2 Counting of human cells 
If not stated differently, peripheral blood mononuclear cells (PBMCs), peripheral blood 
lymphocytes (PBLs), monocytes, macrophages and dendritic cells were counted using an 
automatic CASY cell counter equipped with a 150 µm capillary. For this, cells in CM were 
diluted 1:10000 in CASYton in a CASY tube and cell numbers were determined by three 
subsequent automatic measurements. Human embryonic kidney (HEK) 293T/17 cells and 
HT1080 cells were counted using a Neubauer-improved hemocytometer with a depth of 
0.1 mm. HEK 293T/17 and HT1080 cells were diluted 1:1 with Trypan Blue and incubated 
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for 1 min at RT. A volume of 10 µL was applied to the hemocytometer and Trypan Blue-
negative cells were counted as viable. The cell number in four big squares was determined 
and the concentration of cells/mL was calculated by multiplication of the median number 
of cells per big square with the dilution-factor of 2 and the chamber-factor (104). 
 
3.2.1.3 Isolation of peripheral blood mononuclear cells 
Peripheral blood mononuclear cells were isolated from blood donations of healthy and 
anonymous donors (DRK Blutspendedienst, Frankfurt) containing 30-50 mL blood. The 
blood was diluted with prewarmed PBS to a final volume of 100 mL. A volume of 25 mL of 
this suspension were layered on top of 15 mL prewarmed Histopaque leukocyte separation 
medium (density: 1.077 g/mL) in four 50 mL tubes to fraction the blood constituents. The 
tubes were centrifuged at 573x g for 30 min at 20°C with the minimal acceleration and 
deceleration, respectively. The white interphase containing the PBMCs (“buffy coat”) was 
collected and distributed into 6 new tubes. Wash buffer was added to a volume of 50 mL 
and the suspension was centrifuged to remove cell debris and thrombocytes. Further 
washing steps at different centrifugal forces (1084x g/ 573x g/ 143x g, 8 min, 20°C) were 
performed. Contaminating erythrocytes were lysed by incubation with 10 mL cold 
ammonium chloride-solution for 10-15 min at 20°C. Subsequently, the cells were washed 
with wash-buffer (143x g, 8 min, 20°C), pooled and counted using a CASY cell counter. 
Selection of monocytes was performed by plastic adherence or CD14-MACS. 
 
3.2.1.4 Plastic adherence for the generation of macrophages 
For the generation of human monocyte-derived macrophages (hMDMs) by plastic 
adherence, 50x 106 PBMCs were seeded in a 25 cm2 cell culture flask in 5 mL CM 
supplemented with 1 % human AB serum. Alternatively, 150x 106 PBMCs were seeded in a 
75 cm2 cell culture flask in 15 mL CM supplemented with 1 % human AB serum. By 
incubating for 1 h, monocytes adhered to the tissue culture-treated bottom of the flask. 
The supernatant with the non-adherent cells, containing mainly PBLs, was discarded or 
collected separately for subsequent experiments (3.2.4.4). Adherent cells were washed 
twice with wash-buffer. To differentiate macrophages from monocytes, CM supplemented 
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with 10 ng/mL GM-CSF (to generate hMDM1) or 30 ng/mL M-CSF (to generate hMDM2) 
was added. The cells were incubated for 5-7 days at 37°C. 
 
3.2.1.5 Monocyte isolation by CD14-MACS 
To yield monocytes with high purity, e.g. for siRNA-transfection or to generate hMDDCs, 
CD14-magnetic activated cell sorting (MACS) was performed. Freshly isolated PBMCs were 
washed with 50 mL MACS-buffer (322x g, 8 min, 20°C). Per 100x 106 PBMCs, 95 µL MACS-
buffer and 5 µL α-CD14 antibody-conjugated microbeads were added. Cells were 
resuspended and the suspension was incubated for 15 min at 4°C. Subsequently the cells 
were washed with 50 mL MACS-buffer (322x g, 8 min, 20°C) and the pellet was resuspended 
in 5 mL MACS-buffer. The cell suspension was applied onto a MACS-buffer-equilibrated 
large separation (LS) column. After the suspension entered the column, cells were washed 
with 3x 3 mL MACS-buffer and the flow through, containing PBLs, was discarded or 
collected on ice for later experiments (3.2.4.4). CD14+ monocytes were eluted on ice in 
5 mL MACS-buffer with a plunger. The monocytes were counted with a CASY cell counter. 
For generation of hMDMs, 3x 106 cells per well were seeded in a 6-well plate in a volume 
of 2.5 mL CM. To stimulate the differentiation of the monocytes into hMDM1 or hMDM2, 
the CM was supplemented with GM-CSF (10 ng/mL) or M-CSF (30 ng/mL), respectively. To 
generate hMDDCs, 1.5x 106 monocytes per well were seeded in a 6-well plate in a volume 
of 2.5 mL CM supplemented with 5 ng/mL GM-CSF and 10 ng/mL IL-4. The cells were 
incubated for 5-7 days. After 3 days of cultivation, growth factors were replenished by 
addition of 0.5 mL CM supplemented with the concentrations of GM-CSF, M-CSF or GM-
CSF/IL-4 as stated above. 
 
3.2.1.6 Harvesting of hMDMs and hMDDCs 
After 5-7 days of cultivation, morphological appearance and adherence of hMDMs and 
hMDDCs was checked with a light microscope. Subsequently, the flasks or plates were put 
on ice for 20-30 min to allow the cells to detach from the surface. Macrophages were 
harvested using a cell lifter and were pooled in a 50 mL tube. The flasks were washed once 
with 2 mL cold PBS. Each well was washed with 1 mL cold PBS. Cells were pelleted 
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(143x g, 8 min, 20°C) and resuspended in an appropriate amount of CM, depending on the 
size of the cell pellet, and counted using a CASY cell counter. 
 
3.2.1.7 Generation of hMDMs in Teflon bags 
The isolation of apoptotic Leishmania major promastigote-containing compartments from 
infected hMDMs was performed in the laboratory of a cooperation partner (PD Dr. Norbert 
Reiling, Research Center Borstel). Hence, different protocols for isolation of monocytes and 
generation of macrophages were used. Here, primary macrophages were generated from 
monocytes by cultivation in Teflon bags (Menck et al., 2014; Reiling et al., 2001; van der 
Meer et al., 1982). 
A blood donation containing approx. 250 mL fresh blood was diluted 1:1 with prewarmed 
PBS and 40 mL of this dilution were layered on top of 10 mL Pancoll (density: 1.077 g/mL) 
in 50 mL reaction tubes. Tubes were centrifuged at 1024x g for 40 min at 20°C. The plasma 
on top of the emerging gradient was discarded and the interphase was harvested using a 
Pasteur pipette. The interphases of three gradients were pooled in 50 mL reaction tubes 
on ice. Reaction tubes were filled with cold PBS and centrifuged (545x g, 10 min, 4°C). 
Supernatants were discarded and the pellets were washed with cold PBS. Pellets were 
resuspended in CM without P/S and counted using a Neubauer-improved hemocytometer. 
For elutriation, cells were resuspended in HBSS + 1 % BSA at a concentration of 
5x 106 cells/mL. Elutriation or counter flow centrifugation, is utilizing centrifugal forces for 
the separation of monocytes from PBLs. This was performed by our collaboration partners 
according to their standard protocol (Reiling et al., 2001). After elutriation, 
20-25x 106 monocytes were resuspended in differentiation medium supplemented with 
10 ng/mL M-CSF and seeded in a Teflon bag, which was flushed two times with 50 mL PBS 
using a 50 mL syringe (Menck et al., 2014). Cells were incubated for 7 days at 37°C. To 
harvest hMDM2, Teflon bags were placed on ice for 1 h and cells were detached by pulling 
the bags over the edge of a workbench. Cell suspensions were collected in reaction tubes 
and centrifuged (545x g, 10 min, 4°C).  The cell pellet was resuspended in an appropriate 
volume of CM depending on the pellet size prior to counting in a Neubauer 
hemocytometer.  
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3.2.1.8 Long-time storage and thawing of PBLs 
Supernatants collected from cell culture flasks or wash fractions from CD14-MACS that 
contained PBLs were centrifuged (322x g, 8 min, 20°C) and the pellets were resuspended 
in 1.8 mL cryo-medium. A volume of 900 µL was transferred to a cryo-tube and 100 µL 
DMSO were added. Cryotubes were rapidly transferred to -80°C and stored for further 
usage of the cells. 
Cells were thawed by gently shaking the cryotube in a water bath at 37°C. The thawed PBLs 
were carefully transferred to 7 mL prewarmed CM. Residual DMSO was removed by 
centrifugation (143x g, 8 min, 20°C) and the pellet was resuspended in CM. The cells were 
counted using a CASY cell counter and adjusted with CM to the desired concentration for 
further use. 
 
3.2.1.9 Cultivation of HEK 293T/17 cells 
HEK 293T/17 cells are a human embryonic kidney cell line which is highly susceptible to 
transfection and used for the recombinant production of retroviral. Cells were cultivated in 
DMEM and were sub-cultured twice a week in a 175 cm2 culture flask by splitting at a ratio 
of 1:3. The cell supernatant was discarded and cells were washed with 10 mL prewarmed 
PBS. Cells were detached by addition of 3 mL trypsin/EDTA and incubation at 37°C for 
5 min. Trypsinization was stopped with 9 mL culture medium. A volume of 4 mL of this cell 
suspension was mixed with 20 mL DMEM and transferred into a new 175 cm2 flask. Cells 
were further incubated at 37°C. 
 
3.2.1.10 Cultivation of HT1080 cells 
HT-1080 cells are a fibrosarcoma cell line highly susceptible to Vesicular stomatitis virus 
(VSV)-infection. The surface glycoprotein of the virus (VSV-G) is used in recombinant 
lentiviral vectors allowing for efficient transduction of human cells (3.2.6.2). HT1080 
therefore are used to titrate lentivirus titers. Cells were cultivated in DMEM and were sub-
cultured twice a week in a 75 cm2 culture flask by splitting them at a ratio of 1:10. 
Therefore, the cell supernatant was discarded and cells were washed with 10 mL 
prewarmed PBS. Cells were detached by addition of 2 mL trypsin/EDTA at 37°C for 5 min. 
To stop the enzymatic reaction, 8 mL DMEM were added and 1 mL of this cell suspension 
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was transferred into a new 75 cm2 flask containing 19 mL DMEM. Cells were further 
incubated at 37°C. 
 
3.2.2 Cultivation of Leishmania major promastigotes 
Leishmania major promastigotes (hereafter: Lm) were incubated at 27°C and 5 % CO2. If 
not stated differently, Lm were centrifuged at 2400x g for 8 min at 4°C. 
Lm were cultured in Novy-MacNeal-Nicolle (NNN) modified medium, a biphasic rabbit 
blood-based medium consisting of a solid blood-agar slope and liquid Lm medium 
(hereafter: NNN-blood-agar) (Nicolle, 1908). For passaging, 3 wells of a 7-day-old stationary 
phase Lm-culture were diluted in 3 mL liquid Leishmania medium and counted as described 
below (3.2.2.1). Promastigotes were adjusted to a final concentration of 1x 106/mL and 
1x 105 Lm per well (≙ 100 μL) were transferred to a new blood-agar plate. Parasites were 
incubated at 27°C for 6-8 days until stationary phase Lm were used for AnnexinA5-MACS 
or infection experiments. Parasites were cultured up to 8 serial passages until they were 
discarded. DsRed expressing Lm were cultivated analogous to wild-type Lm whereas the 
Lm medium was supplemented with 20 ng/mL hygromycin to maintain selection pressure 
for keeping the DsRed-encoding plasmids. 
3.2.2.1 Counting of Leishmania major parasites 
Lm were counted in a Neubauer-improved hemocytometer with a depth of 0.02 mm. For 
this, parasites from an in vitro culture were diluted at a ratio of 1:10 in liquid Lm medium 
and 5 µL of the suspension were applied to the hemocytometer. Numbers of viable and 
apoptotic Lm in 16 small squares were counted. Total cell numbers per mL were calculated 
by multiplication of the total cell numbers with the chamber factor (5x 104).  
 
3.2.2.2 AnnexinA5-MACS of stationary phase Leishmania major promastigotes 
Viable and apoptotic Lm were separated from a wild-type stationary phase Lm culture by 
magnetic-activated cell sorting (MACS) using AnnexinA5 (AnxA5) microbeads. These beads 
specifically bind phosphatidylserine (PS) on the surface of apoptotic cells in presence of 
Ca2+ ions. Microbeads are paramagnetic particles, 50 nm in size, that are conjugated to 
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antigen-specific antibodies or other antigen-directed proteins such as AnxA5. Due to their 
small size, binding of the beads to their target does not activate cells.  
Lm were counted and set to the desired cell numbers for the respective experiment. 
Parasites were pelleted and washed twice with 20 mL and 10 mL MACS buffer 1, 
respectively. Subsequently, Lm were resuspended in 40 μL MACS-buffer 1 per 
25x 106 parasites. A volume of 10 µL AnxA5-microbeads was added per 25x 106 parasites 
(viable and apoptotic Lm) and this suspension was incubated for 15 min in the refrigerator. 
After incubation, parasites were washed with 10 mL MACS buffer 1, resuspended in 1 mL 
MACS buffer 1 and applied onto a large separation (LS) column that was pre-equilibrated 
with MACS buffer 1. As soon as the suspension entered, the column was washed with 
3x 3 mL MACS buffer 1 and the flow-through containing mainly unlabeled, AnxA5-non-
binding viable Lm, was collected. For elution of PS-positive, AnxA5-binding apoptotic Lm, 
1x 2 mL and 3x 3 mL MACS buffer 2 which contains no Ca2+ ions, were applied and the 
elution fraction was collected. The cell number and purity of the wash-fraction was 
determined by counting in a hemocytometer. To improve purity of the viable Lm-containing 
fraction, the cells were once more incubated with AnxA5-microbeads as described and 
separated in a large depletion (LD) column that retains labeled, apoptotic Lm. In principle 
the procedure is similar to that for separation on a LS column whereas Lm are applied onto 
the column in a volume of 500 µL MACS buffer 1 and the viable fraction was washed out 
by addition of 3x 1 mL MACS buffer 1. The number of parasites in each fraction was 
determined by counting and cells were labeled for infection experiments and flow 
cytometry (3.2.4.2 and 3.2.9.7) or remained unlabeled for western blot-analysis and 
cytokine analysis by ELISA (3.2.4.6 and 3.2.8.2). When infection with a stationary phase was 
desired, an artificial 1:1 mixture of purified viable and apoptotic Lm was generated. 
 
3.2.3 Cytocentrifugation of hMDMs and Leishmania major promastigotes 
Cytocentrifugation is a rapid method to attach cells onto microscopy slides for microscopic 
analysis. Either 1x 105 hMDMs or 1x 106 Lm were resuspended in 100 µL CM/Lm medium 
or PBS and centrifuged onto a microscopy slide at 75x g for 5 min (hMDMs) or 500x g for 
10 min (Lm) at RT. Slides were air-dried and further stained by Diff-Quick or DAPI to 
visualize the nucleus for fluorescence microcopy analysis. Fluorescent samples were 
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mounted with Mowiol, supplemented with DABCO to retain fluorescence, and a glass 
coverslip. 
 
3.2.4 Infection experiments 
3.2.4.1 Infection of transduced hMDMs for live cell microscopy 
For dynamic imaging of Lm infection in vitro, eGFP-LC3-transduced hMDMs (3.2.6.3) were 
co-incubated with PKH26-stained purified viable or apoptotic Lm. Parasites were set to a 
concentration of 15x 106 cells/mL with CM of which 10 µL were added to hMDMs 
(1.5x 105 Lm, MOI 1). Cells were imaged as described in 3.2.11.3.  
 
3.2.4.2 Infection of hMDMs and hMDDCs for flow cytometry or fluorescence microscopy 
For quantification of infection rates by immunofluorescence microscopy, 0.1x 106 hMDMs 
were seeded in 100 µL in a well of a 12-well chamber slide. Cells were left to adhere for a 
minimum of 30 min and were subsequently co-incubated with viable or apoptotic Lm for 
different times as indicated in the respective experiment. hMDMs were fixed by 4 % PFA 
for 10 min at 4°C. Fixed macrophages were further processed for immunofluorescence 
microscopy as described below (3.2.9.3). 
To assess infection rates of hMDMs and hMDDCs by flow cytometry, 3x 105 cells were 
seeded in 1.5 mL reaction tubes in a volume of 100 µL CM. To investigate the role of CR3 in 
Lm infection, cells were incubated with α-CD11b or the corresponding isotype-control 
(3.1.9) for 30 min at 37°C. Unbound antibody was removed by washing of the cells with 
1 mL CM (68x g, 8 min, 20°C). Alternatively, CD91 knockdown cells or the corresponding 
controls (3.2.7.2) were used at the indicated cell numbers. Subsequently, hMDMs and 
hMDDCs were infected with 3x 106 AnxA5-MACS-purified, CFSE-labeled viable Lm, Alexa 
Fluor 647-SE-labeled apoptotic Lm or an artificial stat. ph. (MOI 10) for 3 h at 37°C. To 
remove non-internalized parasites, cells were washed twice with CM (68x g, 8 min, 4°C) 
and resuspended in 100 µL CM or 100 µL 1 % PFA for later analysis. Infection rates were 
determined by flow cytometry (3.2.10). 
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3.2.4.3 Cytokine analysis upon differential infection with Leishmania major 
To measure the concentrations of secreted cytokines in supernatants of infected hMDMs 
or hMDDCs, 1-3x 105 macrophages were seeded in 1.5 mL reaction tubes. Depending on 
the experimental setup, cells were treated with α-CD11b or the corresponding isotype 
control. Cells were co-incubated with either purified viable or apoptotic Lm or an artificial 
stat. ph. (MOI 10) for 3 h. After co-incubation, cells were washed twice with 1 mL CM (68x g, 
8 min, 20°C). Infected cells were further incubated in 100 µL CM per 1x 105 cells for 21 h at 
37°C. Subsequently, supernatants were collected and frozen at -80°C for later analysis by 
ELISA (3.2.8.2). 
 
3.2.4.4 CFSE-based proliferation assay 
For the T cell proliferation assay, 1.5x 105 CFSE-stained hMDMs were seeded in 1.5 mL 
reaction tubes. CR3 on the surface of the cells was blocked by addition of 1.5 µg α-CD11b 
or cells were treated with the corresponding isotype control and subsequently incubated 
for 30 min at 37°C. After washing with 900 µL CM, cells were infected with 1.5x 106 log. ph. 
or stat. ph. DsRed Lm (MOI 10). Untreated hMDMs served as controls. After 3 h of 
incubation at 37°C, extracellular parasites were removed by washing the cells twice with 
900 μL CM (68x g, 8 min, 20°C). The pellet was resuspended in 375 μL CM and 50 μL of the 
suspension were transferred to a 96-well round bottom plate in 6 replicates. The plates 
were incubated over night at 37°C. 
One day post infection CFSE-stained PBLs were added at a ratio of 1:5 (hMDM:PBL) and the 
cell suspensions were incubated at 37°C for 6 days. To determine the number of 
proliferated T cells after 6 days of co-incubation, 4 replicates were pooled in a 96 well V-
shape plate. The plate was centrifuged (439x g, 8 min, 4°C) and the cell pellets were 
resuspended in 100 μL FACS washing buffer. T cells were stained with an α-CD3 antibody 
and analysis was performed by flow cytometry.  
 
3.2.4.5 Determination of parasite survival by limiting dilution assay 
To assess the survival of viable Lm within hMDMs, a limiting dilution assay was performed 
in NNN-blood-agar plates. By serial dilution of infected cells, the number of internalized 
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parasites can be determined by assessing the last dilution step in which parasite growth 
can be detected (Bogdan et al., 1990; Titus et al., 1985). 
For this, 7x 105 cells were seeded in 1.5 mL reaction tubes in 100 µL CM. Cells were treated 
with α-CD11b or the corresponding isotype control or were left untreated prior to infection 
with an artificial stat. ph. comprised of CFSE or AF647-SE-labeled purified viable and 
apoptotic Lm. At 3 h post-infection, non-internalized Lm were removed by washing twice 
with 1 mL CM. Cells were further incubated in 700 µL CM over night at 37°C. The next day, 
the number of cells per condition were determined with a CASY cell counter. Solutions of 
1x 104 cells /mL were generated with Lm medium. Four replicates of each 200 µL 
(≙ 2x 103 cells) were seeded in a NNN-blood-agar plate and cells were serially diluted in 
1:1.5 steps. Blood-agar plates were incubated at 27°C for 7 days. Determination of the last 
dilution step in which Lm growth could be detected was performed by light microscopy. 
The number of parasites per 1000 hMDMs was calculated from the last dilution that 
showed parasite growth and equals 1.5 exp (mean dilution with parasite growth). 
Remaining infected hMDMs were further incubated at 37°C for 5 days and the generation 
of serial dilutions was repeated as described. 
 
3.2.4.6 Determination of LC3 conversion by western blot analysis 
Western blot analysis was used to assess the induction of LC3-associated phagocytosis 
upon co-incubation of hMDMs or hMDDCs with Lm. For this, 2.5x 105 hMDMs or hMDDCs 
were seeded in a 1.5 mL reaction tube in 100 µL CM. Cells were incubated with α-CD11b or 
the corresponding isotype control for 30 min. Excess antibody was washed away with 1 mL 
CM (68x g, 8 min, 20°C) and cells were differentially infected with purified viable, apoptotic 
or stat. ph. Lm for 3 h. Subsequently, cells were centrifuged (345x g, 8 min, 4°C) and the 
pellet was resuspended in 20 µL 1x Laemmli buffer. Lysates were generated by heating at 
95°C for 10 min. The samples were stored at -20°C. 
 
3.2.5 Magnetic isolation of phagosomes 
3.2.5.1 Isolation procedure for phagosomes 
The isolation of phagosomes harboring apoptotic Lm from macrophages was performed 
according to the modified protocol of Steinhäuser (Steinhäuser et al., 2014, 2013). For this, 
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each 10x 106 hMDM2 generated in Teflon bags (3.2.1.7) were seeded in two petri dishes 
(60 cm2). Adherent cells were co-incubated with 100x 106 (MOI 10) of purified, magnetic 
bead-labeled apoptotic Lm for 1 h at 37°C (3.2.9.5). Subsequently, medium was discarded 
and cells were gently washed with 10 mL cold PBS. Cells were further incubated with 
homogenization buffer (supplemented with 0.2 % EDTA) for 15 min on ice and harvested 
with a cell lifter. After centrifugation (310x g, 10 min, 4°C) cells were resuspended in 500 µL 
of homogenization buffer (supplemented with protease inhibitors) and collected in a 
1.5 mL reaction tube. A sample of 50 µL was taken and 1:1 diluted with homogenization 
buffer (supplemented with 0.2 % EDTA) for later western blot analysis and BCA assay 
(sample: lysate).  
Gentle homogenization of cells was achieved by three rounds of sonication, each followed 
by centrifugation (500x g, 2 min, 4°C) and collection of the supernatants. The approx. 
600 µL of homogenate were filled to 700 µL with homogenization buffer (supplemented 
with protease inhibitors, Cytochalasin D and Benzonase). The sample was incubated at 37°C 
for 5 min to ensure degradation of nucleic acids by the supplemented Benzonase. A sample 
of 50 µL was taken and 1:1 diluted with homogenization buffer (supplemented with 
protease inhibitors, Cytochalasin D and Benzonase) for later western blot analysis and BCA 
assay (sample: homogenate). 
For magnetic isolation, a commercially available permanent-magnet (HOKImag) was used. 
The magnetic chamber is constructed with a high-intensity 2 Tesla magnetic field and a 
device to insert a unique free-flow separation column (Tchikov and Schütze, 2008). After 
loading of the homogenate, magnetically labeled phagosomes are attracted to the walls of 
the column. The system’s advantage is the lack of ferromagnetic particles. Hence, lysates 
of any density can be applied and separated (Steinhäuser et al., 2013; Tchikov and Schütze, 
2008). 
Prior to loading of approx. 650 µL of the homogenate, the plastic column was rinsed with 
homogenization buffer 3. The homogenate was incubated within the magnetic field for 
90 min and washed for 5 min with homogenization buffer (supplemented with protease 
inhibitors) at a flow rate of 250 µL/min. A volume of 100 µL was withdrawn for later 
western blot analysis and BCA assay (sample: non-magnetic fraction). The column was 
washed for another 10 min. The magnetic-fraction, harboring the apoptotic Lm-containing 
phagosomes, was eluted by first releasing the column from the magnetic field. Phagosomes 
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adhering to the walls of the column spontaneously eluted and were collected in a 1.5 mL 
reaction tube. Remaining phagosomes were collected by scraping the sides of the column 
with a plunger of a 1 mL syringe. The eluate was centrifuged (15000x g, 10 min, 4°C) and 
the brownish pellet was resuspended in 100 µL of homogenization buffer (supplemented 
with protease inhibitors). Each 12.5 µL were stored for later western blot analysis and BCA 
assay (sample: magnetic-fraction). Western blot samples were diluted with 6x Laemmli 
buffer and stored at -20°C. The remaining eluate for mass spectrometry was centrifuged 
(15000x g, 10 min, 4°C), rapidly frozen in liquid nitrogen and stored at -80°C. Protein 
amounts of the different elution fractions and western blot samples were determined by 
BCA assay (3.2.8.3). 
 
3.2.5.2 Label-free mass spectrometry and functional protein association network-
analysis  
Mass spectrometry of the isolated apoptotic Lm-containing phagosomes was performed by 
our collaboration partner (Prof. Dr. Stefan Tenzer, University Hospital Mainz). Samples 
were prepared and analyzed by label-free nano ultra-performance liquid chromatography-
coupled mass spectrometry (nanoUPLC-MSE, hereafter: LC-MS). Prior to LC-MS, proteins of 
a sample were proteolytically digested to generate small peptides. These peptides were 
separated  by LC and subsequently identified and quantified by MS (Distler et al., 2016). 
For each sample, three technical replicates were analyzed and data was processed with the 
quantification software ISOQuant (Kuharev et al., 2015). Most abundant human proteins 
were determined by ranking for their overall presence in all independently analyzed 
samples in MS Excel 2010 software. Proteins of interest were further analyzed in regard of 
the number of reported distinct peptides and the coverage of the respective protein 
sequence by these peptides. Most abundant human proteins identified were used for 
functional protein association network-analysis at the STRING-database (Szklarczyk et al., 
2019). Interesting target proteins were further analyzed in vitro regarding their function in 
Lm infection. 
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3.2.6 Virological methods 
3.2.6.1 Production and concentration of lentiviral vectors 
3.2.6.1.1 Transfection of HEK 293T/17 cells with calcium phosphate 
Lentiviral vectors were produced by transfection of HEK 293T/17 cells with a four-plasmid 
system (Kloke et al., 2010). The packaging construct (pPBj-pack) is coding for structural 
lentiviral genes (gag, pol) except the envelope protein. The envelope construct (pMD.G2) 
encodes for the surface G-protein of Vesicular stomatitis-virus (VSV-G). This pseudo-typing 
with the VSV-G protein allows for transduction of a wide variety of cells since it redirects 
vector entry through the endocytic pathway (Naldini et al., 1996). The viral accessory 
protein Vpx targets the host cell restriction factor SAMHD1 to proteasomal degradation 
what enables successful infection of myeloid cells with HIV-1 and related SIV viruses 
(Hrecka et al., 2011; Laguette et al., 2011). Furthermore, Vpx-mediated SAMHD1 
degradation renders primary monocytes highly susceptible to HIV-1 infection and is 
therefore included in the transfection system (pVpxPBjsyn) (Berger et al., 2011). The 
desired transgene is introduced into the cells by the plasmid pPBj-trans which in our project 
codes for eGFP-tagged microtubule-associated protein 1A/1B light chain 3B (pPBj-SW-
eGFP-LC3). 
Transfection was performed with constructs that were already isolated from bacterial cells 
(pPBj-SW-eGFP-LC3) or that can be acquired commercially. Three days prior to transfection, 
each 4.5x 106 HEK 293T/17 cells were seeded into 24 T175-flasks in 20 mL DMEM. One hour 
before transfection the medium was replaced by 5 mL pre-warmed DMEM supplemented 
with 25 μM chloroquine to inhibit fusion of lentiviral-containing endosomes with lysosomes 
and hence increasing transfection efficiency. The four different plasmids were diluted in 
High-purity water and 250 mM CaCl2 was added (Table 2). For 24x T175-flasks a total 
volume of 36 mL was prepared in a 50 mL tube and afterwards split to three tubes à 12 mL. 
The same volume 2x HBS-buffer was added drop wise to each tube while aspirating the 
DNA-CaCl2 solution with a pipette. Subsequently, the precipitate was added drop wise to 
the cells (3 mL/flask). After 8 h and 24 h of incubation medium was replaced by 20 mL and 
9 mL fresh DMEM, respectively. 
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Table 2: Ratios and volumes used for a large-scale transfection of HEK293T/17 cells for lentiviral vector-
production. 
Plasmid 
stock 
concentration  
ratio/ 
concentration 
24x T175 flasks 
pPBj-SW-eGFP-LC3 0.431 µg/µL 1 600 µg 1391,95 µL 
pPBJpack 1 µg/µL 1 600 µg 600 µL 
pMD.G2  1 µg/µL 0,33 198 µg 198 µL 
pVpxPBjsyn  1 µg/µL 0,165 99 µg 99 µL 
CaCl2 2.5 M 250 mM  3600 µL 
High-purity water    30,111 mL 
2x HBS    36 mL 
 
3.2.6.1.2 Concentration of lentiviral vector particles 
At 48 h post-transfection cell-supernatants that contained the pseudo-typed lentiviral 
vector particles were harvested. The medium was replaced by 9 mL fresh DMEM and cells 
were further incubated for 24 h. The supernatants of four flasks were pooled and 
centrifuged (169x g, 10 min, 4°C) to remove dead cells and cell debris. Cleared 
supernatants were sterilized through a 0.45 μm vacuum filter. To enrich vector particles, 
30 mL of the filtered supernatant was transferred to a polyallomer centrifuge tube, sub 
layered with 5 mL of 20 % sucrose and concentrated by ultracentrifugation (82705x g, 2 h, 
4°C). A small aliquot of 1 mL of unconcentrated particles was withdrawn and stored 
at -80°C. After centrifugation, the supernatant was discarded and the pellet containing 
lentiviral particles was resuspended in 50-200 μL of RPMI 1640 without supplements. 
Pellets were dissolved by shaking at 4°C for 15 min. Concentrates were transferred to 2 mL 
tubes and centrifuged (7983x g, 1 min, 4°C). Lentiviral vector particles were stored in 10 µL-
aliquots at -80°C. At 72 h and 96 h post-transfection, vectors were harvested and prepared 
as described. 
 
3.2.6.2 Titration of lentiviral vectors 
Titers of lentiviral vector particles were determined by transduction of HT1080 cells and 
analysis by flow cytometry. One day prior to transduction 5x 104 cells were seeded in 1 mL 
DMEM per well of a 24-well plate. Concentrated vector particle stocks were serially diluted 
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with DMEM (1:500, 1:1000, 1:5000, 1:10000, 1:50000). A volume of 250 μL of the 
respective dilution was added per well. Cells were incubated for 4 h and the medium was 
changed to 500 µL DMEM. After 3-4 days cells were harvested discarding the supernatant 
and addition of 250 µL of PBS/EDTA for 5 min at 37°C. Subsequently, the collected cells 
were washed with PBS (265x g, 5 min, 20°C) and cells were fixed with 200 µL 1 % PFA. 
Vector titers were determined by flow cytometry. For this, dilutions of vector particles that 
resulted in 4-20 % of transduced HT1080 cells were used for calculation. Higher 
transduction efficiencies indicate double-positive cells. Titers were calculated as follows: 
Titer [i.u./mL] = % transduced cells / 100 % x seeded cell number (5x 104) x dilution 
factor x 4. 
 
3.2.6.3 Lentiviral transduction of human monocyte-derived macrophages 
To generate eGFP-LC3-expressing hMDMs for western blot analysis, 2.5x 105 cells were 
seeded in 1.5 mL reaction tubes. For live cell microscopy 1.5x 105 cells were seeded per 
well of an 8-well chamber slide. hMDMs were transduced with lentiviral vector particles at 
a multiplicity of infection (MOI) of 1 and incubated for 4-5 days. 
For western blot samples, transduced hMDMs were harvested 4 h and 24 h post-
transduction. As positive controls, hMDMs were stimulated with the autophagy inducer 
PI-103 (10 µM) for 1 h. Cells were centrifuged (345x g, 8 min, 4°C) and pellets were 
resuspended 20 µL 1x Laemmli buffer and heated at 95°C for 10 min. Lysates were stored 
at -20°C. 
 
3.2.7 Molecular biological methods 
3.2.7.1 Determination of nucleic acid concentration 
Nucleic acid concentrations were determined with a NanoDrop 2000c UV-Vis 
spectrophotometer. For this, 1-2 μL of the DNA or RNA sample were pipetted on the quartz 
cell of the device and concentration was measured at a wavelength of 260 nm in duplicates. 
Synchronous measurement at a wavelength of 280 nm allowed for determination of 
protein impurities of the samples. 
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3.2.7.2 Transfection of hMDMs with small interfering RNA 
We performed knock down of receptors by transfection with small interfering RNA (siRNA). 
For transfection, 3x 106 CD14-MACS separated hMDMs seeded in 6-well cell culture plates 
were washed once with 1 ml RPMI 1640 medium and 1 ml RPMI 1640 was added per well. 
For the transfection, solutions A and B were prepared according to Table 3. Both solutions 
were mixed and incubated for 20 min at RT. The final concentration of siRNA or non-target 
siRNA per well was 20 nM. After 7 h of incubation, cells were washed once with 1 mL CM 
and 2.5 mL CM were added per well. At day 2 post-transfection, hMDMs were harvested, 
counted and used for RNA isolation, characterization by flow cytometry or infection 
experiments. 
Table 3: Preparation of solutions A and B for siRNA transfection of hMDMs per well of a 6-well cell culture 
plate. 
 target siRNA (c=10 µM) non-target siRNA (c=20 µM) 
Solution A   
Transfection buffer 20 µL 20 µL 
RNA transfection reagent 4.6 µL 4.6 µL 
Solution B   
Transfection buffer 20 µL 20 µL 
siRNA (final 20 nM) 2 µL 1 µL 
 
3.2.7.3 RNA isolation from hMDMs 
RNA was isolated from hMDMs with the RNeasy Plus Mini Kit according to the 
manufacturer’s instructions. RNA was either placed on ice for subsequent cDNA synthesis 
or was stored at -80°C. 
 
3.2.7.4 Reverse transcription for synthesis of cDNA 
For cDNA synthesis the ImProm-II Reverse Transcription System Kit was used according the 
manufacturer’s instructions. The used reverse-transcriptase is a RNA-dependent 
polymerase that catalyzes the generation of cDNA from a RNA template. Annealing of 
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random primers serves the generation of random starting points for subsequent cDNA 
synthesis by the reverse-transcriptase (Table 4). 
 Table 4: Preparation of RNA samples for reverse transcription by annealing of random primers. 
Reagent Volume/amount 
Random primer mix 1 µL 
Template RNA 50 ng 
Nuclease-free H2O ad 5 µL 
 
The primer-RNA mixture was incubated for 5 min at 70°C and subsequently chilled on ice. 
A reverse transcription reaction mix was prepared on ice and added to each sample 
(Table 5). 
Table 5: Preparation of the master-mix for reverse transcription of isolated RNA with the ImPromII Reverse 
Transcription Kit. 
Reagent Volume Final concentration 
Nuclease-free H2O 6.5 µL  
ImPromII reaction buffer (5x) 4 µL 1x 
MgCl2 (25 mM) 2 µL 2.5 mM 
dNTP mix (10 mM each) 1 µL 0.5 mM 
RNasin Ribonuclease Inhibitor (20 U/µL) 0.5 µL 10 U 
ImPromII Reverse Transcriptase 1 µL  
 
The reverse transcription was performed in a thermal cycler with the following program 
(Table 6) and samples were subsequently used for quantitative real-time polymerase chain 
reaction (qRT-PCR) or were stored for further use at -20°C. 
Table 6: Thermo cycler program for reverse transcription using the ImPromII Reverse Transcription Kit. 
Amplification step Temperature Time 
Annealing 25°C 5 min 
Reverse transcription 42°C 60 min 
Inactivation  70°C 15 min 
Cooling  4°C ∞ 
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3.2.7.5 Quantitative real-time polymerase chain reaction 
Quantitative real-time PCR (qRT-PCR) was used to amplify DNA and quantify the de novo 
synthesized DNA molecules during analysis in real-time. This allows for determination of 
expression levels of genes by analysis of synthesized cDNA which correlates to the initial 
amount of mRNA. For this, the MESA Blue qPCR MasterMix Plus for SYBR Assay-Kit was 
used according to the manufacturer’s instructions. A master-mix for each cDNA-specific 
primer pair was prepared (Table 7). GAPDH was used as housekeeping-gene for 
normalization. The primers used are listed in 3.1.15. 
Table 7: Preparation of the master-mix for quantitative real-time polymerase chain reaction with the MESA 
Blue qPCR Kit. 
Reagent Volume Final concentration 
MESA Blue qPCR MasterMix (2x) 10 µL 1x 
ddH2O 6 µL  
Primer forward (10 µM) 1 µL 0.5 µM 
Primer reverse (10 µM) 1 µL 0.5 µM 
cDNA 2 µL  
 
The polymerase-chain-reaction was performed in a LightCycler 480 (Table 8). Amplified 
DNA is quantified by detection of the fluorescent dye SYBR Green that intercalates into the 
DNA molecules. Based on the fluorescence-intensity that is proportional to the amount of 
DNA molecules, the amplification of the target genes can be measured. The more DNA was 
present in the beginning of the amplification, the more will be quantified. All samples were 
measured in duplicates. H2O instead of cDNA served as negative control.  
Table 8: Amplification program for quantitative real-time PCR in a LightCycler 480. 
Amplification step Temperature Time Temperature change/s 
Taq activation 95°C 10 min 4.4°C 
45 cycles 
Denaturation 95°C 10 s 4.4°C 
Annealing 60°C 10 s 2.2°C 
Elongation 72°C 15 s 4.4°C 
Melting curve 60-99°C  0.11°C 
Cooling 40°C 20 min 2.2°C 
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Data was analyzed for relative gene expression compared to GAPDH with the 2∆∆CT-method 
(CT: cycle threshold; Livak and Schmittgen, 2001). For this, the cycle in which the 
fluorescence signal significantly exceeds the background signal for the first time is 
determined and normalized to the housekeeping gene. 
 
3.2.8 Protein-biochemical methods and immunoassays 
3.2.8.1 Western blot analysis 
3.2.8.1.1 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate-polyacrylamide gel electrophoreses (SDS-PAGE) is a method used 
to separate proteins according to their respective molecular weight (Laemmli, 1970). 
Proteins were separated on 15 % SDS-polyacrylamide gels that were prepared according to 
a standard protocol (Table 9). Alternatively, precast gradient gels (4 - 20 % polyacrylamide) 
were used. Samples were loaded onto the gel together with a pre-stained molecular weight 
marker. Separation of proteins was performed by electrophoresis in a tank containing cold 
1x running buffer at constant voltage of 120 V. 
Table 9: Components and volume for the preparation of two 15 % polyacrylamide gels for SDS-PAGE. 
Reagent Volume 
 Stacking gel (4 %) Separation gel (15 %) 
ddH2O 2.5 mL 4.5 mL 
Stacking gel buffer (pH 6.8) 1 mL - 
Separating gel buffer (pH 8.8) - 9 mL 
Acrylamide/bis-acrylamide solution (30 %) 0.5 mL 9 mL 
TEMED 5 µL 40 µL 
APS (10 %) 20 µL 180 µL 
 
3.2.8.1.2 Western blotting and protein detection 
SDS-PAGE-separated proteins were transferred from the polyacrylamide gel onto a 
methanol-activated polyvinylidene difluoride (PVDF)-membrane by semi-dry blotting 
(Burnette, 1981). Transfer was performed in presence of western blotting-buffer for 1 h at 
constant 1.5 mA per cm2 of gel. Immobilized proteins were detected by incubation with 
specific antibodies (3.1.9). Prior to incubation, the membrane was blocked in 
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TBST + 5% milk for 1 h at RT to saturate possible unspecific binding sites for the used 
antibodies. Subsequently, the membrane was rinsed with TBST to remove residual milk and 
the membrane was incubated with the primary antibody over night at 4°C with gentle 
agitation. The membrane was washed 3x 10 min with TBST and a secondary HRP-
conjugated antibody was added in TBST + 5 % milk for 1-2 h at RT. The membrane was again 
washed 3x 10 min and proteins were detected by chemiluminescence. For this, the 
membrane was incubated with either ECL- or Luminata Forte-substrate for 2 min and the 
signal was detected by exposition to x-ray film and subsequent development or with a 
digital gel-documentation device. Densitometry analysis of western blot signals was 
performed with the software LabImage 1D or ImageJ/Fiji. Signals of the protein of interest 
were normalized to β-actin which served as loading control.  
 
3.2.8.2 Enzyme-linked immunosorbent assay (ELISA) 
The concentrations of cytokines in cell supernatants of infected cells were determined by 
ELISA according to the manufacturer’s instructions. Prior to analysis, supernatants were 
diluted 1:10. The optical density at a wavelength of 450 nm was recorded in duplicates in 
an absorbance microplate reader. 
Alternatively, a LEGENDplex bead-based immunoassay kit was used to quantify cytokine 
concentrations. The principle is based on the ELISA but utilizes beads with different sizes 
and different internal fluorescence intensities. These beads are conjugated to cytokine-
specific antibodies which allows for detection and quantification of multiple cytokines at a 
time. Read-out was performed in duplicate by flow cytometry according to the 
manufacturer’s instructions. Data was analyzed with the LEGENDplex data analysis 
software. 
 
3.2.8.3 Bicinchoninic acid assay  
The protein concentration of western blot samples and eluate fractions of the phagosome-
isolation were determined in duplicates with a bicinchoninic acid (BCA) assay kit according 
to the manufacturer’s instructions. BCA-reagent was prepared by mixing 6 mL of solution 
A with 120 μL of solution B. Bovine serum albumin (BSA) was serially diluted 1:2 
(2 mg/mL - 31,25 µg/mL) and 10 μL of each dilution or sample were transferred to a 96-well 
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flat bottom plate. Per well, 200 μL BCA-reagent were added and incubated at 37°C for 
30 min in the dark. The optical density at a wavelength of 562 nm was recorded in an 
absorbance microplate reader. 
 
3.2.9 Labeling and staining of hMDMs or Leishmania major promastigotes 
3.2.9.1 AnnexinA5-staining of Leishmania major promastigotes 
To assess purity of the viable and apoptotic fractions after AnxA5-MACS, parasites were 
labeled with FITC-conjugated AnxA5. A volume according to 1x 106 stat. ph., purified viable 
and apoptotic Lm were transferred in a 96-well V-plate in duplicates and centrifuged 
(300x g, 4 min, 4°C). Cells were washed with 100 µL Ringer’s solution and incubated with 
AnxA5-FITC diluted in Ringer’s solution at 4°C for 20 min. Cells were again washed once 
with Ringer’s solution and transferred to microtubes for flow cytometry analysis. Samples 
washed and incubated with PBS that contained no Ca2+ ions served as negative controls. 
 
3.2.9.2 Staining of Leishmania major promastigotes for live cell microscopy 
AnxA5-MACS purified viable and apoptotic parasites were labeled with the PKH26 Red 
Fluorescent Cell Linker Kit. In brief, 1 µL of fluorescent dye was diluted in 600 µL of 
Diluent C. Parasites were resuspended in this dilution and incubated for 10 min at 27°C. 
Cells were washed once with 1 mL CM (2400x g, 8 min, RT) and resuspended in the desired 
volume of CM and used for infection of eGFP-LC3 transduced hMDMs. 
 
3.2.9.3 Staining of infected hMDM for immunofluorescence microscopy 
For the determination of infection rates by microscopy, infected and PFA fixed 
macrophages were permeabilized with 100 µL IF permeabilization buffer per well that 
contained 0.5 % Triton X-100 or 0.5 % Saponin for 10 min at 4°C. This step serves the 
disruption of cellular membranes and enable penetration of antibodies directed against 
intracellular targets.  Following two washing steps with IF washing buffer, cells were 
blocked with 100 µL IF blocking buffer containing 10 % FCS and 10 % human AB serum for 
15 min at 4°C to avoid unspecific binding of the used antibodies. For some experiments, 
macrophages were directly blocked without previous permeabilization. Cells were 
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incubated with primary antibodies directed against the respective target (see 3.1.9) diluted 
in 100 µL IF staining buffer for 30 min at 4°C and washed once with IF staining buffer. For 
fluorescent labeling of primary antibodies, incubation with fluorophore-coupled secondary 
antibodies in 100 µL IF staining buffer was performed for 30 min at 4°C and followed by 
three washes with IF washing buffer. hMDMs were counterstained with DAPI together with 
the secondary antibodies to visualize the nucleus. Buffers were aspirated and the samples 
were mounted with Mowiol, supplemented with DABCO to retain fluorescence, and a glass 
coverslip. Analysis was performed by fluorescence microscopy. 
 
3.2.9.4 Diff-Quick staining  
Diff-Quick staining is usually used to stain histological samples. It can also be of use to stain 
myeloid cells and eukaryotic pathogens. The kit consists of three different solutions. Air-
dried cytospin-slides were incubated for 2 min in fixation solution containing methanol. 
Subsequently, fixed cells were incubated in Staining Solution 1 for 2 min. This eosinophilic 
dye stains proteins in the cytoplasm. Cells were further incubated for 2 min in Staining 
Solution 2, a basophilic dye to stain nucleic acids of the nucleus and the parasites 
kinetoplast. The slides were rinsed in tap water and air-dried for microscopical analysis 
using an AxioPhot microscope. 
 
3.2.9.5 Magnetic labeling of apoptotic Leishmania major 
For magnetic isolation of apoptotic Lm-containing phagosomes, 200x 106 purified apoptotic 
Lm were labeled with magnetic Bionized NanoFerrite (BNF)-dextran beads, 150 nm in size, 
that are conjugated with lipobiotin (LB) on their surface (hereafter: LB-beads). LB integrates 
into cellular membranes and hence can be used to label cells. To assess an optimal 
concentration of beads to label apoptotic Lm, parasites were diluted in 2 mL RPMI 1640 
without supplements and LB-beads were added. Cells were incubated at 4°C over night. 
Labeled apoptotic parasites were centrifuged (3800x g, 6 min, 4°C) and resuspended in 
200 µL CM that were added to 10 mL CM for infection of hMDMs (3.2.5). 
Labeling efficiency was assessed by staining of magnetically labeled apoptotic Lm with 
streptavidin-Cy5, which has a high affinity to biotin. Hence, this molecule binds LB residues 
that were not integrated into the cell membrane and its fluorescence intensity correlates 
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with membrane-bound LB-beads. Apoptotic Lm (2x 106) that were incubated with different 
concentrations of magnetic LB-conjugated microbeads were labeled for 30 min at 4°C in 
the dark in presence of streptavidin-Cy5 diluted 1:200 in RPMI 1640. Cells were washed 
once with 1 mL RPMI 1640 and resuspended in 100 µL PBS. Labeling efficiency was 
determined by flow cytometry. 
 
3.2.9.6 Detection of surface proteins by antibody staining 
1x 105 cells were transferred into each well of a 96-well V-plate and washed with 100 µL 
FACS buffer (300x g, 4°C, 4 min). To avoid unspecific antibody binding, cells were incubated 
with 100 µL FACS blocking buffer at 4°C for 10 min. Cells were washed once more and 
incubated with the respective fluorophore-conjugated antibodies for 30 min at 4°C in the 
dark. After washing as described above, cells were resuspended in 100 µL FACS buffer or 
1 % PBS and transferred to microtubes for flow cytometry analysis. As controls, untreated 
cells and cells that were incubated with a fluorophore-conjugated isotype antibody were 
used. 
 
3.2.9.7 Labeling of Leishmania major promastigotes with CFSE or AF647-SE for infection 
experiments 
For determination of L. major infection rates in hMDMs and hMDDCs, AnxA5-MACSpurified 
parasites were labeled with fluorescent dyes for later flow cytometry analysis. The desired 
number of parasites was transferred to a 15 mL reaction tube and centrifuged (2400x g, 
8 min, 4°C). Apoptotic Lm were resuspended in 6 mL PBS containing 0.5 µg of Alexa Fluor 
647-conjugated succinimidylester (AF647-SE). Viable Lm were resuspended in a 4 µM 
carboxyfluorescein-conjugated succinimidylester (CFSE)-PBS solution. For efficient and 
rapid labeling, cells were incubated for 10 min at 27°C. After incubation, labeled parasites 
were washed once with 6 mL PBS and were resuspended in the desired volume of CM. If 
an artificial stationary phase was needed, labeled parasites were mixed in a 1:1 ratio. 
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3.2.9.8 Labeling of PBLs and hMDMs for T cell proliferation assay 
For the T cell proliferation assay, thawed PBLs were labeled with CFSE which is transferred 
to daughter cells during proliferation and hence can be used to identify proliferating cells 
by a decrease in staining intensity. For labeling, 12x 106 PBLs were transferred in 1 mL CM 
containing 4 µM CFSE. The cells were incubated for 15 min at 37°C. To remove excessive 
CFSE, 7 mL CM were added and the tube was centrifuged (143x g, 8 min, 20°C). The pellet 
was resuspended in 12 mL CM resulting in a concentration of 1x 106 PBLs/mL. The hMDMs 
were labeled analogue to that. 
 
3.2.9.9 DAPI staining of infected hMDMs 
Prior to cytocentrifugation, 0.1x 105 infected hMDMs were incubated with 25 ng/mL of 
DAPI in PBS for 30 min on ice. 
 
3.2.10 Flow cytometry 
Determination of the presence of cellular surface proteins (3.2.9.6) as well as infection 
rates (3.2.4.2, 3.2.4.4) was performed by flow cytometry. Cells were treated as described 
in the given experiment and resuspended in either PBS, CM, FACS buffer or fixed in 1 % PFA 
for later analysis. By flow cytometry, cells can be distinguished by their size (forward 
scatter, FSC) or granularity (side scatter, SSC) by their ability to refract light of a certain 
wavelength. This is used to determine a specific cell population. Moreover, staining of cells 
with a specific fluorophore-conjugated antibody or a fluorescent dye also allows for 
identification of a specific cell-population. In this study, hMDMs and hMDDCs or 
Leishmania major promastigotes were gated by their FSC/SSC properties. For 
hMDMs/hMDDCs and PBLs a minimum of 10000 cells (counts) and for Leishmania 
promastigotes, at least 20000 cells were recorded.  
 
3.2.11 Microscopy 
3.2.11.1 Transmitted light microscopy 
Light microscopy was used in cell culture for analysis of cell growth (Zeiss AxioVert.A1) or 
counting of L. major promastigotes (Zeiss Primo Star). For analysis of Diff-Quick-stained 
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cytospins, a Zeiss AxioPhot-microscope equipped with a high-quality color camera 
(AxioCam IC) and AxioVision 4.8 software was used. 
3.2.11.2 Fluorescence microscopy 
Cytospins containing hMDMs infected with fluorescent parasites were imaged with a Zeiss 
Apotome fluorescence microscope equipped with an AxioCam MRM. Appropriate filter sets 
to detect CFSE and Alexa Fluor 647 were used. Data was acquired with AxioVision 4.8 
software. 
Samples that were prepared for immunofluorescence microscopy were analyzed on a Zeiss 
LSM 7 Live confocal microscope with a Plan-Apochromat 63x/1.40 Oil DICIII objective. The 
LSM 7 Live is equipped with a slit instead of a pinhole to eliminate light that is not coming 
from the focal plane. This scanner allows for the illumination of the sample in a line, not in 
a single point, and therefore enables a rapid scan of the specimen. The spatial resolution is 
lower as for point-scanning confocal microscopes but image acquisition speeds are 
superior. This is of importance, especially in live cell imaging experiments (3.2.11.3). The 
respective fluorophores used were excited with light-emitting diode (LED)-Lasers of the 
following specific wavelengths: 405 nm (DAPI/Hoechst), 488 nm (AF488, eGFP, CFSE), 
561 nm (AF568, PKH24), 635 nm (AF647). Emitted light was collected with a high sensitivity 
detector by setting the specific filter sets for the respective fluorophores. Data was 
analyzed with ZEN 2012 Black/Blue or ImageJ software. 
 
3.2.11.3 Time lapse imaging of Leishmania major infection in hMDMs 
To visualize infection dynamics, live cell imaging was performed with a Zeiss LSM 7 Live 
confocal microscope equipped with a Zeiss Plan-Apochromat 63x/1.40 Oil DICIII objective 
with immersion oil. Image acquisition was controlled with ZEN 2012 Black software. 
Appropriate lasers (488 nm, 561 nm) and filter sets for eGFP and PKH26 were used. Laser 
power was set to 0.2 - 1.5 % to reduce phototoxicity. Data were acquired by Z-stacks 
(number of planes depended on the cells and conditions) over a minimum of 15 h with 
5 min intervals. The incubation-chamber was kept at 37°C and cells were gassed with 
5 % CO2. Data was analyzed and processed in ZEN 2012 Black or ZEN 2012 Blue software. 
Characteristics of infection were manually quantified in ZEN 2012 Black.  
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3.2.12 Statistical analysis 
All data are presented as mean ± standard deviation (SD). The results were analyzed by 
Prism software. Gaussian distribution was tested by d’Agostino normality test. For non-
normal distributed data, the paired Wilcoxon matched-pairs signed-rank test was used 
when all experimental conditions were covered by each group compared. The unpaired 
Mann-Whitney U-test was used when the groups compared did not cover all experimental 
conditions. For normal-distributed data, the paired or unpaired t-test was used (two-tailed 
distribution). The respective test used is indicated in the figure legends. Values of 
p < 0.05 (*), p < 0.01 (**), p < 0.001 (***) and p < 0.0001 (****) were considered significant. 
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4. Results 
4.1 In vitro cultures of Leishmania major promastigotes contain apoptotic parasites 
For axenic in vitro cultivation of Leishmania major promastigotes (Lm), a blood agar system 
is used (Nicolle, 1908). Similar to their growth in vivo in the sand fly vector, parasites show 
two different growth phases during in vitro cultivation (Figure 7A). The first 4-5 days of 
cultivation, Lm grow exponentially. Therefore, this growth phase comprising almost 
exclusively elongated, flagellated and hence motile viable Lm is termed logarithmic phase 
(log. ph.) (Figure 7B, upper panel). From day 4 on, Lm growth enters a plateau phase in 
which proportions of viable parasites eventually undergo apoptosis leading to a round-
shaped morphology of the parasites. These apoptotic Lm are aflagellated, non-motile and 
the apoptosis marker phosphatidylserine (PS) is exposed on their surface. This phase, 
termed stationary phase (stat. ph.) comprises an approximate 1:1 ratio of viable and 
apoptotic Lm (Figure 7B, lower panel).   
 
 
Figure 7: Growth curve of Leishmania major promastigotes. A Parasites were seeded in 96-well NNN-blood-
agar plates and cultivated for 9 days. Total cell numbers per mL (line) and the proportion of viable and 
apoptotic parasites (bars) were determined by manual counting in a hemocytometer. Data are presented as 
mean ± SD for 3-5 independent experiments. B Micrographs show cytospins of log. ph. or stat. ph. Lm stained 
by Diff-Quick. Viable Lm are marked with an arrow, apoptotic Lm are marked with an arrow head (scale 
bars: 5 µm). 
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4.2 Purification of apoptotic and viable Leishmania major by AnnexinA5-MACS 
To investigate the advantageous role of apoptotic Lm in establishment of infection, viable 
and apoptotic Lm were separated from a stationary phase in vitro culture by AnnexinA5 
(AnxA5)-MACS. This method utilizes the ability of AnxA5 to bind to PS on the surface of 
apoptotic cells in a calcium-dependent manner (Figure 8A).  
 
Figure 8: AnnexinA5-MACS separation yields pure apoptotic and viable L. major promastigotes. A Schematic 
presentation of AnxA5-MACS of a stat. ph. L. major parasite culture. Parasites were incubated with AnxA5-
conjugated microbeads in presence of calcium ions. The suspension was applied onto a magnetic LS-MACS-
column in which labeled apoptotic Lm are retained. Viable, non-AnxA5 binding Lm were washed out and 
apoptotic AnxA5-bead decorated Lm were eluted in absence of calcium ions. To further enrich viable 
parasites, the procedure was repeated using a LD-MACS-column. B Purity of the fractions was assessed by 
labeling of the eluted parasite fractions with AnxA5-FITC and flow cytometry analysis. Exemplary data from 
6-7 independent experiments are presented as mean ± SD. C Representative micrographs of the fractions 
that were labeled with CFSE (AnxA5neg) or AF647-SE (AnxA5pos) are shown (arrows: viable Lm, arrow heads: 
apoptotic Lm, scale bar: 10 µm).  
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For this, a 6-8-day old Lm culture was incubated with AnxA5-conjugated microbeads. 
Separation of the viable and apoptotic Lm by AnxA5-MACS in a magnetic field resulted in a 
fraction containing non-AnxA5-binding, elongated, viable Lm (Figure 8B, green) and a 
population of AnxA5-binding, round, apoptotic Lm (Figure 8B, red). Subsequent AnxA5-FITC 
staining and flow cytometry analysis showed a purity of the viable Lm fraction of 
94.3 ± 2.6 % whereas purity of the apoptotic fraction was 94.8 ± 2.3 % (Figure 8C). This 
method was used throughout the study to separate apoptotic from viable Lm for 
subsequent differential infection and investigations on the effects of apoptotic 
promastigotes on myeloid cell infection. 
 
 
4.3 Comparison of infection rates upon differential infection of human monocyte-
derived macrophages by flow cytometry and microscopy 
To investigate whether there are differences in the velocity of uptake between viable and 
apoptotic Lm by hMDM1 and hMDM2, macrophages were co-incubated with purified 
viable or apoptotic Lm. For quantification, we assessed infection rates by flow cytometry 
and fluorescence microscopy and tested the suitability of both methods for further studies 
(Figure 9).  
Quantification by flow cytometry revealed a significantly more rapid interaction of hMDM1 
with apoptotic Lm as compared to the interaction with viable Lm after 30 min of co-
incubation (Figure 9A). Interaction of macrophages with apoptotic and viable Lm did not 
further increase after 90 min of co-incubation. At this timepoint 46.7 ± 32.3 % and 
63.0 ± 12.2 % of hMDM1 were detected to be positive for viable or apoptotic Lm, 
respectively. As expected, interaction of hMDM2 with Lm was in general higher than in the 
pro-inflammatory phenotype which can be attributed to their higher phagocytic capacity 
(Rőszer, 2015). Initially, apoptotic parasites interacted more rapidly with hMDM2 as viable 
Lm whereas after 180 min of co-incubation, a higher interaction of viable Lm (89.7 ± 8 %) 
was found as compared to apoptotic Lm (78.3 ± 12 %). Microscopic determination showed 
lower internalization of viable Lm by hMDM1 (16.1 ± 5.5 %) and apoptotic Lm (9.2 ± 3.6 %) 
after 30 min as compared to flow cytometry (viable Lm: 22.6 ± 27.5 %, apoptotic Lm: 
47.7 ± 16.9 %) and revealed a more rapid internalization of viable Lm over time (Figure 9B). 
The latter was also observed in hMDM2. After 180 min of co-incubation, rates of 
  Results 
69 
 
internalization were almost equal for viable and apoptotic parasites (83.3 ± 5.6 % vs. 
76.7 ± 3.3 %). When infection rates were compared between the two different methods of 
quantification, it was clear that even though there were differences in the velocity of 
interaction of hMDMs with viable and apoptotic Lm, infection rates after 180 min were 
almost equal in hMDM2 whereas higher infection rates for apoptotic Lm were found by 
flow cytometry in hMDM1.  
 
 
Figure 9: Investigation of interaction upon differential infection of hMDM with viable and apoptotic Lm and 
quantification by flow cytometry or microscopy. Pro- and anti-inflammatory macrophages were seeded in 
reaction tubes or chamber slides and infected with purified viable or apoptotic Lm. A Purified viable and 
apoptotic Lm were stained by CFSE or AF637-SE and co-incubated with hMDM1 (blue) or hMDM2 (red) for 
the indicated times. Infection rates were determined by flow cytometry. hMDMs were gated by their 
FCS/SSC-properties (n=4-12 donors). B hMDMs were co-incubated with purified viable or apoptotic Lm and 
fixed with 4 % PFA at the indicated timepoints. Actin was stained with phalloidin-AF488 and Lm were stained 
with a specific antiserum. Infection rates were determined by manual counting of 100 hMDMs (n=2). 
C Exemplary micrographs show hMDMs that fully internalized Lm (left, arrow heads) or hMDMs that were 
not fully internalizing Lm (right, arrow) at 90 min post infection. Data are represented as mean ± SD of a 
minimum of 2 donors from at least 2 two independent experiments and were analyzed by Mann-Whitney U-
test (* p < 0.05). Data were generated with help of Mr. Naphang Ho. 
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Of note, microscopic analysis indicated that Lm promastigotes can stick to the surface of 
macrophages (Figure 9C). This could bias the determination of infection rates by flow 
cytometry since also incompletely internalized parasites are detected by this method. 
Nonetheless, flow cytometry offers a more rapid experimental processing. Moreover, in 
our lab’s standard experimental setup, we infect hMDMs for 3 h. Here it was shown that at 
this time point differences between flow cytometry and microscopy were not striking. 
Hence, we used flow cytometry analysis in most of the following experiments and defined 
the interaction of myeloid cells with viable and apoptotic Lm as “infection” whereas we 
described quantification of infection rates by microscopy as “internalization”. 
 
4.4 Generation of eGFP-LC3-expressing hMDMs by lentiviral transduction and live 
cell imaging of Leishmania major infection 
We and others (Matte et al., 2016) showed that during Leishmania major infection, 
apoptotic and viable Lm are located within unilamellar phagosomes that are positive for 
the autophagy marker protein microtubule-associated protein 1A/1B light chain 3B 
(hereafter: LC3). Ulk1, an autophagic protein that is crucial for canonical autophagy, was 
dispensable for LC3 recruitment towards apoptotic Lm-containing phagosomes (PhD thesis 
M. Thomas, 2015). These studies suggested the non-canonical autophagic process of LC3-
associated phagocytosis (LAP) to play a role in apoptotic parasite uptake and processing 
(Crauwels et al., 2015). Importantly, we and others observed that portions of phagocytosed 
viable Lm that were targeted by LAP escape degradation (Matte et al., 2016; PhD thesis 
M. Thomas, 2015). Hence, we were interested in the fate of LC3-positive, Lm-containing 
phagosomes within the macrophage host cell. To dynamically follow the formation of LC3-
decorated phagosomes and to analyze the effect of LC3 recruitment to the Lm-containing 
compartments, we employed macrophages expressing green fluorescent LC3. To this end, 
macrophages were transduced with lentiviral vectors coding for LC3 which is N-terminally 
fused to the enhanced Green Fluorescent Protein (eGFP-LC3).  
Vectors were produced in a human kidney cell line and particle titers were evaluated by 
titration in HT1080 cells and flow cytometry analysis (data not shown). With the 
determined percentage of eGFP-positive cells, titers were calculated as described in the 
methods section. The calculation gave high titers of 1.72x 108 i.u. (infectious units) of the 
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produced lentiviral vectors. Successful transduction was confirmed by fluorescence 
microscopy of transduced, and hence, eGFP-LC3 expressing HT1080 cells (Figure 10A). 
Since we wanted to investigate LC3 recruitment in the context of LAP, we tested whether 
transduction with lentiviral particles alone already induced conversion of cytosolic LC3 
(LC3-I) to the membrane-bound, lipidated form (LC3-II) in hMDMs. To do so, hMDM1 and 
hMDM2 were transduced, harvested and prepared for SDS-PAGE at 4 h and 24 h post-
transduction (hpt). Lysates were analyzed for endogenous LC3-II by western blot 
(Figure 10B). We detected induction of LC3 conversion 4 h post-transfection in both hMDM 
subtypes. This LC3 conversion was comparable to the samples where control cells were 
stimulated with the canonical autophagy inducer PI-103. After 24 h, the LC3 conversion was 
decreased in hMDM1. We assumed the detected LC3 lipidation shortly after transduction 
to be connected to transduction-induced cell stress. In hMDM2, LC3 conversion was as low 
as in non-transduced cells. In our setting, transduced hMDMs were used 4 days post-
transduction. 
 
Figure 10: Transduction with eGFP-LC3 lentiviral particles transiently induces conversion of endogenous 
LC3 in hMDMs. PBj-SW-eGFP-LC3 vector particles were produced with a four-plasmid system in HEK 293T/17 
cells as described in the methods section. A Lentiviral vector-transduction was tested in HT1080 cells and 
verified by fluorescence microscopy. B To assess a possible induction of endogenous LC3 conversion by 
transduction, hMDM1 and hMDM2 were transduced with PBj-SW-eGFP-LC3 lentiviral vectors for 4 or 24 h 
(hpt: hours post-transduction). The canonical autophagy inducer PI-103 served as positive control for 
conversion of endogenous LC3. Lysates were analyzed by SDS-PAGE and immunoblotting for LC3 and β-actin. 
LC3-II to β-actin levels were determined by densitometry and ratios were normalized to untreated control 
cells. Western blots are representative for one experiment. Data represent the mean ± SD of three donors 
from two independent experiments. 
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To investigate LAP induction in real-time, hMDM1 and hMDM2 were transduced with the 
lentiviral vectors and co-incubated with either purified and labeled apoptotic or viable Lm 
to follow their intracellular fate (Figure 11A).  As expected, time-lapse imaging of eGFP-
LC3-expressing hMDMs showed the accumulation of eGFP-LC3 around proportions of 
viable as well as apoptotic Lm, indicating internalization of these parasites by LAP. The 
elongated morphology of viable parasites was not altered after being sequestered in a LC3+ 
phagosome (Figure 11A). In line with literature, this indicated that, at least partially, viable 
Lm were not degraded within macrophages (Matte et al., 2016). In contrast, parts of 
apoptotic Lm seemed to be processed within LC3+ phagosomes since red-labeled parasites 
disintegrated into smaller particles at a given time after the eGFP signal disappeared 
around the apoptotic parasite (Figure 11B).  
 
Figure 11: Purified viable and apoptotic Lm are sequestered in LC3+ phagosomes in hMDMs. Purified viable 
Lm or apoptotic Lm were labeled with PKH26 and co-incubated with eGFP-LC3-transduced hMDM1 or 
hMDM2 (MOI 1). 3D time-lapse imaging was performed for at least 15 h (1 frame/5 min) on a ZEISS LSM 7 
Live confocal microscope. A Viable Lm in a LC3-positive phagosome with an unaltered morphology after LC3 
is absent. B Apoptotic Lm in a LC3 positive phagosome is degraded over time. Scale bars: as indicated in the 
images. Videos were acquired with help of Mrs. Sylvia Panitz. 
It was shown in murine macrophages, that only a small part of internalized viable Lm are 
sequestered within LC3+ phagosomes (Matte et al., 2016). It is not known if the same is 
true in the human system. Hence, we were interested in quantification of LC3+ phagosomes 
upon differential Lm infection and the temporal characteristics of LC3 recruitment by 
analysis of time-lapse videos (Figure 12). To do so, transduced cells of at least 3 donors 
were infected with purified viable or apoptotic Lm. A minimum of 40 cells from each donor 
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were imaged by time-lapse confocal microscopy. The generated video data was quantified 
for eGFP-LC3 recruitment towards emerging phagosomes and the temporal aspects of 
eGFP-LC3 presence and its impact on degradation of Lm (Figure 12). In hMDM1 we found 
4.7 ± 5.6 % of viable and 6.7 ± 10 % of apoptotic Lm to be sequestered in LC3+ phagosomes 
(Figure 12A). Of note, in M1 macrophages from two of the four donors tested, no LC3 
recruitment towards the phagosome was detected. As expected, in hMDM2 that have a 
higher phagocytic capacity (Biswas et al., 2012), 12.6 ± 8.5 % of viable and 22.8 ± 21.8 % of 
apoptotic Lm were sequestered in LC3+ phagosomes. This was strongly dependent on the 
donor as indicated by the heterogenous distribution. We further determined the temporal 
aspects of LC3 recruitment and whether there are differences between phagosomes 
harboring viable or apoptotic Lm in pro- or anti-inflammatory macrophages. Therefore, we 
assessed the time from internalization of Lm to the detection of green fluorescent signal 
around the parasites (Figure 12B). Only two viable Lm and four apoptotic Lm were found 
within LC3+ phagosomes in hMDM1 over the 15 h period of imaging. Nonetheless, these 
compartments were scored and an average of 22 ± 18 min and 138 ± 222 min passed before 
LC3 recruitment to phagosomes around viable Lm or apoptotic Lm, respectively, became 
visible. In hMDM2 that sequestered more viable and apoptotic parasites in LC3+ 
phagosomes than hMDM1 (Figure 12A), an average of 70 ± 113 min (viable Lm) and a 
significantly shorter time of 34 ± 75 min (apoptotic Lm) passed until LC3 was present on the 
emerging phagosomes. Fusion of LC3- and LC3+ phagosomes with lysosomes is a heavily 
orchestrated event. During LAP, fusion with lysosomes only occurs when LC3 is still present 
on the phagosomal membrane. Thus, loss of LC3 would implement lysosomal fusion 
(Martinez et al., 2015). We quantified the time span that LC3 was accumulated on the 
compartments which indicates a rapid or prolonged fusion with lysosomes (Figure 12C). In 
hMDM1 eGFP-LC3 could be detected for 23 ± 25 min on phagosomes around viable Lm and 
for 116 ± 77 min on phagosomes harboring apoptotic Lm (Figure 12C). In hMDM2, LC3 was 
present on viable Lm-containing phagosomes for 71 ± 75 min. In comparison, transient 
presence of LC3 on phagosomes that harbored apoptotic Lm was 57 ± 76 min. Higher 
numbers of LC3+ phagosomes surrounding apoptotic Lm in hMDM2 as compared to viable 
Lm and a significantly faster LC3 recruitment but shorter presence of the marker protein 
indicated enhanced lysosomal fusion. This prompted us to also quantify the duration from 
internalization to the onset of degradation with respect to presence or absence of eGFP-
LC3 on the compartment membrane in hMDM2 (Figure 12D). Degradation was defined as 
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disintegration of the apoptotic parasites into smaller particles. When LC3 was absent from 
phagosomes, degradation occurred after 558 ± 347 min. By sequestration of apoptotic Lm 
in LC3+ phagosomes, the time to degradation was reduced to 435 ± 246 min. It has to be 
considered, that only few parasites could be tracked until degradation due to restrictions 
in the time frame of imaging. 
 
Figure 12: Quantification of time-lapse imaging of eGFP-LC3-positive compartments within hMDMs. 
Macrophages were co-incubated with PKH26- labeled viable or apoptotic Lm (MOI 1) for 15 h with 
1 frame/5 min. The characteristics of infection were determined by analysis of time lapse videos. A Relative 
number of LC3+ phagosomes in hMDM1 and hMDM2 from 3-5 donors. B Time from infection of hMDMs to 
LC3-recruitment to the phagosome. C Presence of LC3 on the emerging phagosomes. D Time from infection 
to degradation of apoptotic parasites in dependence of absence or presence of LC3 on the phagosomes in 
hMDM2. Data are presented as mean ± SD of a minimum of 40 cells from at least three donors analyzed in 3-
5 independent experiments. The means are indicated by vertical lines. Data was analyzed by unpaired Mann-
Whitney U-test (* p < 0.05). Imaging and quantification were performed with the help of Mrs. Sylvia Panitz. 
Taken together, we found few parasites to be sequestered within LC3+ phagosomes in 
hMDM1. In hMDM2, more apoptotic Lm were present in LC3+ phagosomes as compared to 
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viable Lm and the time to LC3 recruitment was significantly lower. Degradation was 
accelerated when LC3 was recruited towards these compartments. This indicated an 
enhanced internalization of apoptotic Lm by LAP in hMDM2 which results in quicker 
degradation of the dying parasites. Based on these findings, we wanted to further elucidate 
the role of LC3 recruitment, hence, LAP of apoptotic Lm, and the molecular factors that 
trigger this mechanism. In addition, we observed unaltered morphologies of viable Lm that 
were targeted by LC3 indicating resistance to LAP-mediated degradation. 
 
4.5 Evaluation of a possible evasion strategy by viable Leishmania major 
promastigotes 
During time-lapse imaging of viable Lm, we observed an unaltered morphology of viable 
Lm in phagosomes that were targeted by LC3. This was already described by Matte et al. 
and suggests an evasion of LAP which supports the survival of viable parasites. In former 
studies we identified tunnel-like structures that protruded from the viable Lm harboring 
compartment, of which one was found to be connected to the extracellular space 
(PhD thesis M. Thomas, 2015, Figure 13). Before the present project started, only the 
electron microscopy data set (generated by G. Neusser, University Ulm) of this observation 
was available, the 3D reconstruction (performed by A. Weiner, Institut Pasteur, Paris) was 
finished shortly before the beginning of this project.  
We hypothesized these tunnel-like structures to serve the delayed acidification of the 
compartment and possibly mediate dilution of lysosomal hydrolases from the phagosome 
into the extracellular space. Hence, it would serve the inhibition of proteolytic degradation 
of viable Lm. Based on this, we wanted to quantify possible tunnel-structures by 
immunofluorescence staining on viable Lm-infected hMDM2. To increase the chance to 
find tunnel-structures we infected with a MOI of 20. We stained for Lm and the lysosomal 
marker LAMP1 on PFA-fixed macrophages without permeabilization of the plasma 
membranes. This would allow the antibody to only stain the intracellular parasite and 
LAMP1 if it can enter the phagosome through a connection with the extracellular space. 
Further, we scored only parasites/phagosomes that were stained with both, the anti-Lm 
antiserum and anti-LAMP1 (Figure 14A). 
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Figure 13: 3D reconstruction of a viable Lm within a phagosome connected to the extracellular space. Left 
Viable Lm infected hMDM2 were high pressure frozen and processed for focused ion beam scanning electron 
microscopy (FIB-SEM). Image shows one representative slice through the viable Lm-containing phagosome. 
Samples were generated by M. Thomas and FIB-SEM was performed in cooperation with G. Neusser at the 
Institute of Analytical and Bioanalytical Chemistry, University Ulm and P. Walther at the Core Facility for 
Electron Microscopy, University Ulm. Right 3D reconstruction of FIB-SEM data, performed by A. Weiner from 
the group of J. Enninga, Institut Pasteur, Paris. Purple, red and blue structures are part of the Leishmania 
parasite which is tightly enclosed by the green phagosomal membrane. Solid arrows in both images indicate 
tunnel-like structures that are connected to the outside of the cell. Dotted arrows indicate tunnel-structures 
protruding to the inside of the macrophage. 
As controls served viable Lm-infected macrophages that were permeabilized with the 
detergent saponin before immunofluorescence staining. In hMDM2 from two donors we 
found 26.9 ± 10.8 % compartments positive for both stains accumulating after 30 min of 
infection (Figure 14B). 60 min post infection, the proportion of double positive 
compartments was 25.5 ± 2.4 %. At later time points from 1.5 h on (12.7 ± 6.9 %), a sharp 
decline in double positive stains was detected. After 3 h of infection, only 
4.6 ± 2.5 % double positive phagosomes were found. In addition to microscopical analyses 
of tunnel-like structures, we tried to verify possible tunnel-like structures by detection of 
released intraphagosomal proteins in the supernatants of viable Lm infected hMDMs by 
western blot. We hypothesized that e.g. the lysosomal protease cathepsin B were 
introduced into the viable Lm-containing phagolysosome which are in turn led to the 
outside of the cell by the opening. In an initial experiment from one donor we detected 
weak signals for cathepsin B in supernatants from hMDM1 of one donor (data not shown). 
Taken together, preliminary data from two donors suggests that 0.5-1 h post infection, 
about one quarter of infected hMDM2 do form tunnel-like structures connecting the Lm-
harboring phagosomes to the extracellular space. This might indeed suggest formation of 
openings to be a novel evasion strategy but needs more detailed investigations in the 
FIB-SEM Reconstruction
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future. In the further course of the project, based on the live cell imaging data, we focused 
on apoptotic Lm and the factors that mediate their uptake and processing in human 
primary macrophages. 
 
Figure 14: Quantification of Lm- and LAMP1-positive staining, indicating possible tunnel structures. 
A hMDM2 were infected with purified viable Lm (MOI 20). Cells were fixed with PFA and processed for 
immunofluorescence microscopy without permeabilization of the macrophage membranes (upper panel). 
Infected control cells were permeabilizated prior to staining by incubation with the detergent saponin (lower 
panel). B Cells that were fixed at the indicated timepoints after infection were quantified for double positive 
stainings for Lm and the lysosome marker LAMP1. Approximately 100 phagosomes were counted. Data are 
presented as mean ± SD of 2 donors from 2 independent experiments. Data were generated with help of 
Mr. Kevin Brück. 
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4.6 Magnetic isolation of apoptotic Leishmania major-harboring phagosomes 
Dying parasites play a key role in initiation of leishmaniasis (van Zandbergen et al., 2006). 
Based on this and the above findings from live cell imaging, we aimed on the identification 
of receptors and maturation markers that induce or contribute to LAP of apoptotic Lm and 
play a role in biogenesis of the emerging phagosomes. To this end, we magnetically isolated 
apoptotic Lm-containing phagosomes from infected hMDM2. For phagosome isolation, a 
rapid and contaminant-free method, established by Steinhäuser and colleagues, was 
instrumental. In this method, the pathogen is labeled with lipobiotin (LB)-coated magnetic 
microbeads and can be magnetically isolated from a cell lysate together with the 
surrounding phagosomal membrane (Steinhäuser et al., 2014, 2013) (Figure 15). In 
previous experiments we already showed that LB-microbead-coated apoptotic Lm can be 
sequestered within LC3+ phagosomes in hMDMs (PhD thesis M. Thomas, 2015). 
 
Figure 15: Schematic presentation of the magnet-based compartment isolation. AnxA5-MACS purified 
apoptotic Lm were labeled with lipobiotin (LB)-coated magnetic beads and co-incubated with hMDM2 for 
1 h. Cells were lysed by sonication and lysates were applied onto a column in a strong magnetic field. 
Phagosomes containing magnetically labeled apoptotic Lm were retained within the magnetic field. Washing 
of the column yielded a non-magnetic fraction and the apoptotic Lm-harboring phagosomes were eluted 
(magnetic fraction). 
To yield high amounts of apoptotic Lm-containing phagosomes, we first determined the 
optimal amount of LB-microbeads to efficiently label purified apoptotic parasites by testing 
increasing microbead concentrations (Figure 16). A concentration of 200 µg/mL led to the 
highest grade of Lm labeling without aggregation of the parasites. A proportion of 89 % of 
the apoptotic Lm were conjugated to LB-microbeads as found by Streptavidin (SA)-Cy5 
labeling of remaining LB-residues on the surface of the microbeads. Efficient LB-microbead 
labeling was further demonstrated by determination of the mean fluorescence intensity 
(MFI) of SA-Cy5 which was highest at a concentration of 200 µg/mL. Thus, this 
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concentration of beads was used to label AnxA5-MACS purified apoptotic parasites in the 
following isolation procedure. The isolated amounts of protein for mass spectrometry 
analysis were determined by BCA assay (Table 10). 
 
Figure 16: Apoptotic Lm are efficiently labeled with lipobiotin-coated magnetic microbeads. AnxA5-MACS- 
purified apoptotic Lm were incubated with 25-200 µg/mL lipobiotin (LB)-coated magnetic beads at 4°C 
overnight. Labeling efficiency was assessed by staining of non-integrated residues of LB with Streptavidin 
(SA)-Cy5 and flow cytometry. Formation of aggregates was assessed by gating apoptotic Lm by their FSC/SSC-
properties (con: unstained control; n=1). 
During phagosome isolation, aliquots of the cell lysate, the homogenate after sonication, 
the non-magnetic and the eluted magnetic fraction were collected and analyzed by 
western blot for enrichment of Lm-specific proteins within the magnetic fraction 
(Figure 17). As expected, analysis revealed high amounts of Lm-specific proteins within the 
magnetic fraction (M). The presence of the mitochondrial protein Cox4 as well as the 
nuclear pore complex component Nup62 in the magnetic fraction indicated a possible 
partial co-isolation of components of mitochondrial and nuclear compartments. In 
addition, the lipidated form of LC3 (LC3-II) could be detected on isolated phagosomes. Of 
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note, almost no cytosolic, non-lipidated LC3 (LC3-I) was present in the magnetic fraction 
indicating isolation of LC3- phagosomes as well as the portion of LC3+ phagosomes (see 4.4, 
Figure 12A).  
Table 10: Amount of protein measured in isolated phagosomes as quantified by BCA assay. 
Donor Amount of isolated protein for mass spectrometry 
1 26 µg 
2 31 µg 
3 25 µg 
4 4 µg 
5 44 µg 
6 60 µg 
 
The phagosome isolation was performed for six donors and the magnetic fractions were 
analyzed for their proteome by label-free liquid chromatography-coupled mass 
spectrometry (LC-MS) in cooperation with Stefan Tenzer (University Hospital Mainz, 
Germany). By LC-MS and subsequent data analysis, 1015 Leishmania-specific as well as 
1998 human host cell-derived, proteins were identified. The quantity of human proteins 
was determined within each sample and the 40 most abundant proteins throughout all the 
samples were used for a functional protein association network (STRING-) analysis 
(Figure 18, Table 11). In accordance with western blot analysis, mitochondrial proteins such 
as mitochondrial ATPases ATP5A1 and ATP5B, IMMT (inner membrane protein MIC60, part 
of the MICOS complex) or mitochondrial heat-shock proteins (HSPA5, HSP90) could be 
detected in high amounts within the lysates of the magnetic fraction. Many more peptides 
with a mainly high sequence coverage for 216 mitochondrial proteins indicated co-isolation 
of phagosomes with mitochondria or a connection of both compartments (data not 
shown). 
  Results 
81 
 
 
Figure 17: Western blot analysis of samples collected 
during magnetic isolation of phagosomes. Samples of the 
phagosome isolation were analyzed by SDS-PAGE and 
western blot with the indicated antibodies/antisera 
regarding enrichment of Lm and cellular proteins (L: lysate, 
H: homogenate, NM: non-magnetic fraction, M: magnetic 
fraction; 5 µg protein/lane). Western blot analysis was 
performed for two donors used in the isolation procedure 
and is representative for one donor. 
 
 
Of note, LC3 was not detected in our MS screen. Intriguingly, alongside proteins of the 
cytoskeleton, such as Talin-1, Filamin-A or Dystonin, we identified the phagocytic receptors 
Low-density lipoprotein receptor-related protein 1 (LRP1, CD91) and the Complement 
Receptor 3 subunits Integrin αM (ITGAM, CD11b) and Integrin β2 (ITGB2, CD18). For CD91, 
80 peptides with a sequence coverage of 30 % were discovered. For CD11b, 38 peptides 
with a coverage of 71 % and for CD18, 39 peptides with a coverage of 48 % were identified. 
Interestingly, CD91, in conjunction with calreticulin that binds to complement component 
C1q, is described to be involved in the phagocytosis of apoptotic cells (Ogden et al., 2001). 
Complement Receptor 3 is known to be one of the major receptors that facilitate 
internalization of viable Leishmania promastigotes as well as L. major amastigotes (Mosser 
and Edelson, 1985; Rosenthal et al., 1996; Wenzel et al., 2012). Moreover, high amounts of 
Talin-1, known to be crucial for CR3-mediated phagocytosis, further suggest a role for this 
receptor in uptake of apoptotic Lm (Lim et al., 2007). 
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Figure 18: STRING analysis of the 40 most abundant host cell-derived proteins as identified by LC-MS. 
Complement Receptor 3 subunits ITGAM (Integrin αM; CD11b) and ITGB2 (Integrin β2; CD18) as well as LRP1 
(Low-density lipoprotein receptor-related protein 1; CD91) are in bold. MS data represent 6 donors from 
4 independent experiments. 
Taken together, phagosome isolation showed enrichment of Lm proteins and LC3+ 
compartments in the eluted fraction. As expected from our live cell imaging data we could 
not exclusively isolate LC3+ compartments as anticipated on the basis of former 
observations at the beginning of the project (Crauwels et al., 2015). Mass spectrometry 
revealed proteins of the phagocytosis and autophagy machinery to be present in the 
compartment which indicated at least partial isolation of LAP compartments which was 
supported by the presence of lipidated LC3-II in the magnetic fraction in western blot 
analysis. The expected detection of LC3 by MS was absent whereas the apoptotic cell 
receptors CD91 and CR3 were found in high abundance within the compartment and were 
further investigated regarding their role in the interaction with apoptotic Lm.  
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Table 11: Mass spectrometric identification of highly abundant proteins in isolated compartments. Protein 
and gene name and PDB accession of proteins identified by LC-MS in phagosomes harboring apoptotic Lm 
sorted by declining amounts. Proteins that were investigated in more detail in this study are written in bold 
(PDB: Protein Data Bank, www.rcsb.org/pdb). 
 
  
Description Gene PDB entry
Neuroblast differentiation-associated protein AHNAK AHNK_HUMAN
Myosin-9 MYH9 MYH9_HUMAN
Filamin-A FLNA FLNA_HUMAN
Golgin subfamily B member 1  GOLGB1 GOGB1_HUMAN
Ryanodine receptor 2  RYR2 RYR2_HUMAN
Talin-1 TLN1 TLN1_HUMAN
Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5  MACF1 MACF1_HUMAN
Plectin PLEC PLEC_HUMAN
Ras GTPase-activating-like protein IQGAP1 IQGAP1 IQGA1_HUMAN
Nebulin  NEB  NEB NEBU_HUMAN
Prolow-density lipoprotein receptor-related protein 1  LRP1 LRP1_HUMAN
Dystonin  DST DYST_HUMAN
Vimentin  VIM VIME_HUMAN
Myoferlin MYOF MYOF_HUMAN
ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN
Fibrous sheath-interacting protein 2  FSIP2 FSIP2_HUMAN
Integrin beta-2 ITGB2 ITB2_HUMAN
ATP synthase subunit alpha, mitochondrial  ATP5A1 ATPA_HUMAN
A-kinase anchor protein 9  AKAP9  AKAP9 AKAP9_HUMAN
Sodium/potassium-transporting ATPase subunit alpha-1 ATP1A1 AT1A1_HUMAN
Stress-70 protein, mitochondrial HSPA9 GRP75_HUMAN
Nesprin-2 SYNE2 SYNE2_HUMAN
Pyruvate kinase PKM PKM KPYM_HUMAN
Endoplasmin HSP90B1 ENPL_HUMAN
E3 ubiquitin-protein ligase HERC2 HERC2 HERC2_HUMAN
78 kDa glucose-regulated protein HSPA5 GRP78_HUMAN
CD44 antigen CD44 CD44_HUMAN
Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN
Obscurin OBSCN OBSCN_HUMAN
Annexin A2 ANXA2 ANXA2_HUMAN
E3 SUMO-protein ligase RanB2 RANBP2 RBP2_HUMAN
60 kDa heat shock protein, mitochondrial HSPD1 CH60_HUMAN
Protocadherin Fat 2 FAT2 FAT2_HUMAN
Chromodomain-helicase-DNA-binding protein 7 CHD7 CHD7_HUMAN
Integrin alpha-M ITAM ITAM_HUMAN
Dynein heavy chain 5, axonemal DNAH5 DYH5_HUMAN
Aconitate hydratase, mitochondrial ACO2 ACON_HUMAN
Prelamin-A/C LMNA LMNA_HUMAN
MICOS complex subunit MIC60 IMMT MIC60_HUMAN
Receptor-type tyrosine-protein phosphatase C PTPRC PTPRC_HUMAN
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4.7 Phenotypic characterization of human monocyte-derived phagocytes 
Prior to investigations on the function of CD91 and CR3 in apoptotic Lm internalization, we 
sought to confirm the presence of both receptors on monocyte-derived macrophages. We 
further checked the two receptors’ expression by monocyte-derived dendritic cells 
(hMDDCs) which were previously shown to lack LC3 recruitment upon stimulation with Lm 
(PhD thesis P. Crauwels, 2015). To ensure the correct in vitro polarization of hMDM1 and 
hMDM2 and generation of hMDDCs, we additionally checked the expression of known 
surface proteins of the professional APCs employed in this study. Characterization was 
performed by antibody staining of the respective markers (Figure 19). The mannose 
receptor CD14, which is generally accepted as marker for monocytes and macrophages 
(Collin et al., 2013), was present on hMDM1 and highly abundant on hMDM2. In 
accordance with literature, the scavenger receptor CD163 which is known to be specific for 
anti-inflammatory macrophages, was highly abundant on hMDM2 (Biswas et al., 2012). 
CD1a, a dendritic cell receptor capable of glycolipid presentation, was mainly found on 
hMDDCs as well as in minor amounts on hMDM1 (Ohradanova-Repic et al., 2016; Sloma et 
al., 2008). The C-type lectin receptor CD209 (DC-SIGN) was highly expressed by hMDDCs 
and present in lower numbers on hMDM2. The mannose receptor CD206 is described as a 
pro-inflammatory macrophage marker and relevant for phagocytosis of viable Lm 
(Chakraborty et al., 2001, 1998). We detected this receptor in high numbers on hMDM1 
and on hMDDCs and to lower extend on hMDM2. Furthermore, Complement Receptor 3 
(subunit CD11b) was detected on all three cell types, showing a stronger expression on 
hMDM1 and hMDDCs than on hMDM2. CD91 could be confirmed on the surface of hMDM1 
as well as hMDM2 (Costales et al., 2013). Interestingly, hMDDCs lack this receptor. 
Taken together, by measuring the expression of cell type-specific surface markers, we could 
confirm the expected phenotypes of our in vitro-generated hMDM1, hMDM2 and hMDDC. 
Similar to CD206, CR3 is expressed in higher amounts in hMDM1, suggesting a higher 
phagocytosis capacity of this cell type which does not correlate with our previous 
observations (Figure 11A). hMDDCs, although expressing similar amounts of CD206 and 
CR3 as hMDM1, are known to be relevant for anti-leishmanial immune reactions but do not 
serve as host cell for parasite growth (Zahn et al., 2010). Interestingly, in hMDDCs, LAP was 
not induced upon Lm infection (PhD thesis P. Crauwels, 2015). This raised the question if 
CD91, not present on hMDDCs, may play a role in LAP of apoptotic Lm in hMDMs. 
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Figure 19: Characterization of in vitro-generated human monocyte-derived macrophages and dendritic 
cells. Monocytes were isolated from blood donations. hMDM1 (blue), hMDM2 (red) and hMDDCs were 
generated by cultivation for 5-7 days in presence of either GM-CSF, M-CSF or GM-CSF and IL-4, respectively. 
Characterization of the generated cells was performed by antibody staining of the specific cell surface 
markers CD14, CD206, CD163, CD1a, and CD209 as well as of CR3 and CD91 and subsequent analysis by flow 
cytometry. Data are presented as mean ± SD of 3-33 donors from at least 3 independent experiments. No 
statistical evaluation was performed. Histograms are representative for one donor (n.d. = not detectable). 
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4.8 Cytokine production of antigen-presenting cells upon differential infection with 
Leishmania major promastigotes 
In addition to the phenotypical characterization by antibody staining of surface markers, 
we employed ELISA to check for the cytokine profiles of the generated monocyte-derived 
cells upon differential infection with purified viable or apoptotic Lm or an artificial stat. ph. 
of the parasites. hMDM1 are described to produce high amounts of pro-inflammatory 
mediators whereas hMDM2 are characterized by high release of IL-10, depending on the 
stimuli (Italiani and Boraschi, 2014). Infection with viable Lm was expected to trigger pro-
inflammatory cytokine release whereas co-incubation of antigen-presenting cells with 
apoptotic Lm was expected to induce secretion of anti-inflammatory mediators. In 
addition, we hypothesized that the presence of apoptotic Lm in a stat. ph. Lm culture 
counteracts the pro-inflammatory response that is induced by viable Lm upon infection. 
This in turn could lead to decreased inflammation as a prerequisite that allows viable Lm 
to survive within hMDMs.  
To get an overview of cytokine production upon Lm infection, we used a bead-based 
multiplex assay for the analysis of supernatants from viable or apoptotic Lm-infected cells 
(Appendix A). Multiplex data revealed strong differences in secretion of the pro-
inflammatory cytokines IL-1β, IL-8, IL-6 and TNF-α. In addition, the anti-inflammatory IL-10 
was found to be altered between viable and apoptotic Lm-infected hMDMs. These 
cytokines were analyzed in more detail by ELISA (Figure 20, Figure 21). IL-1β, an important 
pro-inflammatory cytokine in leishmaniasis (Maspi et al., 2016), was secreted by pro-
inflammatory hMDM1 that where infected with purified viable Lm (Figure 20A). Compared 
to this, secretion of IL-1β was elevated in the presence of apoptotic Lm alone or stat. ph. 
Lm. The same was observed for differentially infected hMDM2 whereas in hMDDCs, IL-1β 
production compared to viable or stat. ph. Lm infected cells, was increased when 
challenged with purified apoptotic Lm. Production of IL-6, a cytokine that can act in a pro- 
and anti-inflammatory manner, was highly induced in hMDM1 in presence of purified 
viable or apoptotic Lm (Figure 20B). Stat. ph. infected hMDM1 showed a strongly reduced 
IL-6 secretion. In anti-inflammatory hMDM2, production of IL-6 was increased in presence 
of viable Lm as compared to cells that were incubated with pure apoptotic Lm or stat. ph. 
parasites. In hMDDCs, IL-6 expression slightly increased when viable Lm were absent during 
infection. The very potent pro-inflammatory cytokine IL-8 plays a key role in early stages of 
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Lm infection in vivo by triggering the recruitment of PMNs (Alexander et al., 1999). In 
general, IL-8 was present in high concentrations in supernatants from infected hMDMs and 
hMDDCs (Figure 20C). Production by hMDM1 was increased in presence of apoptotic Lm 
as compared to viable Lm-infected hMDM1. In supernatants of hMDM2, IL-8 was detected 
in equal amounts when cells were incubated with purified viable or apoptotic Lm whereas 
the challenge with a stat. ph. Lm even increased production. Low amounts of IL-8 were 
already present in uninfected cells. 
 
Figure 20: Analyses of IL-1β, IL-6 and IL-8 secretion of differentially Lm-infected hMDMs and hMDDC. 
hMDMs and hMDDCs were co-incubated with a MOI 10 of either purified viable Lm (circle) or apoptotic Lm 
(square) or an artificial stationary phase (triangle). Three hours post-infection, cells were washed twice and 
further incubated for 21 h. Supernatants were harvested and analyzed by ELISA for their respective content 
of (A) IL-1ß, (B) IL-6, (C) IL-8. Data are presented as mean ± SD of 7-9 donors from at least 3 independent 
experiments (n.d.: not detectable). Data was analyzed by unpaired Mann-Whitney U-test (A, B) and paired t-
test (C) (* p < 0.05). Data were generated with the help of Mr. Naphang Ho. 
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TNF-α is an essential pro-inflammatory cytokine during infection and is long known to play 
an important role in leishmaniasis (Liew et al., 1990; Nashleanas et al., 1998). In 
supernatants of hMDM1 that were infected with only viable Lm, we detected 
700 ± 909 pg/mL TNF-α. Other than expected, concentrations increased to 
1090 ± 959 pg/mL and 1146 ± 935 pg/mL in presence of either purified apoptotic Lm or 
stat. ph. Lm (Figure 21A). Moreover, the amount of TNF-α in supernatants of viable Lm-
infected hMDM2 was significantly higher (1481 ± 1605 pg/mL) as compared to pro-
inflammatory hMDM1. TNF-α production was significantly decreased (483 ± 452 pg/mL) as 
compared to viable Lm-infected hMDM2 when cells were co-incubated with purified 
apoptotic Lm. Infection with stat. ph. Lm resulted in a significant increase of TNF-α 
secretion similar to viable Lm-infected cells (1340 ± 1303 pg/mL). In hMDDCs, 
concentrations of TNF-α upon infection with only viable Lm were comparable to hMDM1. 
In comparison, presence of only apoptotic Lm or an artificial stationary phase strongly 
increased TNF-α secretion. The anti-inflammatory cytokine IL-10 was detected to a similar 
extend upon infection of hMDM1 and hMDM2 with viable Lm (2237 ± 2028 pg/mL 
and 2318 ± 2712 pg/mL) (Figure 21B). In both cell types, challenge with pure apoptotic Lm 
increased IL-10 production. This increase was significant for hMDM1 (6881 ± 5099 pg/mL) 
and hMDM2 (5612 ± 2724 pg/mL), both infected with an artificial stat. ph. as compared to 
viable Lm-infected cells. In hMDDCs, secretion of IL-10 was lower for all conditions but was 
also slightly increased in presence of apoptotic Lm alone or stat. ph. Lm. 
Altogether, we found no significant differences in secretion of the pro-inflammatory 
mediators IL-1β and IL-6 between the macrophage phenotypes or dendritic cells. In 
hMDM2, stat. ph. Lm infection increased release of IL-8. Of interest, between the 
differential infection conditions within a cell type, no expected reduction of secretion of 
IL-1β, IL-6 or IL-8 in presence of apoptotic Lm was observed. For TNF-α and IL-10 significant 
changes in release upon the differential infection conditions were found. In presence of 
apoptotic Lm TNF-α secretion in hMDM2 was downregulated and a release of IL-10 was 
significantly increased in both macrophage subtypes. This indicated that presence of 
apoptotic Lm effectively modulates the release of these important cytokines in human 
macrophages.  
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Figure 21: Analyses of TNF-α and IL-10 secretion by differentially Lm-infected hMDMs and hMDDC. hMDMs 
and hMDDC were co-incubated with a MOI 10 of either purified viable Lm (circle) or apoptotic Lm (square) or 
an artificial stationary phase (triangle). Three hours post-infection, cells were washed twice and further 
incubated for 21 h. Supernatants were harvested and analyzed by ELISA for their respective content of (A) 
TNF-α and (B) IL-10. Data are presented as mean ± SD of 8-10 donors from at least 3 independent experiments 
and were analyzed by Mann-Whitney U-test (* p < 0.05). Data were generated with the help of Mr. Naphang 
Ho. 
 
4.9 Manipulation of CD91 on human monocyte-derived macrophages 
Since we could demonstrate the correct differentiation of the generated monocyte-derived 
macrophages and dendritic cells based on surface marker characterization, we aimed on 
investigation of the role of CD91 in uptake of apoptotic Lm. To do so, we sought to 
manipulate the receptor on hMDM1 and hMDM2 by blocking it with a specific α-CD91 
functional monoclonal antibody (α-CD91). As controls, isotype antibody-treated cells were 
used. We first tested the blocking efficiency as well as stability of blocking over time 
(Figure 22A). Dendritic cells were not addressed here, since CD91 was not expressed on 
this cell type (see Figure 19). Blocking was checked by flow cytometry after staining of the 
receptor with PE-conjugated α-CD91 that recognizes the same epitope as the blocking 
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antibody. Thus, the PE-conjugated α-CD91 antibody could only bind to the receptor if the 
latter had not been occupied by the blocking antibody. After 90 min of incubation with 
α-CD91, hMDM1 and hMDM2 showed a decrease in α-CD91-PE-specific staining of 86 ± 3 % 
and 84 ± 10 %, respectively, as compared to the isotype-treated control cells. The time of 
infection with Lm in our experimental setting is 3 h. Hence, the staining of α-CD91-treated 
hMDMs was also assessed 3 h post-incubation. Interestingly, the capacity to stain CD91 
with the PE-conjugated α-CD91 after 3 h was strongly increased as compared to the 90 min 
post-incubation for both hMDM1 (35 ± 12 %) and hMDM2 (40 ± 4 %). This indicated that 
binding of the functional antibody to the receptor was not stable over time and therefore, 
inhibition of ligand binding was not given. To assess the functional role of CD91, we 
employed a small interfering RNA (siRNA)-based knockdown approach. Specific siRNA can 
be introduced into the cell by transfection and binds to its complementary mRNA molecule 
which in turn gets degraded by a specialized protein cascade (Whitehead et al., 2011). 
hMDMs were transfected with CD91-specific siRNA or non-target siRNA or were left 
untreated. Two days post transfection, knockdown-efficiency was checked on the protein-
level by staining with α-CD91-PE and flow cytometry and on the RNA level by RT-PCR 
(Figure 22B). Treatment with non-target control RNA resulted in a slight decrease of RNA 
and protein-levels in hMDM1 and a high heterogeneity between donors was observed. In 
hMDM2, transfection with non-target siRNA showed no effect. Upon CD91 siRNA 
treatment, the amounts of CD91-specific mRNA were decreased by 80 ± 12 % in hMDM1 
and by 63 ± 12 % in hMDM2. This was confirmed by flow cytometry analysis which revealed 
decreased presence of the receptor on the cell surface by 87 ± 7 % on hMDM1 and by 
76 ± 5 % on hMDM2 as compared to untreated macrophages. The successful knockdown 
of CD91 allowed us to investigate the receptor’s role in internalization of apoptotic Lm. 
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Figure 22: Analysis of blocking or siRNA-mediated knockdown of CD91 on hMDMs. A hMDMs were 
incubated in the absence or presence of α-CD91 or an isotype control for 30 min. Excess antibody was 
removed by washing. Blocking of CD91 was assessed by staining of the cells with a fluorophore-conjugated 
α-CD91-PE antibody of the same clone after 90 min and 180 min. Histograms are exemplary for hMDM1 and 
are representative for one donor (n=2-5). B hMDMs were transfected with CD91-specific siRNA, a non-target 
control siRNA or were left untreated. Two days post-transfection, knockdown efficiency was determined on 
the RNA level by quantitative RT-PCR using CD91-specific primers (n=8-9). Presence of CD91 protein was 
assessed by flow cytometry by staining of surface CD91 with α-CD91-PE (n=5-6). Histograms are 
representative for one donor. Data are presented as mean ± SD from at least 3 independent experiments and 
were analyzed by paired t-test (B RNA) or Wilcoxon matched-pairs signed-rank test (B Protein) (* p < 0.05, 
**** p < 0.0001). Data were generated with the help of Mr. Marcel Seibert. 
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4.10 The influence of CD91 knockdown on infection with apoptotic Leishmania 
major promastigotes 
It is known that viable Lm are recognized and phagocytosed by a wide variety of receptors 
(Ueno and Wilson, 2012). Hence, to assess whether CD91 might also be involved in the 
interaction with viable parasites, CD91-knockdown cells were infected with viable Lm 
(Figure 23A). As controls served non-target siRNA-treated or untreated hMDMs. In 
hMDM1, we found that 75 ± 10 % of the cells interacted with viable Lm which was slightly 
decreased in knockdown macrophages (Figure 23B).  
 
Figure 23: Knockdown of CD91 does not alter Lm infection rates of hMDMs. A CD91-specific siRNA-
transfected hMDM1 and hMDM2 were co-incubated with purified apoptotic or viable Lm (MOI 10) for 3 h. 
Infection rates were determined by flow cytometry. hMDMs were gated by their FSC/SSC-properties. Prior to 
infection, viable and apoptotic Lm were labeled with CFSE or AF647-SE, respectively. Viable or apoptotic Lm-
infected cells were detected in Q1 or Q2. B Quantification of infection rates of untreated, non-target RNA- or 
CD91-specific siRNA transfected hMDMs co-incubated with either purified viable or apoptotic Lm. Data are 
presented as mean ± SD of 4-5 donors from at least 3 independent experiments. 
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With apoptotic Lm, infection rates were slightly lower and, similar to infection with viable 
Lm, downregulation of CD91 had no effect. As expected, in hMDM2 infection rates were 
higher than in hMDM1. Nevertheless, when untreated hMDM2 were compared to 
knockdown cells, no significant differences in rates of cells that interacted with viable or 
apoptotic Lm were found. Co-incubation of control siRNA-treated cells showed the same 
effect as CD91-specific siRNA treatment in both cell types. 
Taken together, our results suggest that CD91 is not involved in the phagocytosis of viable 
or apoptotic Lm by human monocyte-derived pro- and anti-inflammatory macrophages. 
Hence, in the course of the study we concentrated on CR3 which was also identified within 
isolated apoptotic Lm-containing phagosomal compartments and which is known to be 
involved in the uptake of viable Lm (Ueno and Wilson, 2012). 
 
4.11 Manipulation of CR3 on monocyte-derived antigen-presenting cells 
Since we did not observe an effect of CD91 downregulation on the infection rates of 
hMDMs we aimed on assessing the role of CR3 in phagocytosis of apoptotic Lm as, so far, 
CR3 has only been described to be of importance for the internalization of viable Lm 
(Mosser and Edelson, 1985; Rosenthal et al., 1996). We modulated the receptor by siRNA 
knockdown on hMDM1 and hMDM2 (Figure 24). Cells were transduced with siRNA that 
specifically targets mRNA that codes for the CR3 subunit CD11b/integrin αM, with non-
target siRNA or were left untreated. Downregulation of CD11b to 27 ± 19.5 % and 
14.7 ± 9.6 % of the untreated control in hMDM1 and hMDM2 was detected by qRT-PCR. A 
decreased surface expression of the receptor was confirmed by antibody staining and flow 
cytometry (27.3 ± 14.9 % in hMDM1, 47 ± 8.3 % in hMDM2). Similar to the knockdown of 
CD91, we detected a strong off-target effect in hMDM1 that were transfected with non-
target siRNA as indicated by a high heterogeneity between the donors. 
To assess a possible effect of siRNA transfection on the polarization of macrophages, 
surface expression of CD14, CD163, CD1a and CD209 were investigated (Figure 25). CD14 
was not altered between untreated and non-target siRNA- or CD11b siRNA-transfected 
hMDM1 and hMDM2. Higher expression of CD14 on the latter was in line with our previous 
results (Figure 19). 
  Results 
94 
 
 
Figure 24: Knockdown of CR3 by specific siRNA. hMDMs were transfected with CD11b-specific siRNA, a non-
target control siRNA or were left untreated. Two days post-transfection, knockdown efficiency was 
determined on the RNA level by quantitative RT-PCR using CD11b-specific primers (n=4). Presence of CD11b 
protein was assessed by flow cytometry and staining of surface CR3 with α-CD11b-PE (n=5). Histograms are 
representative for one donor. Data are presented as mean ± SD of 4 donors from at least 2 independent 
experiments and were analyzed by Wilcoxon matched-pairs signed-rank test. Data were generated with the 
help of Mr. Marcel Seibert and Mr. Naphang Ho. 
CD163, the marker for anti-inflammatory M2 phenotype was found to be highly expressed 
by hMDM2. Its presence on the surface was not altered upon siRNA treatment. 
Interestingly, the expression of the dendritic cell marker CD1a, also found to be present in 
low amounts on hMDM1, was increased by 2.7-fold upon transfection of this macrophage 
phenotype with siCD11b whereas transfection with the non-target siRNA did not affect its 
expression. Moreover, when hMDM2 were treated with non-target siRNA or CD11b-
specific siRNA, surface expression of the DC marker CD209 that was also detected on 
hMDM2 before, was reduced by 50 %.  
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Figure 25: Characterization of siCD11b-transfected human monocyte-derived macrophages. hMDM1 (blue) 
and hMDM2 (red) were generated from isolated monocytes by cultivation for 5-7 days in presence of GM-
CSF or M-CSF, respectively. Cells were transfected with siRNA and characterization was performed by 
antibody staining of the specific cell surface markers CD14, CD163, CD1a, and CD209 and subsequent analysis 
by flow cytometry. Data present the mean ± SD of 4 donors from 2 independent experiments. No statistical 
analysis was performed. Data was generated with the help of Mr. Naphang Ho. 
Since we found only small interference of RNA transfection on the polarization of hMDMs, 
we first determined infection rates of hMDM1 and hMDM2 that were co-incubated with 
viable or apoptotic Lm by fluorescence microscopy. Infected hMDMs were stained for actin 
with fluorophore-conjugated phalloidin and visualization of Lm was performed by staining 
with a Lm-specific antiserum (Figure 26). In hMDM1 we observed reduction of infection 
rates for both, viable and apoptotic Lm in siCD11b treated knockdown cells. Internalization 
of apoptotic Lm by knockdown hMDM1 as compared to untreated macrophages was 
strongly decreased (76.9 ± 4.2 % vs. 46.7 ± 17.3 %). Infection rates of hMDM1 that were 
treated with a non-target control siRNA were also found to be slightly reduced. In anti-
inflammatory hMDM2, no reduction of infection rates with viable Lm were observed 
whereas a decrease from 74.2 ± 12.7 % in untreated to 61.3 ± 5.2 % in knockdown hMDM2 
challenged with apoptotic Lm was found. 
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Figure 26: Knockdown of CD11b decreases infection rates of apoptotic Lm in hMDM1 and hMDM2. 
Untreated, non-target siRNA or CD11b-specific siRNA-transfected hMDM1 and hMDM2 were co-incubated 
with purified apoptotic or viable Lm (MOI 10) for 3 h. Cells were fixed and processed for immunofluorescence 
staining.  Infection rates were quantified manually by fluorescence microscopy on a Zeiss LSM 7 Live confocal 
microscope. Data are presented as mean ± SD of 4 donors from 2 independent experiments and were 
analyzed by unpaired Mann-Whitney U-test. Data were generated with the help from Mr. Naphang Ho. 
Nonetheless, we also checked the influence of an α-CD11b specific monoclonal antibody 
that had been used in other studies from our group and showed to efficiently inhibit the 
binding of viable Lm to primary human pro- and anti-inflammatory macrophages 
(PhD thesis S. Machado de Oliveira, 2016). As we defined flow cytometry to be the method 
of choice for determination of infection rates between monocyte-derived phagocytes and 
Lm, we employed this unbiased method in the following experiment. As controls served 
cells of the same subtype that were left untreated or that were co-incubated with an 
isotypic antibody. To check the efficiency and stability of receptor blocking, α-CD11b-
treated and control cells were incubated with a PE-conjugated α-CD11b-antibody of the 
same clone directly after CD11b treatment or 3 h later (Figure 27). Compared to controls, 
we detected a strong decrease in the mean fluorescence intensities (MFI) of 70 % for 
hMDM1 and hMDM2 when treated with functional α-CD11b directly after 30 min of 
incubation with the blocking antibody. The capacity to stain for CR3 at 3 h after α-CD11b 
treatment even decreased further indicating a very stable blocking of the receptor. The MFI 
of CR3 on hMDDCs was decreased by 50 %. This indicated partial blocking of CR3 on all 
three cell types which was pronounced on hMDMs.  
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Figure 27: Efficient blocking of Complement Receptor 3 with an α-CD11b antibody. hMDMs and hMDDCs 
were incubated with the α-CD11b antibody or an isotype control for 30 min. Blocking stability was assessed 
by staining of the cells with a phycoerythrin (PE)-conjugated α-CD11b antibody of the same clone (dashed 
line: PE-conjugated isotype control) and flow cytometry analysis directly and 180 min after co-incubation with 
the functional antibody. Data are presented as mean ± SD of 3-8 donors from at least 3 independent 
experiments. Histograms are representative for hMDM2 from one donor. Data were generated with the help 
of Mr. Marcel Seibert. 
 
4.12 Inhibition of CR3 significantly reduces interaction with apoptotic 
Leishmania major promastigotes 
To assess the role of the receptor for phagocytosis of apoptotic Lm, α-CD11b or isotypic 
antibody treated cells or untreated control cells were co-incubated with purified apoptotic 
Lm. As controls, purified viable Lm or an artificial 1:1 mixture of viable and apoptotic Lm, 
resembling a stat. ph. promastigote culture (stat. ph., Figure 7), were used. Cells were gated 
as shown in Figure 28. When α-CD11b-treated hMDM1 were infected with stat. ph. Lm, 
infection rates of cells with viable Lm (Q1) or only apoptotic Lm (Q2) were not altered as 
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compared to equally infected control cells (Figure 29A). Interestingly, a significant 
reduction in the number of hMDM1 that interacted with both, apoptotic and viable Lm, 
was found (27 ± 11 % vs. 20 ± 8 %). A proportion of 57 % of hMDM1 challenged with only 
viable Lm were infected and no reduction in infection rates was observed when cells were 
pre-treated with α-CD11b. Of note, a strong but no significant decline in infection rates 
from 51 ± 9 % to 43 ± 10 % was found in cells co-incubated with apoptotic Lm alone.  
 
Figure 28: Gating strategy to identify infection of hMDMs or hMDDCs with Lm. Infection of 
hMDMs/hMDDCs with Lm was determined by gating hMDMs and hMDDCs by their FSC/SSC-properties. 
Viable or apoptotic Lm-positive phagocytes were detected in Q1 or Q2, respectively. Double positive cells 
were detected in Q3. Micrographs exemplary show infected cells from Q1, Q2 and Q3. Prior to infection, 
viable and apoptotic Lm were labeled with CFSE or AF647-SE, respectively.  
Anti-inflammatory hMDM2 play a role in tissue homeostasis and apoptotic cell removal 
(Tomiotto-Pellissier et al., 2018). In line with this, in anti-inflammatory hMDM2 we found 
an enhanced interaction of macrophages with apoptotic Lm or with both, viable and 
apoptotic Lm, upon challenge with a stat. ph. Lm mixture, as compared to hMDM1 
(Figure 29B). The number of stat. ph. infected cells that interacted only with apoptotic Lm 
was significantly reduced from 31 ± 11 % to 22 ± 12 % in the presence of α-CD11b. As 
expected, in hMDM2 that were challenged with only apoptotic Lm, infection rates were 
higher by 22 % than in hMDM1. Moreover, co-incubation with pure apoptotic Lm in the 
presence of α-CD11b resulted in a significant decrease of infection rates (73 ± 4 % to 
64 ± 8 %).  
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Figure 29: Blocking of CR3 results in decreased interaction of apoptotic Lm with hMDMs. hMDM1 (blue), 
hMDM2 (red) or hMDDCs (grey) were left untreated or incubated with α-CD11b or an isotype control prior 
to co-incubation with either an artificial stat. ph. or purified viable or apoptotic Lm. Viable Lm were stained 
with CFSE, apoptotic Lm were stained with AF647-SE. Infection rates were determined by flow cytometry. 
Viable Lm infected cells were detected in Q1, apoptotic Lm positive cells in Q2 and cells that internalized 
viable and apoptotic Lm were detected in Q3. Data are presented as mean ± SD of a minimum of 8-14 donors 
from at least 6 independent experiments and was analyzed by paired t-test (* p < 0.05, ** p < 0.01). 
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In hMDDCs, we detected a significantly higher infection of the cells with viable parasites 
when cells were co-incubated with stat. ph. Lm in presence of α-CD11b (5 ± 4 % to 9 ± 6 %, 
Figure 29C). In hMDDCs infected with viable Lm alone, blocking of CR3 also significantly 
increased the interaction (25 ± 14 % vs. 33 ± 17 %). 
Taken together, the data point to a functional role of Complement Receptor 3 in the 
interaction of hMDMs with apoptotic Lm but not in hMDDCs. Based on the immune 
silencing properties of apoptotic cell uptake, we further hypothesized that the diminished 
interaction and hence a decreased phagocytosis of apoptotic Lm upon inhibition of CR3 
inhibits the production of anti-inflammatory cytokines. 
 
4.13 CR3 modulation prior to Leishmania major infection leads to alterations in 
TNF-α and IL-10 secretion 
We observed significant alterations in TNF-α release in hMDM2 and in IL-10 secretion by 
pro- and anti-inflammatory macrophages when we co-incubated these cells with apoptotic 
Lm (Figure 21). This raised the question whether the decreased interaction of primary 
monocyte-derived macrophages with apoptotic Lm and the connected lower 
internalization as shown by flow cytometry analysis upon CR3 receptor blocking affects the 
production of pro- and anti-inflammatory cytokines. To this end, hMDMs were 
differentially infected in the presence or absence of α-CD11b or the isotype control and 
secretion of TNF-α and IL-10 was analyzed by ELISA (Figure 30). Dendritic cells were not 
investigated since neither a significant reduction in interaction with apoptotic Lm nor 
significant alterations in cytokine production were observed in previous experiments in the 
present study (Figure 21 and Figure 29). 
When hMDM1 were treated with α-CD11b and infected with purified viable Lm, secretion 
of TNF-α was strongly reduced (324 ± 471 pg/mL) as compared to untreated control cells 
(581 ± 867 pg/mL) (Figure 30A). The same trend was observed for hMDM1 that were 
challenged with only apoptotic Lm (226 ± 230 pg/mL vs. 92 ± 117 pg/mL) or stat. ph. 
parasites (623 ± 764 pg/mL vs. 257 ± 326 pg/mL). In hMDM2, the production of TNF-α was 
diminished upon co-incubation of the cells with viable or stat. ph. Lm in presence of 
α-CD11b. Apoptotic Lm in general induced only a weak secretion of TNF-α in hMDM2 
(156 ± 191 pg/mL), which was not altered in presence of α-CD11b.  
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Figure 30: Blocking of CR3 results in strong reduction of TNF-α and IL-10 secretion by hMDMs. hMDM1, 
hMDM2 and hMDDC generated from CD14 MACS-purified monocytes were treated with α-CD11b or its 
corresponding isotype control for 30 min. Cells were differentially infected for 3 h and non-internalized 
parasites were removed. 24 h post-infection, supernatants were collected and analyzed for (A) TNF-α and (B) 
IL-10 by ELISA. Data are presented as mean ± SD from 3-7 donors of at least 3 independent experiments and 
were analyzed by paired Wilcoxon matched-pairs signed-rank test (* p < 0.05). Data were generated with the 
help of Mr Naphang Ho. 
IL-10 production by untreated hMDM1 that were co-incubated with viable or apoptotic Lm 
was generally weaker in this experiment (Figure 30B) as compared to the previously 
obtained data (Figure 21B). In presence of α-CD11b, we detected a reduced production of 
IL-10 in hMDM1 infected with viable Lm (590 ± 270 pg/mL) as compared to untreated 
hMDM1 (900 ± 400 pg/mL). Other than described before, higher amounts of IL-10 were 
secreted by hMDM2 as compared to hMDM1. Nonetheless, as expected, co-incubation of 
hMDM2 with apoptotic Lm alone (990 ± 690 pg/mL) or stat. ph. Lm (1660 ± 950 pg/mL) in 
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presence of α-CD11b led to a significant reduction of cytokine secretion to 660 ± 460 pg/mL 
(apoptotic Lm) and 1120 ± 1000 pg/mL (stat. ph. Lm), respectively. 
Taken together, blocking of CR3 had a significant effect on secretion of anti-inflammatory 
IL-10 in hMDM2 when challenged with pure apoptotic parasites or an infectious stat. ph. 
Lm mixture. This further indicated a connection between the diminished interaction with 
apoptotic Lm in presence of α-CD11b and the establishment of an anti-inflammatory milieu 
in vitro. Based on this we further evaluated the effect of CR3 blocking on the induction of 
LC3 conversion and hence the ability of CR3 to trigger LC3-associated phagocytosis of 
apoptotic Lm. 
 
4.14 Blocking of CR3 reduces the LC3 conversion in hMDM2 upon uptake of 
apoptotic Leishmania major promastigotes 
Blocking of CR3 significantly reduced the interaction of hMDM2 with apoptotic Lm and the 
production of anti-inflammatory IL-10 by hMDM2. In former studies from our group as well 
as in time-lapse microscopy experiments of differentially infected hMDMs (4.4), we 
observed that Lm can be internalized by LAP. Portions of both, viable and apoptotic 
promastigotes, resided within LC3+ phagosomes in which they are eventually degraded 
(Figure 11 and Figure 12). Interestingly, Gluschko et al. showed that engagement of CR3 by 
the food-borne bacterium Listeria monocytogenes on murine macrophages resulted in LAP 
induction which helped in resolution of infection (Gluschko et al., 2018). Hence, we wanted 
to examine whether blocking of CR3 also leads to a diminished induction of LC3 conversion 
during Leishmania major promastigote infection. In former studies we already excluded 
LC3 lipidation after Lm infection to be a result of canonical autophagy, hence determination 
of LC3 conversion by western blot correlates to induction of LC3-associated phagocytosis 
of Lm (PhD thesis R. Bohn, 2017; PhD thesis M. Thomas, 2015). In hMDM1, infection with 
viable or stat. ph. Lm resulted in slightly increased LC3-II to β-Actin ratios, indicating an 
enhanced conjugation of LC3 to phagosomal membranes (Figure 31A). In hMDM1 
challenged with apoptotic Lm alone, no LC3 conversion was detected compared to 
uninfected control cells. These data are in line with previous observations by live cell 
imaging in this study in which LC3 recruitment to Lm-containing phagosomes was almost 
exclusively observed in hMDM2. In accordance, LC3 conversion in infected hMDM2 was 
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overall higher as compared to hMDM1 and almost no differences were detectable between 
the infection conditions in untreated macrophages (viable Lm: 1.9-fold induction, apoptotic 
Lm: 2.2-fold induction, stat. ph. Lm: 2.1-fold induction) (Figure 31B). Upon treatment with 
α-CD11b, LC3 lipidation significantly declined in presence of apoptotic (1.3-fold induction) 
or stat. ph. Lm (1.3-fold induction) as compared to untreated controls. In CR3-modulated 
hMDM2 harboring viable Lm, we detected only weak changes in LC3 conversion. 
 
Figure 31: LC3-associated phagocytosis of apoptotic L. major promastigotes is reduced by inhibition of CR3 
in hMDM2. hMDMs were pre-incubated with either α-CD11b, its corresponding isotype control or were left 
untreated. Cells were co-incubated with viable, apoptotic or stat. ph. Lm (MOI 10) for 3 h. Lysates were 
analyzed by SDS-PAGE and immunoblotting for LC3 and β-Actin. LC3-II to β-Actin levels were determined by 
densitometry. Ratios were normalized to untreated control cells. Western blots are representative for one 
experiment. Data are presented as mean ± SD of a minimum of 5-14 donors of at least 2 independent 
experiments and was analyzed by unpaired Mann-Whitney U-test (* p < 0.05). 
 
Taken together our data reveal a significant reduction of LC3 conversion in hMDM2 upon 
treatment with α-CD11b in the presence of apoptotic Lm alone or a stat. ph. infectious Lm 
mixture. This indicates a possible role of CR3 in induction of LC3-associated phagocytosis 
of apoptotic L. major promastigotes. It was now of interest whether a decreased uptake of 
apoptotic Lm and hence, the reduced induction of IL-10 production and LC3 conversion had 
an effect on the activation of the adaptive immune system. 
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4.15 Decreased uptake of apoptotic Leishmania major promastigotes in presence of 
CR3 does not affect T cell proliferation 
Crauwels et al. showed that during infection, the presence of apoptotic Lm within a stat. 
ph. reduced the Lm-specific T cell proliferation (Crauwels et al., 2015). In the present study, 
we observed that TNF-α production was strongly decreased in presence of the CR3 
inhibiting antibody. In addition, release of the potent anti-inflammatory cytokine IL-10 was 
significantly downregulated by CR3 inhibition in stat. ph. Lm-infected hMDM2. Based on 
these findings, we hypothesized that modulation of CR3 inhibits uptake of apoptotic Lm 
and hence, secretion of IL-10 is decreased. This in turn could result in higher T cell 
proliferation stimulated by e.g. TNF-α. To investigate this, we infected hMDM1 and 
hMDM2 with stat. ph. Lm in presence of α-CD11b or an isotype control. Log. ph. parasites, 
comprised almost exclusively of viable Lm, served as positive control since they were found 
to induce a high T cell proliferation (Crauwels et al., 2015). 24 h post infection, CFSE-labeled 
autologous PBLs were added. Six days later, CD3-positive T cells were identified by antigen 
staining and their proliferation was assessed by determination of the CFSElow cells within 
the population using flow cytometry (Figure 32A). In the presence of log. ph. or stat. ph. 
Lm-infected hMDMs, lymphocytes clustered around the macrophages indicating close 
vicinity for receptor binding and PBL activation (Figure 32B). 
In hMDM1, as expected, log. ph. Lm induced a high T cell proliferation (47.1 ± 21.2 %) 
whereas in the presence of apoptotic Lm, proliferation was significantly reduced 
(33.6 ± 20.7 %) (Figure 33A). Other than anticipated, the blocking of CR3 did not lead to a 
decrease of CFSElow T cells (32.1 ± 22.8 %). In the presence of the isotype control, no 
interference with T cell proliferation was observed. Infection of hMDM2 with log. ph. Lm 
also resulted in proliferation of 34.6 ± 10.1 % of the T cell population. Equally to hMDM1, 
the T cell proliferation in presence of a stat. ph. Lm infected hMDM2 was significantly 
decreased to 21.3 ± 9.0 %. Treatment of hMDM2 with α-CD11b prior to infection showed 
no effect on T cell proliferation (20.5 ± 9.2 %). 
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Figure 32: Gating strategy for determination of proliferated T cells. A hMDMs were treated with α-CD11b 
or the isotype control for 30 min or were left untreated. Cells were infected with a log. ph. Lm or stat. ph. Lm 
(MOI 10) for 3h. At 24 h post-infection autologous, CFSE-labeled lymphocytes (PBLs) were added in a ratio of 
1:5. After 6 days of co-culture T cells were analyzed by flow cytometry. Cells were gated by their FSC/SSC-
properties and proliferation was assessed by determination of CFSElow-cells. B Micrographs exemplary show 
PBLs in co-culture with hMDMs infected with log. ph. or stat. ph. Lm after 6 days. Data were generated by 
Mrs. M. Boeck. 
It is notable that T cell proliferation in presence of log. ph. Lm- and stat. ph. Lm-infected 
hMDM2 was lower than in hMDM1. Co-incubation of both macrophage subtypes with the 
isotypic antibody or α-CD11b without subsequent infection did not result in T cell 
stimulation.  
 
Figure 33: T cell proliferation is unaltered in presence of α-CD11b. hMDMs were co-incubated with log. ph. 
or stat. ph. Lm (MOI 10) in presence or absence of α-CD11b or in presence of an isotype control. Proliferation 
was determined as described in Figure 32A. Data are presented as mean ± SD of 11 donors from at least 3 
independent experiments and were analyzed by paired t-test (*** p < 0.001). Data were generated by Miriam 
Boeck. 
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Contrary to our hypothesis, reduced phagocytosis of apoptotic Lm by blocking of CR3 and 
thus, a decrease in anti-inflammatory IL-10 production and LC3 conversion, did not alter 
the activation of an adaptive immune response.  
 
4.16 Blocking of CR3 and the effect on parasite survival 
Inhibition of CR3 did not influence T cell proliferation. Thus, we addressed the question 
whether uptake of apoptotic Lm via CR3 affects survival of viable Lm within the host 
macrophages. We hypothesized that during infection, apoptotic Lm support 
transformation of viable Lm into the amastigote stage and multiplication. Hence, 
diminished uptake of apoptotic Lm by CR3 blocking could lead to a decrease in parasite 
growth. 
To study this, hMDMs were infected with stat. ph. Lm, with or without pre-incubation with 
α-CD11b or the isotypic control, and differences in survival of the viable portion were 
assessed by limiting dilution assay 1 and 6 days post infection (dpi). One day post infection, 
we found more viable parasites per 1000 cells in CD11b-blocked hMDM1 (1270 ± 1320) as 
compared to untreated or isotype treated cells (960 ± 250 and 930 ± 1160) (Figure 34). As 
expected, in hMDM1, after 6 days of cultivation, the number of parasites declined in 
untreated control cells (422 ± 190) indicating parasite killing. An even higher decrease in 
viable Lm was found in hMDM1 that were treated with α-CD11b (120 ± 110) suggesting the 
decrease in apoptotic Lm uptake negatively affects survival of viable Lm. Of note, 
preincubation of the cells with the isotypic control resulted in the same decrease of 
parasites per 1000 hMDM1 (71 ± 46). In hMDM2, the initial parasite load 1 dpi was 
260 ± 240 parasites per 1000 untreated hMDM2. This was reduced in isotype-treated as 
well as in α-CD11b-treated macrophages (108 ± 49 and 106 ± 54 parasites per 1000 
hMDM2). After 6 days, the number of intracellular viable Lm was decreased to 171 ± 70 in 
untreated control cells. Compared to this, we observed a slight reduction of parasite 
numbers in hMDM2 that were pre-treated with α-CD11b (130 ± 105 parasites). Isotype 
treatment of hMDM2 also impacted survival of viable Lm in this subtype. 
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Figure 34: Survival of viable Lm is not altered upon inhibition of CR3. hMDM1 and hMDM2 were infected 
with stat. ph. Lm (MOI 10) for 3 h in the presence or absence of α-CD11b or the isotype control. 21 h post 
infection, 2x 103 hMDMs were serially diluted in quadruplicate wells (1.5-fold dilutions) in NNN-blood-agar 
plates and incubated for 7 days at 27°C (1 dpi). The serial dilution was repeated 6 days post infection (6 dpi). 
Parasite survival was determined by calculation from the last dilution that showed parasite growth and equals 
1.5exp (mean dilution with parasitic growth). Data are presented as mean ± SD from 3-6 donors from at least 
2 independent experiments and were analyzed by paired Wilcoxon matched-pairs signed-rank test. 
In summary, as expected, we found parasite killing in hMDM1 which was enhanced when 
cells were treated with α-CD11b. In hMDM2 survival of viable Lm was slightly diminished 
6 dpi upon CR3 blocking indicating no strong effect on the intracellular survival and 
multiplication of viable Lm. This suggests – at least in our setting - no particular role for 
apoptotic Lm internalization by CR3 in augmenting viable parasite survival. Notably, 
treatment of hMDMs with isotype control antibodies also influenced survival of the viable 
population. 
 
0
1000
2000
3000
untreated
isotype control
anti-CD11b
0
200
400
600
untreated
isotype control
anti-CD11b
6 dpi
0
1000
2000
3000
v
ia
b
le
L
m
/1
0
0
0
 h
M
D
M
1
0
200
400
600
v
ia
b
le
L
m
/1
0
0
0
 h
M
D
M
2
1 dpi
h
M
D
M
1
h
M
D
M
2
  Discussion 
108 
 
5. Discussion 
We hypothesized that viable and apoptotic Leishmania major promastigotes are 
internalized by primary human macrophages in a process termed LC3-associated 
phagocytosis. Viable parasites escape degradation and multiply within the phagosomal 
compartment whereas processing of apoptotic parasites results in an anti-inflammatory 
host cell response that supports survival of the viable Leishmania population. 
Using live cell imaging, we demonstrated that indeed portions of viable and apoptotic 
L. major promastigotes (Lm) are targeted by LC3-associated phagocytosis (LAP) in human 
monocyte-derived macrophages (hMDMs). Quantification of live cell imaging videos 
revealed a more rapid recruitment of LC3 to phagosomes that contained apoptotic Lm in 
hMDM2. Data suggested that apoptotic promastigotes are degraded in LAP-compartments 
but viable Lm resist degradation. We investigated the presence of openings from the 
phagosome to the extracellular space as possible evasion strategy for viable promastigotes 
by immunofluorescence staining of infected, non-permeabilized macrophages. 
Quantification indicated tunnel-structures to be present on a quarter of all viable Lm-
containing phagosomes. With the focus on cytokine production, we found that in addition 
to secretion of anti-inflammatory IL-10, and other than hypothesized, apoptotic Lm also 
induced production of pro-inflammatory cytokines in hMDMs and human monocyte-
derived dendritic cells (hMDDCs). Successful purification of apoptotic Lm-containing 
phagosomes and subsequent mass spectrometric analyses of their proteome revealed 
approximately 1000 leishmanial and 2000 human proteins within the compartments and 
identified the host phagocytic receptors CD91 and CR3 to be highly abundant. We did not 
find connections between CD91 and LAP of Lm since knockdown of the receptor showed 
no influence on the internalization of viable or apoptotic Lm by hMDMs. Modulation of CR3 
by siRNA knockdown or with a functional antibody was successful and decreased uptake of 
apoptotic Lm. Antibody blocking resulted in  downregulation of TNF-α and IL-10 production 
in both hMDM phenotypes and a reduced LC3 conversion upon co-incubation of hMDM2 
with apoptotic or stationary phase (stat. ph.) Lm. However, the reduced internalization of 
apoptotic Lm was not affecting Lm-specific T cell proliferation. After infection of hMDMs 
with stat. ph. Lm, intracellular survival of viable Lm was reduced when hMDM1 were 
treated with the inhibitory antibody. Survival was slightly reduced when uptake of 
apoptotic Lm was inhibited by antibody treatment of hMDM2. 
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Live cell imaging of Leishmania major promastigote infection 
Apoptotic promastigotes, present in the infectious Leishmania inoculum, are targeted by 
LC3-associated phagocytosis which results in downregulation of the adaptive immune 
response (Crauwels et al., 2015). From several investigations on infection with pathogenic 
bacteria, fungi and parasites, but also from studies addressing uptake of apoptotic cells, it 
was reported that LAP targets, at least temporally, only portions of internalized microbes 
or cells (reviewed in Schille et al., 2017). This is in line with our findings from live cell 
microscopy in which only few phagosomes that contained apoptotic Lm but also 
phagosomes that harbored viable Lm were detected to be LC3-positive. Disparities in LC3 
recruitment between the present study and previous data from our group, in which a 
majority of apoptotic Lm were found to be in compartments positive for LC3 (Crauwels et 
al., 2015), might be attributed to the different infection conditions, imaging techniques and 
sample preparations. In contrast to the analysis of LC3 compartments in Lm-infected 
macrophages at a fixed time point of 3 h post infection, we employed 3D live cell 
microscopy to image viable or apoptotic Lm uptake by transduced macrophages. It is 
eminent that LC3 recruitment occurs within less than 3 h after parasite internalization. 
Thus, live cell imaging is the superior method since the dimension of time can be taken in 
account providing a surplus of information as compared to fixed samples (Stephens and 
Allan, 2003). 
In hMDM2, LC3 was recruited significantly quicker towards apoptotic Lm-containing 
compartments than to compartments harboring viable Lm. Martinez et al. described that 
apoptotic SVEC epithelial cells are targeted by LC3 as early as 35 min post-internalization 
in murine macrophages in vitro and LAP resulted in rapid degradation of apoptotic SVEC 
cells within 2 h post LC3 recruitment. This is in line with the mean duration of 35 min for 
LC3 recruitment towards apoptotic Lm-containing phagosomes in hMDM2 observed in our 
study. For apoptotic Lm, degradation following LC3 recruitment was also enhanced as 
compared to degradation of apoptotic Lm within phagosomes that lack LC3. The fact that 
LC3 dissociated from phagosomes before the onset of degradation is confirmed by data by 
Romao et al. who investigated zymosan-containing LC3+ phagosomes in hMDMs (Romao et 
al., 2013). In contrast, Martinez and colleagues reported that LC3 has to be present on the 
phagosome to facilitate lysosomal fusion in murine macrophages (Martinez et al., 2011).  
These contradicting data show that it must be considered that there are strong differences 
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in LAP between the murine and the human system. In the murine system, LAP is more 
rapidly and LC3+ phagosomes are short-lived (Martinez et al., 2011; Sanjuan et al., 2007). 
In human macrophages, LC3 compartments were shown to persist for 4 h and more (Romao 
et al., 2013) which is in line with our observations. Romao et al. further propose LAP vesicles 
to be stabilized and serve the prolonged MHCII antigen presentation (Romao et al., 2013; 
Romao and Münz, 2014). In contrast, our data suggest a more rapid decoration of 
phagosomes with LC3 which mediates an accelerated fusion with lysosomes. To clarify this, 
a higher number of LC3+ phagosomes that contain apoptotic Lm should be analyzed 
regarding degradation of the cargo. For this, apoptotic Lm conjugated to pHrodo, a pH 
sensitive dye, could be used (Miksa et al., 2009). The fluorescence of this dye gradually 
increases with decreasing phagosomal pH, indicating fusion with lysosomes. This should be 
combined with automated particle tracking to evaluate the data in an unbiased manner. 
Hence, a more detailed analysis of apoptotic Lm uptake and degradation could be 
performed. 
We found viable Lm to resist degradation within LC3-positive compartments which is in 
concordance with previous studies showing that viable Lm escape LAP by the action of the 
Leishmania surface metalloprotease GP63 (Matte et al., 2016). This evasion could also be 
the reason for the small number of viable parasites in LC3+ compartments as detected by 
live cell imaging in the present study but does not explain the impaired degradation of 
viable Lm in phagosomes that were already LC3-decorated. Viable Lm are highly active and 
dynamic during uptake by macrophages. Forestier et al. described the flagellar movement 
of viable L. donovani promastigotes to serve the re-orientation within the cell. As a result, 
continuous oscillatory parasite movement leads to host cell membrane wounding 
(Forestier et al., 2011). This might explain the detection of a compartment harboring a 
viable Lm parasite which was connected to the extracellular space by a tunnel-like structure 
in former studies. In the present study, a first attempt to quantify such tunnel-like 
structures by immunofluorescence microscopy revealed their presence for a quarter of all 
viable Lm-harboring phagosomes early after infection. This further strengthens our 
assumption that tunnel-structures, connecting the phagosome with the extracellular space, 
could delay or impair acidification of the phagolysosome or serve the exclusion of 
hydrolytic enzymes that would otherwise facilitate parasite degradation. For a more 
detailed analysis of this, one could employ inducible expression of a fluorescent marker by 
  Discussion 
111 
 
viable Lm (Taheri et al., 2015). Expression could be induced by a low molecular weight 
compound that is not membrane permeable and exclusively internalized by viable 
promastigotes. If there was a connection from the outside of the cell to the phagosome, 
the compound could be internalized by the parasite and initiate transcription of the 
fluorescent protein-coding gene whereas absence of a tunnel-like structure would deny 
induction of fluorescent protein synthesis. Inducible recombinant production of proteins in 
non-pathogenic L. tarentolae is already in use (Niimi, 2012). Alternatively, a synthetic 
substrate for the leishmanial surface protease GP63 could be used which fluoresces upon 
cleavage (Bouvier et al., 1993). The respective reporter system should be combined with 
high resolution light microscopy techniques on live cells such as STED (Vicidomini et al., 
2018) or a correlative light and electron microscopy (CLEM) approach using live cell 
confocal imaging together with FIB-SEM or STEM to confirm openings from the phagosome 
to the outside of the cell on the ultrastructural level. 
We conclude that the mechanism of LAP is preferred for uptake of portions of viable and 
apoptotic Lm by anti-inflammatory hMDM2 which allows for rapid processing of the 
internalized apoptotic parasites. Our data emphasize that live cell imaging is the method of 
choice to quantify compartment formation during Lm infection since temporal information 
is included. Light microscopy confirmed tunnel structures within the infected host 
macrophage that might serve viable Lm survival but need to be investigated in detail by 
combination of reporter systems with more sophisticated microscopy methods in future 
studies.  
 
Cytokine secretion upon differential infection with Leishmania major promastigotes 
We confirmed the correct differentiation of in vitro-generated macrophages and dendritic 
cells by antigen staining which is in line with reports from literature (Biswas et al., 2012; 
Collin et al., 2013; Sloma et al., 2008; Tomiotto-Pellissier et al., 2018). We further 
categorized hMDMs and hMDDCs by their cytokine profiles upon Lm infection. Intriguingly, 
we found pro-inflammatory cytokine production upon stimulation with apoptotic Lm. This 
contradicts not only our hypothesis but also in vitro studies from Fadok and colleagues that 
showed that uptake of apoptotic cells inhibits production of IL-1β and IL-8 (Fadok et al., 
1998). However, in line with our findings, in a study from Kurosaka et al. it was reported 
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that the secretion of pro-inflammatory mediators is enhanced in macrophages that were 
co-incubated with apoptotic thymocytes (Kurosaka et al., 2001). Niessen and colleagues 
described apoptotic cell-derived microparticles in combination with IFN-α to induce 
inflammatory responses in human monocytes (Niessen et al., 2015). Of note, in our 
multiplex data set, IFN-α was found to be secreted by hMDM2 in response to apoptotic Lm. 
Induction of pro-inflammatory signaling upon apoptotic cell ingestion can also be caused 
by an inefficient degradation (Fadok et al., 2001) which in our study might be linked to a 
high burden of apoptotic Lm and impaired capability to degrade all internalized apoptotic 
promastigotes. This should be tested by co-incubation of macrophages with differing MOIs 
of Leishmania parasites followed by ELISA analysis of cell supernatants. 
We detected a high TNF-α release upon infection of macrophages with viable parasites 
which was increased in hMDM2, probably due to the more efficient uptake of Lm as 
compared to hMDM1. TNF-α is described to be reduced upon internalization of apoptotic 
cells (Michlewska et al., 2009). In line with this, TNF-α production upon stimulation of 
hMDM2 with apoptotic Lm was reduced. Data from Crauwels and Caldas indicated an 
increased production of IL-10 in presence of viable Lm in human macrophages. This was 
proposed to counteract an overwhelming pro-inflammatory response by TNF-α or IFN-γ 
but could not be confirmed by our experiments on characterization of myeloid cells (Caldas 
et al., 2005; Crauwels et al., 2015).  
An augmented IL-10 release after co-incubation of hMDMs with apoptotic or stat. ph. Lm 
confirms studies by van Zandbergen that showed the other major anti-inflammatory 
cytokine TGF-β to be secreted by phagocytes in response to purified apoptotic Lm 
(Zandbergen et al., 2006). Further supporting our observations, Freire-de-Lima and 
colleagues reported that upon investigations of Trypanosoma cruzi infection, that 
apoptotic parasites severely increased production of anti-inflammatory cytokines which 
supported viable parasite growth (Freire-de-Lima et al., 2000). Also, in vitro studies on Lm-
infected murine macrophages revealed that release of the potent anti-inflammatory IL-10 
upon internalization of apoptotic PMNs enabled parasite replication and suggests crucial 
roles for IL-10 in parasite survival by counteracting inflammation (Filardy et al., 2010).  
In our study, secretion of IL-1β, IL-6 and IL-8 by monocyte-derived myeloid cells occurred 
upon infection with pure viable but also upon co-incubation with apoptotic or stat. ph. Lm 
and independently of the infected monocyte-derived cell type. In vivo infection with viable 
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Lm induces the production of pro-inflammatory mediators such as IL-1β, IL-8, IL-6 and 
TNF-α (Maspi et al., 2016). In vitro, Crauwels et al. found an increased production of pro-
inflammatory IL-1β, IL-6 and TNF-α in log. ph. Lm-infected hMDM2 whereas production of 
these cytokines was decreased in presence of apoptotic Lm (Crauwels et al., 2015). 
Induction of pro-inflammatory cytokine secretion might serve the recruitment of more 
phagocytes which increases uptake of viable Lm from the infectious inoculum. This auto-
adjuvant function might allow more viable Lm to reside within host cells, transform into 
amastigotes and multiply. 
In conclusion, IL-10 which was secreted in higher amount upon uptake of apoptotic Lm 
might counteract an overwhelming inflammatory response. It is of interest whether the 
release of IL-10 is sufficient to facilitate a balance of the cytokine response. Therefore, 
more investigations on cytokine secretion (e.g. on the potent anti-inflammatory cytokine 
TGF-β) in response to differential infection are needed. We assume that a high pro-
inflammatory cytokine production by hMDMs and hMDDCs upon internalization of 
apoptotic Lm could serve the recruitment of more phagocytes to the site of infection, 
enhancing uptake of viable Lm.  Modulation of single cytokines by use of neutralizing 
antibodies could further decipher the impact of the single mediators and their role in 
human Leishmania infection. 
 
Phagosome isolation and mass spectrometry 
The isolation of pathogen-containing phagosomes for identification and characterization of 
molecules involved in cargo internalization has been used for decades (Berton et al., 1982; 
Zeichner, 1983). The method employed here was established by Steinhäuser et al. and 
allowed to enrich phagosomes from a relatively small number of murine macrophages as 
previously demonstrated for Listeria monocytogenes- and Mycobacteria-containing 
compartments (Steinhäuser et al., 2013). The phagosomal proteome was screened for host 
cell-derived proteins which provided a dataset of about 2000 targets of which we focused 
on the most abundant proteins, as discussed below. Unexpectedly, western blot analysis 
and MS also revealed presence of high amounts of mitochondrial proteins within the 
isolated compartments (data not shown, available on request). Enrichment of some of 
these mitochondrial proteins within the samples makes it unlikely to be a simple 
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contamination. Recent research suggests that mitochondria-derived vesicles (MDVs) 
transport mitochondrial ROS to phagosomes that contain Staphylococcus aureus. It was 
shown that this mechanism contributes to killing and degradation of the bacteria (Abuaita 
et al., 2018). Surprisingly, in our study, e.g. Cox4 and mitochondrial ATPases that were 
found to be highly abundant in the phagosomes, as identified by MS, are all located at the 
inner mitochondrial membrane which makes it unlikely that these proteins are part of 
MDVs. In a study from West et al. they found that engagement of TLRs leads to recruitment 
of mitochondria to phagosomes, thereby augmenting antimicrobial ROS production within 
the compartment (West et al., 2011). TLR2, which was present in our isolated phagosomes, 
could account for this observation in our study. Moreover, fusion of mitochondria with 
components of the endolysosomal system, independent from mitophagy, has been 
reported earlier which could also be a reason for co-isolation of parts of this organelle 
(McLelland et al., 2016). Investigating a possible connection of apoptotic Lm-containing 
phagosomes with mitochondria by microscopy could provide first insights in elucidating the 
presence of numerous mitochondrial proteins within samples of the isolated phagosomes. 
The LAP marker protein LC3 was detected almost exclusively in its PE-conjugated form 
(LC3-II) within the magnetic fraction after phagosome isolation, indicating isolation of LC3+ 
phagosomes. However, the proportion of LC3-decorated phagosomes within the total 
amount of isolated phagosomes remained unclear. The initial hypothesis of this study was 
based on the finding that a vast majority of all apoptotic Lm in hMDM2 reside within LC3+ 
phagosomes (Crauwels et al., 2015). Hence, we expected to almost exclusively isolate these 
LAP compartments. As observed by live cell microscopy, only a small proportion of 
phagosomes are decorated with LC3. To improve enrichment of only LC3+ compartments 
in future experiments, phagosomes could be labeled for LC3 with fluorophore-conjugated 
antibodies and separated from LC3- phagosomes by fluorescence-activated cell sorting. The 
drawback of this approach would be the very likely degradation of the compartments’ 
proteome since devices for cell sorting are usually not cooled. Also, in the non-magnetic 
fraction of our present isolation, we detected LC3-II which could be attributed to 
autophagosomes or an incomplete isolation of parasite-containing phagosomes. Possible 
co-isolation of autophagosomes should be excluded by verification of absence of the 
autophagy specific protein p62/sequestosome-1 in the magnetic fraction by western blot 
as it is known to be dispensable for phagocytosis and LAP of apoptotic Lm or Listeria 
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monocytogenes (Crauwels et al., 2015; Lam et al., 2013). Remarkably, no LC3 but the Atg3 
component of the LC3 lipidation machinery (Atg7-Atg3) was detected by MS. The absence 
of LC3 is very likely to be caused by MS-specific features, since LC3 was identified using a 
well-established and specific antibody in western blot analysis. It is known that lipidated 
proteins and peptides, like LC3-II, can be hard to ionize (ion suppression) which denies 
detection by MS (Tate et al., 2015). In addition, lipid-interacting proteins often resist 
complete proteolytic digestion prior to mass spectrometry, or the associated lipids make 
MS-analysis challenging (Hoofnagle and Heinecke, 2009). 
Concluding, the performed magnetic isolation technique allowed for specific enrichment 
of Lm-containing phagosomes from hMDM2. Moreover, MS analysis of the phagosomal 
proteome serves as powerful tool to determine candidates for characterization of 
phagocytic pathways and compartment maturation providing numerous targets for 
detailed investigation of phagosome biogenesis and maturation. An assumed connection 
between apoptotic Lm-containing phagosomes and mitochondria could be investigated by 
microscopical analyses of Lm-phagosomes in connection with e.g. the mitochondria-
specific fluorescent probe MitoTracker.  
 
Function of CD91 and CR3 in Leishmania major promastigote phagocytosis 
MS identified the phagocytic receptors CD91 and CR3 to be present in high amounts within 
isolated phagosomes. Both receptors are known for phagocytosis of apoptotic cells 
(Mevorach et al., 1998; Ogden et al., 2001). We detected CD91 exclusively on hMDMs 
contradicting observations that found CD91 to be highly present on monocyte-derived 
dendritic cells (Cappelletti et al., 2015). In contrast to the present study in which we 
determined expression of CD91 on immature hMDDCs, Cappelletti et al. examined 
activated, mature monocyte-derived dendritic cells. Stat. ph. Lm-infected hMDDCs lack LAP 
(PhD thesis P. Crauwels, 2015), thus, we hypothesized that this receptor might trigger LAP 
of apoptotic Lm in hMDMs.  
Binding of an α-CD91 antibody for blocking of the receptor seemed to be a transient event 
which could be the result of a high turnover of the receptor. The amount of LRP4, a 
structurally closely related receptor of the same family, was shown to be decreased by 
more than 50 % after 3 h of incubation in a pulse-chase experiment (Melman et al., 2002). 
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In the present study, downregulation of CD91 synthesis in hMDMs by specific siRNA was 
efficient but did not affect the internalization of viable or apoptotic Lm. It is known that 
CD91 also serves as a main regulator of inflammation in macrophages (Gaultier et al., 2008). 
CD91 signaling inhibits NF-κB activation and includes downregulation of the TNF receptor 
on the cell surface of macrophages, prohibiting autocrine TNF-α signaling (Gaultier et al., 
2008). In CD91-deficient macrophages, the response to the inflammatory agent LPS is 
enhanced as compared to CD91 positive cells (Mantuano et al., 2016). In addition, CD91 
affects murine macrophage polarization by promoting the anti-inflammatory phenotype, 
giving further hints for a functional role of the receptor in establishment of an anti-
inflammatory microenvironment (May et al., 2013). These reports suggest a negative 
regulation of inflammatory mediators by CD91 signaling which could serve the 
establishment of the anti-inflammatory response elicited by engagement by apoptotic 
cells. To proof this hypothesis, supernatants of CD91 knockdown cells and untreated 
hMDMs should be analyzed regarding possible alterations in the secretion of pro-
inflammatory cytokines such as TNF-α upon co-incubation with apoptotic Lm.  
For decades, CR3 is known to mediate phagocytosis of viable Lm (Mosser and Edelson, 
1985) and is described as receptor for apoptotic cells (Mevorach et al., 1998; Skoberne et 
al., 2006). To date, all studies addressing the role of CR3 in phagocytosis of Leishmania by 
macrophages use purified metacyclic parasites from liquid cultures and neglect the 
presence of apoptotic promastigotes within the infectious inoculum in the natural route of 
infection (Polando et al., 2013; Rosenthal et al., 1996; Ueno et al., 2009). However, it was 
recently shown that in PMNs infection with viable Lm increases the expression of CR3. This 
in turn leads to an enhanced uptake of apoptotic PMNs and thus higher viable Lm survival 
showing the relevance of apoptotic cell uptake by CR3 for Lm infection (Salei et al., 2017). 
Mevorach et al. reported that uptake of apoptotic thymocytes or PMNs by human 
macrophages is decreased by ~60 % when CR3 was blocked with a functional antibody 
(Mevorach et al., 1998). Further, phagocytosis of apoptotic Jurkat cells opsonized with iC3b 
was strongly decreased in presence of a functional blocking antibody (Takizawa et al., 
1996). In line with this, blocking of CR3 with an antibody significantly inhibited 
internalization of apoptotic Lm by hMDMs in the present study. In contrast to earlier 
investigations (Beller et al., 1982; Cooper et al., 1988; Mosser and Edelson, 1985), 
phagocytosis of viable Lm was not inhibited by CR3 blocking in our experiments. Only when 
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CR3 was knocked down by siRNA treatment, an effect on viable Lm internalization could be 
observed. Previous studies employed a different clone of the functional monoclonal CR3 
specific antibody and focused on murine macrophages which could be causative for the 
varying results. As reported by Wilson and Pearson, the α-CD11b clone used in the present 
study was not as effective in inhibition of viable L. donovani promastigote-attachment to 
hMDMs which could account for the poor or non-detectable inhibition of interaction of 
viable Lm  (Wilson and Pearson, 1988). 
The low but significant differences in interaction of hMDMs with apoptotic Lm upon CR3 
blocking could be explained by availability of several receptors on the macrophage surface 
facilitating internalization of the apoptotic parasites, similar to viable Lm (Ueno and Wilson, 
2012). This is in line with our MS screen of phagosomes which revealed presence of 
multiple receptors known to be involved in phagocytosis (data not shown). Further, 
treatment of macrophages and dendritic cells with α-CD11b did not block all CD11b 
receptor subunits on the surface of the cells. Since, we do not know how few un-blocked 
receptors might be sufficient to facilitate binding and entry of a Lm parasite, the incomplete 
blocking of CR3 might explain the low but clear inhibition of apoptotic Lm uptake. In 
addition to the infection rates that display the percentage of infected cells, also the parasite 
load per cell should be determined microscopically which would allow to assess possible 
differences in the number of internalized viable and apoptotic Lm.  
In this study, hMDDCs internalized viable as well as apoptotic Lm but to a lower extend 
than hMDMs. CR3 blocking on DCs resulted in significantly higher uptake of viable Lm, 
indicating elevated susceptibility. This might be explained by an increased usage of other 
receptors upon CR3 blocking as reported from studies on murine DCs and macrophages 
(Schönlau et al., 2000; von Stebut and Tenzer, 2018). In addition, blocking with a 
monoclonal antibody could stimulate DCs, activate them and result in an even higher 
phagocytosis. Further, in Leishmania infection, monocyte-derived DCs preferably 
internalize the amastigote life stage and mainly serve the antigen presentation at the 
inflammatory site explaining low infection rates (Feijó et al., 2016; Woelbing et al., 2006). 
Nonetheless, DCs are a crucial player in Leishmania promastigote infection since they are 
the major antigen-presenting cells and effective mediators for the activation of the 
adaptive immune system (von Stebut and Tenzer, 2018). 
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In sum, we found CD91 not to contribute to uptake of viable or apoptotic Lm but literature 
suggests that it could play a role in anti-inflammatory signaling in macrophages on which 
should be aimed at in future studies. Our data, for the first time, provide evidence that CR3 
is involved in the internalization of apoptotic Lm. For viable Lm, inaccessibility of CR3 due 
to antibody blocking might be compensated by usage of other receptors by allowing for 
unimpeded entry into the cell.  Our data indicate, as known for viable Lm, that not only a 
single receptor is responsible for internalization of the apoptotic parasites. Other receptors 
found in the MS screen should be investigated by modulation analogous to CD91 and CR3. 
 
CR3 blocking and the effect on cytokine secretion 
The high secretion of TNF-α by macrophages in presence of viable Lm was strongly 
decreased in α-CD11b treated cells. This indicates a functional role of CR3 in the induction 
of TNF-α signaling as reported by Huang et al. who found CR3 depletion resulting in 
decreases in TNF-α upon infection with Histoplasma capsulatum (Huang et al., 2015). 
Moreover, our observations in the present study are in agreement with results from 
Crauwels et al. who detected a diminished TNF-α production in hMDM2 infected with stat. 
ph. Lm as compared to infection with viable, log. ph. Lm. Our data also show that in hMDM2 
apoptotic Lm downregulate TNF-α production and are in line with the report from Voll et 
al. in which apoptotic PBLs inhibit LPS-induced TNF-α release (Voll et al., 1997). 
Interestingly, when we treated hMDM2 with the CR3-specific functional antibody, IL-10 
production in presence of purified viable or apoptotic Lm or stat. ph. promastigotes was 
drastically reduced. This indicates a role for CR3-mediated phagocytosis in modulation of 
the anti-inflammatory cytokine response towards Leishmania infection and is supported by 
the fact, that CR3 facilitates silent entry of cargo into the macrophage first described by the 
group of David Sacks (Da Silva et al., 1989). Murine macrophages deficient for Atg7, which 
is part of the LC3 conjugation machinery in LAP, also showed reduced IL-10 production in 
presence of apoptotic cells which was accompanied by an increase in pro-inflammatory 
IL-1β and IL-6 (Martinez et al., 2011). This, in regard of the decreased IL-10 production in 
presence of α-CD11b, points to a possible role of CR3 in LAP induction serving the rapid 
degradation of apoptotic Lm as described above. 
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It should be mentioned that our study gives contradicting results for release of TNF-α and 
IL-10 in untreated but differentially infected hMDMs. Higher TNF-α secretion induced by 
viable Lm, as detected in the latter experiments regarding cytokine production in 
connection with CR3 inhibition is in line with literature (Afonso et al., 2008; Crauwels et al., 
2015). It is in so far unexpected, that the parasite and cell preparations as well as conditions 
of infection were the same throughout the study. It might be speculated that infection rates 
were different or that the strong heterogeneity between the donors tested is connected to 
different outcomes of TNF-α and IL-10 secretion. Blood donations for monocyte isolation 
come from healthy but anonymous donors with an unknown disease-history and lifestyle 
which surely could affect experimental results (ter Horst et al., 2016). Of note, in CR3 
blocking-experiments, TNF-α secretion seems to depend on IL-10 secretion and vice versa 
in both macrophage subtypes. This further strengthens the proposed mechanism of 
counteraction of an overwhelming inflammation by IL-10 (Crauwels et al., 2015). 
In conclusion, despite contradicting data on cytokine production, data infers that the viable 
Lm-induced TNF-α production in hMDM1 can be modulated by CR3 inhibition. Significant 
reduction in IL-10 secretion upon CR3 blocking in apoptotic Lm-challenged hMDM2 further 
strengthens the evidence for the anti-inflammatory character of CR3 which suggests an 
immune regulating role in Lm infection.  
 
CR3 and LAP induction 
In accordance with our findings from live cell imaging experiments, LC3 lipidation was 
elevated in hMDM2 and occurred equally often upon infection with viable, apoptotic or 
stat. ph. Lm. Gluschko et al. recently found CR3 to induce LAP in mice that are infected with 
Listeria monocytogenes (Gluschko et al., 2018). Concordantly, here we showed that 
inhibition of CR3 clearly reduced LC3 lipidation and hence LAP of apoptotic Lm. This could 
implicate either that the reduced uptake of apoptotic Lm also decreases the proportion of 
LC3 targeted phagosomes or that CR3 is responsible for induction of LAP. The latter is 
supported by the fact, that LC3 conversion is almost reduced to the level of non-infected 
hMDM2 upon challenge with apoptotic or stat. ph. Lm. In contrast, the weak detected 
residual LC3 conversion after CR3 blocking and infection could implicate that a co-receptor 
is involved in induction of LAP. Several receptors are described to trigger LAP e.g. TLR2, 
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Fc receptors, Dectin-1 or Tim-4 (Huang et al., 2009; Kyrmizi et al., 2013; Martinez et al., 
2011; Sanjuan et al., 2007). TLR2 was identified in our MS screen (data not shown) and it 
could be assumed that TLR2 and CR3 might function in a cooperative manner. TLR2 
interacts with surface LPG of Lm. To assess a functional role of TLR2 in LAP of apoptotic Lm 
and the possible engagement of LPG, the presence of LPG on the surface needs to be 
verified. 
In line with the claim that CR3 induces LAP is a report from Li et al. who found CR3 to trigger 
phagocyte ROS production, crucial for LC3 recruitment, downstream of Shp2 and Erk 
signaling (Li et al., 2015). For a more detailed elucidation of CR3-mediated LAP, recruitment 
of other factors that are important for LAP such as the NADPH oxidase (and subsequent 
ROS generation) and Rubicon should be quantified by immunofluorescence (IF) with or 
without modulation of CR3 (Martinez et al., 2015).  Western blot analyses as performed in 
the present study should be employed in addition to fluorescence microscopy using either 
antibody staining or transduction of hMDMs with lentiviral particles, that code for the 
respective fluorescence-coupled protein to be analyzed, for elucidation of the LAP pathway 
during apoptotic Lm uptake as suggested by Klionsky et al. (Klionsky et al., 2016). 
In conclusion, with the present study we provide first evidence for CR3-mediated LC3-
associated phagocytosis in Leishmania pathogenesis. CR3 extends the list of receptors that 
induce LAP in infection scenarios and should be analyzed in more detail by means of 
quantification of differences in recruitment of LAP hallmarks such as Rubicon and the 
NADPH oxidase towards phagosomes by microscopy and modulation of the intracellular 
signaling cascades of CR3. 
 
The effect of CR3 blocking on T cell proliferation and Leishmania major survival 
T cell proliferation upon infection of hMDMs with log. ph. Lm or stat. ph. Lm is in line with 
our previous report in which Crauwels et al. showed that in vitro infection of hMDM2 with 
stat. ph. Lm partly inhibited Lm-specific T-cell proliferation as compared to infection with 
log. ph. Lm (Crauwels et al., 2015). The capacity to stimulate T cells is more pronounced in 
hMDM1 than in hMDM2 which is in concordance with higher MHCII expression and pro-
inflammatory cytokine production in this cell type (Mills and Ley, 2014). Upon blocking of 
CR3 and the resulting decrease in apoptotic Lm uptake, we expected T cell proliferation to 
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be increased as compared to infection of untreated macrophages which we did not detect 
in our T cell proliferation assay. As reported by Chandra et al., human macrophages 
infected with stat. ph. L. donovani promastigotes can induce a shift from TLR2 triggered TH1 
responses to TH2 responses (Chandra and Naik, 2008). Further, L. major-specific TH1 cells 
could be polarized to TH2 T cells by stimulation with the anti-inflammatory IL-4 in vitro 
(Mocci and Coffman, 1997). A possible shift from TH2 to TH1 should be investigated by 
characterization of the CD3+ population that were co-incubated with infected CR3 
antibody-blocked or non-blocked hMDMs. To do so, intracellular staining for STAT4/T-bet 
(TH1 specific transcription factors) and STAT6/GATA3 (TH2 specific transcription factors) 
could be performed (Levine et al., 2017).  
When we investigated the effect of reduced apoptotic Lm internalization upon CR3 
blocking on survival of the viable population within macrophages, we expected that a 
decreased uptake of apoptotic Lm from the stat. ph. inoculum diminishes survival of viable 
Lm. Lm-infected macrophages are able to not only activate T cells but also to modulate 
inflammation in a paracrine fashion by activating neighboring macrophages. In limiting 
dilution assays viable promastigotes showed an enhanced survival in hMDM2 on day 6 
post-infection as compared to hMDM1 which is in line with the lower microbicidal and 
inflammatory activity of the M2 subtype (Atri et al., 2018; Tomiotto-Pellissier et al., 2018). 
Interestingly, blocking of CR3 even decreased parasite survival within hMDM1 but the 
isotype control antibody had the same effect. Treatment of cells with isotype antibodies 
might stimulate Fc receptors which can negatively regulate intracellular growth of viable 
promastigotes by induction of pro-inflammatory signaling (Newton and Dixit, 2012). 
Leishmania survival in anti-inflammatory macrophages and upon CR3 inhibition tended to 
decrease which is in line with the previous observations from this study of reduced uptake 
and IL-10 release upon CR3 blocking. Nonetheless, the limiting dilution assay might not be 
sensitive enough to detect the expected effects of CR3 modulation. PCR-based methods 
are more specific and reliable but make it hard to differentiate between amastigotes and 
promastigotes by the lack of an equally expressed housekeeping gene across the life stages 
(Ouakad et al., 2007). In addition, presence of apoptotic Lm-derived nucleic acids might 
bias the results. A way to determine viable parasite loads within cells would be manual 
counting of parasite nuclei of Diff-Quick stained samples. This could be extended by 
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immunofluorescence staining of generated cytospins and automated, computer-aided 
counting. 
Concluding, activation of the adaptive immune system was not found to be altered by a 
decreased internalization of apoptotic Lm upon inhibition of CR3.  Future experiments 
should examine TH1/TH2 polarization with focus on manipulation of CR3 but also other 
receptors e.g. CD91. The same accounts for the assessment of survival of viable L. major 
promastigotes, especially to circumvent antibody-induced stimulations whereas here, a 
more sensitive and reliable method of read-out could be found in PCR applications. Hence, 
one could verify the observed results that indicate enhanced killing of L. major 
promastigotes in pro-inflammatory macrophages when uptake of the apoptotic Lm fraction 
is impaired. 
 
6. Concluding remarks 
With the present study we confirmed LC3-associated phagocytosis to be responsible for 
internalization of a portion of viable and apoptotic Lm by hMDM2. The latter are targeted 
more rapid by LC3 resulting in efficient degradation. Leishmania infection is a highly 
dynamic process and it is obvious that analysis of infection by live cell microscopy is 
superior to investigations of fixed samples. Viable parasites might resist degradation by 
establishment of tunnel-like structures suggesting an unknown evasion strategy of viable 
Leishmania major promastigotes. Characterization of phagocytes confirmed our hypothesis 
that apoptotic Lm induce an anti-inflammatory cytokine response in hMDMs possibly 
serving to balance action of pro-inflammatory mediators.  Identification of CR3 and CD91 
in isolated phagosomes that contained apoptotic Lm by mass spectrometry and 
subsequent functional characterization in a human infection model for the first time 
revealed an important role for CR3 in internalization of apoptotic Lm. In contrast, CD91 was 
neither involved in phagocytosis of viable nor apoptotic Lm but may serve the control of 
the inflammatory microenvironment upon apoptotic Lm internalization which we suggest 
to be investigated in future studies. The reduced uptake of apoptotic Lm by inhibition of 
CR3 downregulated the anti-inflammatory cytokine response in subsequent infection in 
hMDM2 further emphasizing CR3 to be of importance in establishment of leishmaniasis in 
humans. Moreover, CR3 is a trigger for LC3-associated phagocytosis of apoptotic L. major 
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promastigotes in human monocyte-derived anti-inflammatory macrophages. Induction of 
LAP and the inhibitory effects of CR3 modulation on apoptotic parasite uptake and cytokine 
production were more pronounced in hMDM2. Data suggest hMDM2 to be the preferred 
target cell for Leishmania promastigotes and indicates a major role for CR3 on anti-
inflammatory macrophages in initial Leishmania infection. 
Future research will focus on in-detail microscopical elucidation of LAP of apoptotic Lm in 
hMDM2. It will further aim on (1) the role of CD91 in inflammation during Leishmania 
infection and (2) investigations on other factors that are involved in apoptotic Lm-
processing found by our mass spectrometry screen. Ultrastructural analyses will determine 
the role of tunnel structures in evasion of degradation by viable promastigotes and might 
define a possible target for therapeutic intervention to treat leishmaniasis. 
 
 
Figure 35: Conclusion. Portions of viable and apoptotic Lm are internalized by LAP which is more pronounced 
in hMDM2. Live cell imaging confirms that viable Lm are able to resist degradation possibly facilitated by 
tunnel-structures found on a quarter of viable Lm-containing phagosomes. Uptake of apoptotic Lm resulted 
in decreased production of TNF-α and upregulation of IL-10 in hMDM2 whereas viable Lm increased TNF-α 
and IL-10 production. CD91 and CR3 are highly abundant in phagosomes harboring apoptotic parasites. CD91 
is not involved in Leishmania internalization but might serve the control of the inflammatory environment 
during infection. CR3 blocking inhibits uptake of apoptotic promastigotes and reduces secretion of TNF-α and 
IL-10. LC3 conversion is inhibited by blocking of CR3 which indicates LAP of apoptotic Lm to be triggered by 
CR3. Further hallmarks of LAP such as the NADPH oxidase or Rubicon should be investigated in following 
studies. 
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7. Appendix 
 
Appendix A: Cytokine profiles of hMDMs and hMDDCs upon infection with purified viable or apoptotic Lm.  
Cells were co-incubated with either purified viable or apoptotic Lm or left untreated. Cytokine concentrations 
were determined by flow cytometry using a LEGENDplexTM Multi-analyte Flow Assay Kit (Biolegend) according 
to the manufacturer’s instructions (n=1; n.d.: not detectable). Data were generated with the help of Mr 
Naphang Ho. 
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